data_2lle_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lle _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.247 0.546 . . . . 2.21 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 1.02 110.07 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 1.04 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 1.05 110.213 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 1.0900000000000001 109.763 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56000000000000005 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 1.1499999999999999 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 1.0900000000000001 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 2.2999999999999998 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.33000000000000002 111.32 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 3.52 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.8500000000000001 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 1.01 111.299 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 1.0900000000000001 110.289 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.9100000000000001 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.45000000000000001 111.467 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 2.3999999999999999 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 1.0700000000000001 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 2.1600000000000001 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.17000000000000001 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.4399999999999999 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 1.03 109.903 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 1.03 110.032 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 1.1100000000000001 111.03 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.70999999999999996 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 1.0700000000000001 112.654 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 1.0800000000000001 112.438 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 2.4500000000000002 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.78000000000000003 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.8899999999999999 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 3.02 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.9099999999999999 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.26000000000000001 112.12 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 1.0600000000000001 110.609 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6000000000000001 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.992 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 1.0700000000000001 110.406 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 2.3300000000000001 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 1.0600000000000001 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.97999999999999998 111.531 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 3.4500000000000002 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 1.1299999999999999 110.056 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67000000000000004 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.20999999999999999 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.9099999999999999 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 1.03 110.689 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.8599999999999999 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 1.04 110.038 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 1.04 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 1.01 110.225 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.92000000000000004 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.88 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 110.141 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.8999999999999999 111.836 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.40999999999999998 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.1099999999999999 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.6400000000000001 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0800000000000001 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 2.2400000000000002 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 1.03 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 1.05 110.87 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.2200000000000002 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.227 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 1.0700000000000001 110.101 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 3.04 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 1.04 112.733 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.17999999999999999 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 1.03 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.7799999999999998 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.25 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.84999999999999998 110.518 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 1.23 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 1.0700000000000001 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.53000000000000003 110.894 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 1.0600000000000001 111.008 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 1.05 110.694 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 1.04 111.574 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 1.04 110.492 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68000000000000005 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 1.1599999999999999 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14999999999999999 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.5900000000000001 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 1.03 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 1.04 109.321 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 1.04 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 3.1600000000000001 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 1.0600000000000001 111.235 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 1.03 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 2.4500000000000002 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 1.1000000000000001 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.31 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.17000000000000001 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 1.3700000000000001 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.97 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 1.1399999999999999 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 1.0800000000000001 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.95999999999999996 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 1.01 109.041 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 1.02 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 1.02 110.007 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65000000000000002 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 1.01 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 1.3899999999999999 109.377 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 1.54 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 1.1000000000000001 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.23000000000000001 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.16 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 1.0800000000000001 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 1.03 110.83 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.19 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 1.04 109.79 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.87 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.6200000000000001 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17000000000000001 113.247 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.5899999999999999 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 2.4300000000000002 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.19 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 1.01 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17999999999999999 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 1.04 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 1.05 110.256 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 1.04 110.989 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 2.5 110.899 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.17000000000000001 110.708 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 1.03 110.634 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 1.02 110.314 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.6899999999999999 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 1.0900000000000001 110.834 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.9700000000000002 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 1.3 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.14000000000000001 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 1.0 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.14999999999999999 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.3500000000000001 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 1.01 109.671 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 1.03 109.272 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 1.02 109.692 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 1.05 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 1.0700000000000001 109.931 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.6600000000000001 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76000000000000001 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 1.0800000000000001 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.8999999999999999 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.70999999999999996 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.23999999999999999 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.75 109.806 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27000000000000002 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 1.0 112.293 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.1899999999999999 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.095 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 1.04 110.336 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.7400000000000002 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.45000000000000001 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 1.04 110.973 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.16 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.20000000000000001 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 1.0800000000000001 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 1.03 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 1.1399999999999999 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 1.0700000000000001 110.556 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.14000000000000001 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 1.03 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 1.0600000000000001 109.227 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 1.05 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.78000000000000003 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14999999999999999 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.19 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 1.0600000000000001 111.31 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.22 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.7999999999999998 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 1.3899999999999999 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.2999999999999998 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.17999999999999999 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 1.05 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.6699999999999999 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 1.05 111.497 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.20999999999999999 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 1.0600000000000001 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 1.02 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.96999999999999997 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17000000000000001 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 1.03 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 1.04 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 1.04 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.97999999999999998 110.163 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 1.1000000000000001 110.994 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.6899999999999999 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 1.03 112.575 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27000000000000002 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 2.1099999999999999 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.68000000000000005 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.7599999999999998 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.31 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.71 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.2799999999999998 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 1.0700000000000001 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.8600000000000001 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.89000000000000001 110.81 179.661 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.25 0.548 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.268 0.556 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.532 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.261 0.553 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.257 0.551 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.205 0.526 . . . . 0.0 111.615 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 121.279 0.561 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.274 0.559 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.169 0.509 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.237 0.402 0 CA-C-O 121.248 0.547 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.415 0.626 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.27 0.557 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.556 -0.535 . . . . 2.6200000000000001 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.09 19.91 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.332 -0.705 . . . . 0.48999999999999999 112.867 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -109.98 135.74 50.35 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 118.253 1.026 . . . . 2.21 111.455 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 1.0600000000000001 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 1.02 110.07 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 1.04 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 1.05 110.213 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 1.0900000000000001 109.763 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56000000000000005 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 1.1499999999999999 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 1.0900000000000001 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 2.2999999999999998 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.33000000000000002 111.32 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 3.52 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.8500000000000001 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 1.01 111.299 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 1.0900000000000001 110.289 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.9100000000000001 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.45000000000000001 111.467 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 2.3999999999999999 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 1.0700000000000001 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 2.1600000000000001 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.17000000000000001 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.4399999999999999 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 1.03 109.903 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 1.03 110.032 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 1.1100000000000001 111.03 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.70999999999999996 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 1.0700000000000001 112.654 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 1.0800000000000001 112.438 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 2.4500000000000002 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.78000000000000003 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.8899999999999999 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 3.02 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.9099999999999999 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.26000000000000001 112.12 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 1.0600000000000001 110.609 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6000000000000001 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.992 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 1.0700000000000001 110.406 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 2.3300000000000001 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 1.0600000000000001 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.97999999999999998 111.531 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 3.4500000000000002 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 1.1299999999999999 110.056 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67000000000000004 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.20999999999999999 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.9099999999999999 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 1.03 110.689 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.8599999999999999 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 1.04 110.038 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 1.04 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 1.01 110.225 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.92000000000000004 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.88 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 1.1100000000000001 110.141 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.8999999999999999 111.836 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.40999999999999998 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.1099999999999999 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.6400000000000001 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 1.0800000000000001 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 2.2400000000000002 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 1.03 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 1.05 110.87 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.2200000000000002 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.227 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 1.0700000000000001 110.101 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 3.04 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 1.04 112.733 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.17999999999999999 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 1.03 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.7799999999999998 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.25 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.84999999999999998 110.518 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 1.23 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 1.0700000000000001 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.53000000000000003 110.894 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 1.0600000000000001 111.008 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 1.05 110.694 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 1.04 111.574 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 1.04 110.492 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68000000000000005 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 1.1599999999999999 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14999999999999999 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.5900000000000001 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 1.03 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 1.04 109.321 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 1.04 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 3.1600000000000001 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 1.0600000000000001 111.235 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 1.03 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 2.4500000000000002 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 1.1000000000000001 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.31 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.17000000000000001 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 1.3700000000000001 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.97 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 1.1399999999999999 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 1.0800000000000001 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.95999999999999996 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 1.01 109.041 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 1.02 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 1.02 110.007 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65000000000000002 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 1.01 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 1.3899999999999999 109.377 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 1.54 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 1.1000000000000001 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.23000000000000001 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.16 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 1.0800000000000001 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 1.03 110.83 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.19 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 1.04 109.79 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.87 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.6200000000000001 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17000000000000001 113.247 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.5899999999999999 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 2.4300000000000002 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.19 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 1.01 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17999999999999999 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 1.04 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 1.05 110.256 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 1.04 110.989 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 2.5 110.899 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.17000000000000001 110.708 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 1.03 110.634 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 1.02 110.314 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.6899999999999999 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 1.0900000000000001 110.834 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.9700000000000002 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 1.3 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.14000000000000001 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 1.0 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.14999999999999999 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.3500000000000001 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 1.01 109.671 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 1.03 109.272 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 1.02 109.692 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 1.05 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 1.0700000000000001 109.931 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.6600000000000001 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76000000000000001 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 1.0800000000000001 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.8999999999999999 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.70999999999999996 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.23999999999999999 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.75 109.806 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27000000000000002 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 1.0 112.293 -176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.1899999999999999 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.095 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 1.04 110.336 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.7400000000000002 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.45000000000000001 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 1.04 110.973 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.16 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.20000000000000001 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 1.0800000000000001 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 1.03 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 1.1399999999999999 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 1.0700000000000001 110.556 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.14000000000000001 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 1.03 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 1.0600000000000001 109.227 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 1.05 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.78000000000000003 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14999999999999999 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.19 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 1.0600000000000001 111.31 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.22 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.7999999999999998 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 1.3899999999999999 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.2999999999999998 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.17999999999999999 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 1.05 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.6699999999999999 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 1.05 111.497 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.20999999999999999 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 1.0600000000000001 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 1.02 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.96999999999999997 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17000000000000001 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 1.03 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 1.04 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 1.04 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.97999999999999998 110.163 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 1.1000000000000001 110.994 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.6899999999999999 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 1.03 112.575 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27000000000000002 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 2.1099999999999999 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.68000000000000005 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.7599999999999998 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 1.0900000000000001 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.31 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.71 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.2799999999999998 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 1.0700000000000001 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.8600000000000001 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -61.41 -48.96 78.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.89000000000000001 110.81 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.47 -38.35 89.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.705 -0.68 . . . . 1.1799999999999999 111.195 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.44 -44.49 96.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.234 -0.439 . . . . 2.75 111.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -59.86 -37.96 80.78 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.591 0.219 . . . . 2.8100000000000001 111.591 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -77.74 -1.07 29.44 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.162 0.801 . . . . 0.63 113.162 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.13 28.08 62.93 Favored Glycine 0 C--N 1.344 1.013 0 C-N-CA 121.143 -0.551 . . . . 0.70999999999999996 111.745 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.3 t -103.32 116.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.635 -0.506 . . . . 1.3799999999999999 109.635 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.01 160.84 33.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.103 -0.499 . . . . 4.1900000000000004 110.571 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 62.7 mt -83.89 160.21 21.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.046 -0.524 . . . . 5.6100000000000003 110.437 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -65.03 91.37 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.234 -0.439 . . . . 6.5 110.731 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -150.1 172.54 15.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.026 -0.534 . . . . 9.0500000000000007 110.52 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -102.34 132.41 48.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.058 -0.519 . . . . 10.26 110.497 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -103.74 136.95 42.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 11.33 110.536 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -149.3 110.48 4.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.052 -0.522 . . . . 13.84 110.545 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -134.87 153.37 52.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 14.359999999999999 110.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.052 -0.975 . . . . 16.449999999999999 110.473 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.886 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.96 135.81 50.22 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.181 0.991 . . . . 0.0 111.493 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.19 -48.97 79.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.88 -39.66 95.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.218 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.74 -42.69 99.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.309 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.07 -37.42 79.83 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -83.47 4.84 26.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.01 28.04 72.26 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.6 t -99.42 119.84 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.98 -63.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -157.15 126.97 6.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.21 126.56 39.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -156.85 156.77 33.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.78 136.78 52.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.441 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -102.34 135.02 44.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -105.46 141.99 35.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.572 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -119.58 141.17 49.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.588 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.0 12.09 20.17 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.937 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -109.99 135.7 50.42 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.218 1.009 . . . . 0.0 111.378 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -61.26 -48.84 79.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.73 -37.97 88.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.149 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -62.47 -45.18 94.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.267 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -59.89 -37.91 80.74 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -75.66 -4.5 40.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.63 28.06 40.39 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.912 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -80.0 121.45 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -84.03 150.06 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.846 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.42 162.39 15.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -65.82 114.08 4.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -160.0 -180.0 8.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -102.46 133.71 46.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -65.34 -50.47 65.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -137.31 162.06 34.58 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.55 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -159.11 33.44 0.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.514 -179.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.15 19.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.946 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -110.02 135.77 50.32 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 118.22 1.01 . . . . 0.0 111.348 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.33 -48.4 81.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.49 -37.66 86.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.07 -45.89 91.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.364 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -59.77 -37.29 78.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -77.21 -2.65 35.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.1 28.06 50.76 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.852 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.7 t -79.98 127.77 39.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.38 129.87 39.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.787 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.6 mt -102.06 140.34 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.472 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -65.3 -37.81 88.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -135.99 154.31 51.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -158.16 -55.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -100.19 143.75 30.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -132.21 90.76 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.511 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -102.65 -52.56 3.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.591 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.547 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.03 20.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.912 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.92 135.82 50.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.245 1.022 . . . . 0.0 111.29 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.96 -47.82 84.67 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.35 -38.68 90.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.118 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -61.97 -44.81 95.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -59.57 -37.27 78.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -80.12 1.87 26.32 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.48 27.97 62.45 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.922 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.62 117.69 42.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -143.03 173.08 11.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.697 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.5 mt -101.97 143.16 32.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.55 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -129.66 127.0 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.477 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -158.83 152.18 22.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.543 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -108.36 131.87 54.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.573 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.09 32.99 3.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.687 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -127.42 165.82 19.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.553 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -102.27 139.63 37.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.545 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.621 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.13 20.08 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.403 -0.665 . . . . 0.0 112.984 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -109.94 135.75 50.3 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 118.197 0.998 . . . . 0.0 111.563 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -61.39 -48.93 78.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 73.1 mt -62.55 -38.11 88.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.297 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -59.76 -38.07 80.79 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -77.1 -2.05 32.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.11 28.01 54.72 Favored Glycine 0 C--N 1.344 1.003 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.942 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.17 116.96 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -158.56 -51.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.612 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.03 135.82 57.75 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -76.36 162.95 27.46 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.581 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -78.78 117.04 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -139.87 -65.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -137.74 103.78 5.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -133.28 143.53 49.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -102.63 32.08 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.756 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.518 -179.589 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.23 19.78 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.915 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -109.96 135.82 50.21 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.168 0.984 . . . . 0.0 111.502 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -61.46 -49.28 77.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.45 -37.98 88.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -62.49 -45.73 91.7 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -59.84 -36.74 77.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -78.62 -1.3 33.58 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.16 34.09 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.047 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.6 t -79.94 131.87 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.78 125.66 25.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.062 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.9 tt -135.2 115.27 13.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.31 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -116.72 132.47 56.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.632 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.97 146.78 16.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.486 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -124.0 129.9 51.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -135.94 -63.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -133.17 155.96 48.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.445 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -128.91 114.68 16.77 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.8 t60 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.571 -179.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.13 12.22 19.76 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.854 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -109.88 135.77 50.24 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.123 0.961 . . . . 0.0 111.528 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -61.49 -48.9 78.97 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.69 -38.24 89.59 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.198 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.52 -44.47 96.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -59.83 -37.65 79.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -78.13 -1.07 30.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.45 28.02 41.32 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.021 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.97 119.22 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -90.05 146.96 23.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.53 141.51 32.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.487 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.75 119.04 38.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -159.97 154.36 23.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -137.22 119.77 16.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.654 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -111.38 110.66 21.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.38 -41.9 88.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.614 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -118.4 130.79 56.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.514 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 63.6 m170 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.493 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.68 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -109.94 135.82 50.2 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.022 0.911 . . . . 0.0 111.615 -174.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -61.2 -48.73 80.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.72 -38.37 90.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.189 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.46 -43.88 97.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.339 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.67 -37.75 79.6 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -79.64 1.76 25.06 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.66 28.04 48.67 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.052 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.34 121.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -138.82 168.31 20.1 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.73 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 15.8 tp -100.13 138.74 36.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.72 -41.6 95.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -105.1 111.5 24.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -160.06 90.5 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -145.43 163.0 35.99 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.561 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -158.1 -59.35 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -133.72 149.84 51.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.49 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.606 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptp . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.73 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.643 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -109.99 135.81 50.24 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.108 0.954 . . . . 0.0 111.687 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -61.28 -48.66 80.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.82 -39.14 93.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.58 -43.15 99.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.309 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.81 -38.74 82.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.592 0.234 . . . . 0.0 111.514 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -79.32 2.0 23.01 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.14 68.78 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.2 t -93.82 116.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -154.99 167.67 29.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.44 125.3 54.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.364 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -96.56 107.81 20.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -160.0 -62.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.51 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -136.38 170.09 16.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -102.99 129.45 49.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.494 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -138.69 118.97 13.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -137.45 154.85 49.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.495 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.898 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.91 135.81 50.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.204 1.002 . . . . 0.0 111.414 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.95 -48.2 82.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 73.3 mt -62.39 -38.39 89.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.233 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.08 -44.99 95.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.438 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -59.86 -37.29 78.88 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -79.18 0.61 27.67 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 73.59 28.0 66.31 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.726 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.36 121.86 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -136.76 -63.91 0.6 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.9 tt -154.12 110.19 3.25 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.574 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -131.09 145.21 51.92 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -158.33 -54.02 0.07 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -126.91 122.0 33.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.026 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -160.08 112.11 2.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.538 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -124.18 144.29 50.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.502 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -135.17 137.01 42.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.465 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.58 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 119.888 -0.101 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.14 12.13 19.76 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.753 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.92 135.9 50.06 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 118.005 0.903 . . . . 0.0 111.619 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -61.09 -48.48 81.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 mt -62.56 -39.03 92.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.216 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -62.73 -44.02 97.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -37.08 78.2 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -80.12 2.05 25.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.11 28.21 58.79 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.85 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.98 146.65 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -63.99 125.44 24.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.1 tp -119.07 142.09 48.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.9 146.91 54.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -65.47 118.33 9.27 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.591 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -124.24 145.02 49.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.459 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -104.16 130.31 51.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.554 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.06 88.73 0.83 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.22 -34.56 7.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.629 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.16 12.07 19.73 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.677 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -109.89 135.85 50.11 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.116 0.958 . . . . 0.0 111.749 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.27 -46.81 88.51 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.7 mt -62.86 -40.15 96.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.036 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -61.53 -43.83 98.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.504 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -59.55 -36.13 75.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -85.56 7.57 22.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.21 28.02 29.15 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.371 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.89 162.29 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -52.22 128.15 24.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.9 -178.57 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -151.73 -176.12 5.49 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.382 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -66.08 138.83 58.02 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.454 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -87.5 102.18 14.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.627 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -67.09 -39.73 86.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -106.54 -178.74 3.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.52 166.34 18.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.514 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.543 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.49 12.29 47.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.389 -0.673 . . . . 0.0 112.745 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -109.85 135.82 50.13 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.163 0.982 . . . . 0.0 111.596 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.71 -46.89 88.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.34 -38.9 91.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.193 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -61.85 -44.75 96.21 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.448 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -59.73 -37.1 78.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -81.52 3.61 24.26 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.08 62.18 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 118.343 0.519 . . . . 0.0 112.049 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.59 125.97 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -84.4 132.18 34.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.66 164.94 20.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.522 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.24 -33.58 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -90.7 172.09 8.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -97.86 161.1 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.604 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -123.99 170.28 10.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.457 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.55 157.12 43.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -128.94 133.82 47.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.511 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.498 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 119.844 -0.122 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.07 12.16 19.94 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.961 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -109.9 135.77 50.25 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.207 1.003 . . . . 0.0 111.428 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -61.04 -48.26 82.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.54 -38.86 91.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.144 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.33 -44.2 97.05 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.273 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.58 -36.52 76.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -83.13 5.65 21.89 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.96 27.99 35.94 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.316 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.95 150.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -63.97 153.53 36.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.29 177.14 5.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.582 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.24 174.55 2.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.539 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -65.4 142.6 58.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -65.46 94.83 0.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.62 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -69.02 158.15 35.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.535 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.22 165.75 17.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -102.49 142.61 33.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.56 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.635 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.05 12.2 19.99 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.37 -0.683 . . . . 0.0 112.876 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -110.02 135.85 50.2 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.211 1.006 . . . . 0.0 111.299 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -61.08 -48.47 81.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 69.9 mt -62.59 -38.17 89.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.203 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -45.95 90.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.72 -36.5 76.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -79.22 -1.2 35.29 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.55 28.17 33.47 Favored Glycine 0 C--N 1.344 1.004 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.985 175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.5 t -79.91 159.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -59.99 127.76 33.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.576 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 58.3 mt -73.07 159.84 32.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.583 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -104.15 32.06 4.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -142.25 32.83 1.52 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.745 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -147.78 162.44 39.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -91.04 136.81 32.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -65.15 -35.99 82.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.659 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -95.86 124.63 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.532 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtm . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.19 12.16 19.61 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.788 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.84 135.83 50.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.02 0.91 . . . . 0.0 111.678 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.93 -45.5 94.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 68.0 mt -63.82 -44.88 91.92 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.365 -177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -66.16 -35.01 79.34 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.521 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -60.54 -38.83 85.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.426 0.155 . . . . 0.0 111.405 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -83.69 6.18 21.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.86 28.15 72.28 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.42 116.93 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -154.9 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.23 129.5 51.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.84 104.39 8.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.5 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -146.13 149.72 34.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.404 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -64.82 -36.03 83.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -102.77 136.08 43.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -137.99 -48.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.719 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -130.69 161.9 30.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.612 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.247 0.546 . . . . 1.6799999999999999 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 0.17999999999999999 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 0.12 110.07 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 0.16 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 110.213 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 0.22 109.763 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56000000000000005 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 0.47999999999999998 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 0.37 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 1.8300000000000001 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.31 111.32 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 2.8799999999999999 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.8500000000000001 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 0.23999999999999999 111.299 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 0.27000000000000002 110.289 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.4500000000000002 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.20000000000000001 111.467 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 1.95 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 0.20000000000000001 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 1.6399999999999999 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.14999999999999999 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.4399999999999999 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 0.17999999999999999 109.903 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 0.11 110.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.17999999999999999 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 111.03 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.70999999999999996 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 0.26000000000000001 112.654 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 0.32000000000000001 112.438 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 1.95 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.48999999999999999 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.8899999999999999 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 2.5600000000000001 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.22 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.25 112.12 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 0.19 110.609 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6000000000000001 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.17000000000000001 110.992 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.818 HG23 HG21 ' A' ' 56' ' ' ILE . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 0.17000000000000001 110.406 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 1.8100000000000001 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 0.16 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.17999999999999999 111.531 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 2.79 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' CG1' ' A' ' 18' ' ' VAL . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 0.27000000000000002 110.056 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67000000000000004 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.20000000000000001 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.1000000000000001 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 0.14999999999999999 110.689 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.2799999999999998 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 44' ' ' ILE . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 0.12 110.038 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.17000000000000001 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 0.14999999999999999 110.225 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.23999999999999999 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.28000000000000003 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 110.141 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.504 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.4500000000000002 111.836 -176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.39000000000000001 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.02 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.2200000000000002 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.28000000000000003 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 1.6899999999999999 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 0.20999999999999999 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 0.20000000000000001 110.87 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.2200000000000002 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 0.17000000000000001 111.227 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 0.19 110.101 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 2.6000000000000001 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 0.20000000000000001 112.733 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.14999999999999999 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 0.17000000000000001 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.2000000000000002 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.19 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.72999999999999998 110.518 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 0.48999999999999999 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 0.20999999999999999 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.33000000000000002 110.894 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 0.16 111.008 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 0.14000000000000001 110.694 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 0.14000000000000001 111.574 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 0.14999999999999999 110.492 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68000000000000005 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 0.93999999999999995 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14000000000000001 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.0800000000000001 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 0.16 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.61 HD11 ' HB1' ' A' ' 85' ' ' ALA . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 0.12 109.321 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 0.16 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 2.5800000000000001 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.83 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 0.32000000000000001 111.235 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 0.14999999999999999 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 1.9099999999999999 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 0.29999999999999999 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.25 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.14999999999999999 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 0.98999999999999999 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.8300000000000001 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 0.28000000000000003 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 0.23999999999999999 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.17000000000000001 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.723 HG21 HG13 ' A' ' 139' ' ' VAL . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 0.10000000000000001 109.041 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.13 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.493 HG23 HG13 ' A' ' 119' ' ' VAL . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.10000000000000001 110.007 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65000000000000002 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 0.13 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 152' ' ' ILE . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 0.70999999999999996 109.377 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.91000000000000003 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 0.25 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.22 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.14000000000000001 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 0.32000000000000001 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 108' ' ' ILE . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.13 110.83 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.17000000000000001 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 0.16 109.79 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.19 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.1599999999999999 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17000000000000001 113.247 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.0899999999999999 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 1.78 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.17999999999999999 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.17999999999999999 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17000000000000001 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 0.14999999999999999 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 0.22 110.256 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 0.12 110.989 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 1.9199999999999999 110.899 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.14000000000000001 110.708 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 0.11 110.634 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 0.14999999999999999 110.314 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.6899999999999999 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 0.14000000000000001 110.834 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.5099999999999998 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 0.97999999999999998 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.13 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 0.11 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.14999999999999999 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.3500000000000001 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.794 HD11 HD12 ' A' ' 175' ' ' LEU . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 0.12 109.671 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 0.13 109.272 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 0.12 109.692 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.13 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.17999999999999999 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 0.17000000000000001 109.931 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.1600000000000001 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76000000000000001 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 0.34999999999999998 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.4100000000000001 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.40000000000000002 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.20000000000000001 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.17000000000000001 109.806 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27000000000000002 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.543 ' HA ' HD12 ' A' ' 166' ' ' ILE . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 0.14000000000000001 112.293 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.1899999999999999 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.703 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.16 111.095 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 0.14000000000000001 110.336 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.0699999999999998 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 165' ' ' MET . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 0.14999999999999999 110.973 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.14999999999999999 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.19 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 0.29999999999999999 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 0.25 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 0.32000000000000001 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 147' ' ' ILE . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 0.22 110.556 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.13 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 0.11 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.12 109.227 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 0.11 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.14999999999999999 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14000000000000001 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.16 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 0.26000000000000001 111.31 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.16 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.2799999999999998 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 0.56000000000000005 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.2999999999999998 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.33000000000000002 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.16 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 0.23999999999999999 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.6699999999999999 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 0.13 111.497 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.19 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 0.20000000000000001 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 0.14000000000000001 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.13 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17000000000000001 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 0.13 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 0.11 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 0.13 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.14000000000000001 110.163 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 0.23000000000000001 110.994 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.3100000000000001 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 0.22 112.575 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27000000000000002 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 1.23 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.52000000000000002 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.25 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 0.25 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.27000000000000002 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.3100000000000001 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.2799999999999998 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 0.22 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.28 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.38 110.81 179.661 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 57' ' ' ILE . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' CE ' ' A' ' 67' ' ' MET . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.702 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 56' ' ' ILE . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' OE1' HG21 ' A' ' 18' ' ' VAL . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 44' ' ' ILE . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 30' ' ' THR . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.784 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.628 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.543 ' CE ' HD12 ' A' ' 33' ' ' ILE . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ILE . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 121' ' ' THR . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.549 HD11 ' HB1' ' A' ' 85' ' ' ALA . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 139' ' ' VAL . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 119' ' ' VAL . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 108' ' ' ILE . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' HG23 ' A' ' 83' ' ' THR . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 131' ' ' LEU . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 137' ' ' VAL . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.731 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 175' ' ' LEU . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 169' ' ' VAL . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 192' ' ' ALA . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.697 ' HA ' HD12 ' A' ' 166' ' ' ILE . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.724 ' O ' HG23 ' A' ' 169' ' ' VAL . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 165' ' ' MET . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 147' ' ' ILE . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.44 ' HE1' ' CG ' ' A' ' 215' ' ' GLU . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.44 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.44 ' CG ' ' HE1' ' A' ' 186' ' ' MET . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 199' ' ' ALA . 47.8 mtmt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.25 0.548 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.64 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.851 HG23 HG21 ' A' ' 56' ' ' ILE . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 18' ' ' VAL . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 50' ' ' ILE . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 18' ' ' VAL . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.851 HG21 HG23 ' A' ' 44' ' ' ILE . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.814 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.64 ' N ' HG22 ' A' ' 34' ' ' THR . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.814 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD22 ' CE1' ' A' ' 79' ' ' PHE . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.803 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 HG13 ' A' ' 119' ' ' VAL . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 152' ' ' ILE . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 131' ' ' LEU . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.815 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.612 HD11 HD12 ' A' ' 175' ' ' LEU . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.457 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.663 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.612 HD12 HD11 ' A' ' 147' ' ' ILE . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.664 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 211' ' ' ILE . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.268 0.556 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 61' ' ' ALA . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.836 HG21 HG23 ' A' ' 44' ' ' ILE . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.865 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.673 ' N ' HG22 ' A' ' 34' ' ' THR . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.865 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 121' ' ' THR . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.568 HD11 ' HB1' ' A' ' 85' ' ' ALA . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 79' ' ' PHE . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.704 HG21 HG13 ' A' ' 139' ' ' VAL . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 119' ' ' VAL . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 152' ' ' ILE . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 108' ' ' ILE . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.525 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 175' ' ' LEU . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.592 HD21 ' HG2' ' A' ' 165' ' ' MET . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 166' ' ' ILE . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.592 ' HG2' HD21 ' A' ' 149' ' ' LEU . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 163' ' ' THR . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 165' ' ' MET . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 147' ' ' ILE . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.54 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.553 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.553 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.532 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 17' ' ' ALA . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' GLY . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 57' ' ' ILE . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.759 HG23 HG21 ' A' ' 56' ' ' ILE . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 50' ' ' ILE . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 47' ' ' ILE . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG23 ' A' ' 44' ' ' ILE . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 30' ' ' THR . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.711 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 34' ' ' THR . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.617 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 33' ' ' ILE . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.534 HG22 ' HE3' ' A' ' 73' ' ' LYS . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' HE3' HG22 ' A' ' 69' ' ' ILE . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' A' ' 62' ' ' MET . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.44 HD11 ' HB1' ' A' ' 85' ' ' ALA . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.727 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 119' ' ' VAL . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 152' ' ' ILE . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 108' ' ' ILE . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.749 HG13 HG21 ' A' ' 106' ' ' VAL . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.602 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 169' ' ' VAL . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' MET . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 147' ' ' ILE . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.411 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.571 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.261 0.553 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 14' ' ' GLY . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 61' ' ' ALA . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 41' ' ' ILE . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.681 ' OE1' HG21 ' A' ' 18' ' ' VAL . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.583 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.634 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.679 HG21 HG23 ' A' ' 44' ' ' ILE . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 33' ' ' ILE . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.605 ' N ' HG22 ' A' ' 34' ' ' THR . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 33' ' ' ILE . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HG2' HD13 ' A' ' 41' ' ' ILE . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.791 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.504 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.598 HD11 ' HB1' ' A' ' 85' ' ' ALA . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.56 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.56 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 119' ' ' VAL . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HG3' HD12 ' A' ' 152' ' ' ILE . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.532 HG13 HG23 ' A' ' 108' ' ' ILE . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 175' ' ' LEU . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.711 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 111' ' ' LYS . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.406 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.608 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 147' ' ' ILE . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.711 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 211' ' ' ILE . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.406 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.553 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB1' ' A' ' 202' ' ' ALA . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.659 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 14' ' ' GLY . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 5' ' ' VAL . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 58' ' ' VAL . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.653 HG22 ' N ' ' A' ' 61' ' ' ALA . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 56' ' ' ILE . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.626 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 18' ' ' VAL . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 44' ' ' ILE . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' N ' HG22 ' A' ' 34' ' ' THR . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 72' ' ' ILE . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 69' ' ' ILE . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.73 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.503 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.565 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.509 HG23 HG13 ' A' ' 119' ' ' VAL . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HG3' HD12 ' A' ' 152' ' ' ILE . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 108' ' ' ILE . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.503 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.467 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.693 ' HA ' HD12 ' A' ' 166' ' ' ILE . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 163' ' ' THR . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 165' ' ' MET . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 147' ' ' ILE . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 211' ' ' ILE . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.257 0.551 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 38' ' ' MET . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 67' ' ' MET . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE3' ' O ' ' A' ' 10' ' ' ASP . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 44' ' ' ILE . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 56' ' ' ILE . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.823 HG21 HG23 ' A' ' 44' ' ' ILE . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG21 ' HB1' ' A' ' 71' ' ' ALA . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.542 ' CG ' HD12 ' A' ' 33' ' ' ILE . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' A' ' 41' ' ' ILE . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.721 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 85' ' ' ALA . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.721 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 139' ' ' VAL . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 119' ' ' VAL . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 152' ' ' ILE . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 HD12 ' A' ' 175' ' ' LEU . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.455 HD13 ' HA3' ' A' ' 124' ' ' GLY . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.697 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.671 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 147' ' ' ILE . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.62 ' HA ' HD11 ' A' ' 211' ' ' ILE . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.412 HD13 HG21 ' A' ' 211' ' ' ILE . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HD3' HD11 ' A' ' 28' ' ' ILE . 70.7 mttt . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.205 0.526 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 61' ' ' ALA . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.725 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 56' ' ' ILE . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' HG21 ' A' ' 18' ' ' VAL . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.741 HG21 HG23 ' A' ' 44' ' ' ILE . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.591 ' SD ' HD12 ' A' ' 33' ' ' ILE . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.691 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.509 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.691 HD22 ' CE1' ' A' ' 79' ' ' PHE . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.687 HG21 HG13 ' A' ' 139' ' ' VAL . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.485 HG23 HG13 ' A' ' 119' ' ' VAL . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.446 ' HG3' HD12 ' A' ' 152' ' ' ILE . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG13 HG23 ' A' ' 108' ' ' ILE . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.511 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.415 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.621 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.511 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.616 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.608 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 165' ' ' MET . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.621 HD12 HD11 ' A' ' 147' ' ' ILE . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 211' ' ' ILE . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 121.279 0.561 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.623 HG11 ' HB2' ' A' ' 17' ' ' ALA . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.437 HG23 ' OE1' ' A' ' 16' ' ' GLU . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' OE1' HG23 ' A' ' 12' ' ' THR . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.663 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 67' ' ' MET . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 61' ' ' ALA . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.841 HG23 HG21 ' A' ' 56' ' ' ILE . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 ' CG1' ' A' ' 18' ' ' VAL . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.841 HG21 HG23 ' A' ' 44' ' ' ILE . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 71' ' ' ALA . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.574 ' HE3' HD12 ' A' ' 33' ' ' ILE . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.747 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.495 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.648 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.747 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 119' ' ' VAL . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.516 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.762 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.709 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 147' ' ' ILE . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.414 ' HE1' ' CB ' ' A' ' 215' ' ' GLU . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.543 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.414 ' CB ' ' HE1' ' A' ' 186' ' ' MET . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.274 0.559 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.64 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 5' ' ' VAL . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 56' ' ' ILE . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 18' ' ' VAL . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 44' ' ' ILE . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.793 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.624 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 33' ' ' ILE . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.806 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.806 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.579 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.579 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.731 HG21 HG13 ' A' ' 139' ' ' VAL . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.454 HG23 HG13 ' A' ' 119' ' ' VAL . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.449 ' HG3' HD12 ' A' ' 152' ' ' ILE . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' ILE . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 106' ' ' VAL . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 HD12 ' A' ' 175' ' ' LEU . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.5 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 166' ' ' ILE . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.673 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 165' ' ' MET . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 147' ' ' ILE . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.715 ' HB ' HD12 ' A' ' 148' ' ' LEU . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.169 0.509 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 7' ' ' ILE . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 57' ' ' ILE . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.528 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 61' ' ' ALA . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.721 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.735 HG23 HG21 ' A' ' 56' ' ' ILE . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.578 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 30' ' ' THR . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.405 ' HB2' HD12 ' A' ' 80' ' ' ILE . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.63 ' N ' HG22 ' A' ' 34' ' ' THR . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 59' ' ' CYS . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 121' ' ' THR . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.62 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.62 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.624 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 146' ' ' GLU . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 HG13 ' A' ' 119' ' ' VAL . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HG3' HD12 ' A' ' 152' ' ' ILE . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 108' ' ' ILE . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.811 ' O ' HG23 ' A' ' 139' ' ' VAL . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 132' ' ' LEU . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 106' ' ' VAL . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.547 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 105' ' ' VAL . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 178' ' ' ILE . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 111' ' ' LYS . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.601 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 163' ' ' THR . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.721 ' HB ' HD12 ' A' ' 148' ' ' LEU . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.237 0.402 0 CA-C-O 121.248 0.547 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 17' ' ' ALA . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.653 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' HB ' ' A' ' 57' ' ' ILE . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 61' ' ' ALA . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 56' ' ' ILE . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.714 ' OE1' HG21 ' A' ' 18' ' ' VAL . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 18' ' ' VAL . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 80' ' ' ILE . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.561 ' HB2' HD12 ' A' ' 80' ' ' ILE . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 34' ' ' THR . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.69 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 59' ' ' CYS . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.493 HG23 ' HB ' ' A' ' 121' ' ' THR . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.712 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 95' ' ' LEU . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.712 HD11 ' HB1' ' A' ' 85' ' ' ALA . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.603 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 146' ' ' GLU . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.782 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG13 ' A' ' 119' ' ' VAL . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 152' ' ' ILE . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 108' ' ' ILE . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 126' ' ' LYS . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 122' ' ' TYR . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.778 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.782 HG13 HG21 ' A' ' 106' ' ' VAL . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HB2' HG22 ' A' ' 105' ' ' VAL . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 175' ' ' LEU . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 169' ' ' VAL . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' A' ' 111' ' ' LYS . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.711 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.681 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.611 HD12 HD11 ' A' ' 147' ' ' ILE . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 211' ' ' ILE . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.415 0.626 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 21' ' ' TYR . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.515 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.712 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 56' ' ' ILE . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.641 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 44' ' ' ILE . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.78 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.579 ' N ' HG22 ' A' ' 34' ' ' THR . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' HD13 ' A' ' 41' ' ' ILE . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.461 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' CE1' ' A' ' 79' ' ' PHE . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 119' ' ' VAL . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 152' ' ' ILE . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.58 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 108' ' ' ILE . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.57 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 137' ' ' VAL . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 175' ' ' LEU . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.706 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 169' ' ' VAL . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 111' ' ' LYS . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.707 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.668 ' HA ' HD12 ' A' ' 166' ' ' ILE . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 163' ' ' THR . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 165' ' ' MET . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 147' ' ' ILE . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.707 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HA ' HD11 ' A' ' 211' ' ' ILE . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.27 0.557 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.689 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 44' ' ' ILE . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 56' ' ' ILE . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.57 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.529 HD11 HG13 ' A' ' 18' ' ' VAL . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 44' ' ' ILE . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' N ' HG22 ' A' ' 34' ' ' THR . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 69' ' ' ILE . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 69' ' ' ILE . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.729 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.507 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.536 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.561 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.561 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 146' ' ' GLU . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.746 HG21 HG13 ' A' ' 139' ' ' VAL . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 119' ' ' VAL . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 152' ' ' ILE . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 108' ' ' ILE . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.507 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 131' ' ' LEU . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 137' ' ' VAL . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.785 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' HG22 ' A' ' 105' ' ' VAL . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 175' ' ' LEU . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 169' ' ' VAL . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.484 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.7 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.669 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 163' ' ' THR . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 147' ' ' ILE . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.7 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.643 ' HA ' HD11 ' A' ' 211' ' ' ILE . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.512 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.643 HD11 ' HA ' ' A' ' 185' ' ' LYS . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 211' ' ' ILE . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.7 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.639 ' OE1' HG21 ' A' ' 18' ' ' VAL . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.609 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.827 HG21 HG23 ' A' ' 44' ' ' ILE . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.775 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HD12 ' A' ' 80' ' ' ILE . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.627 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.627 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.575 ' HG2' HD13 ' A' ' 41' ' ' ILE . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 59' ' ' CYS . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 86' ' ' VAL . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.519 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.651 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.614 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 146' ' ' GLU . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.795 HG21 HG13 ' A' ' 139' ' ' VAL . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 119' ' ' VAL . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 108' ' ' ILE . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 137' ' ' VAL . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.795 HG13 HG21 ' A' ' 106' ' ' VAL . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HB2' HG22 ' A' ' 105' ' ' VAL . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 175' ' ' LEU . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 169' ' ' VAL . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.641 ' HA ' HD12 ' A' ' 166' ' ' ILE . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 169' ' ' VAL . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 163' ' ' THR . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 165' ' ' MET . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.635 HD12 HD11 ' A' ' 147' ' ' ILE . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' A' ' 211' ' ' ILE . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.413 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.654 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG13 ' HB ' ' A' ' 12' ' ' THR . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 8' ' ' VAL . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.699 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.763 HG23 HG21 ' A' ' 56' ' ' ILE . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.601 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.763 HG21 HG23 ' A' ' 44' ' ' ILE . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.764 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 69' ' ' ILE . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.821 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.582 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.821 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 HG13 ' A' ' 139' ' ' VAL . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 119' ' ' VAL . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HG3' HD12 ' A' ' 152' ' ' ILE . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 108' ' ' ILE . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.818 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.588 HD11 HD12 ' A' ' 175' ' ' LEU . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 165' ' ' MET . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.724 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.7 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 147' ' ' ILE . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.705 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.724 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.403 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.556 -0.535 . . . . 2.1200000000000001 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.09 19.91 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.332 -0.705 . . . . 0.46999999999999997 112.867 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -109.98 135.74 50.35 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 118.253 1.026 . . . . 1.6799999999999999 111.455 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 0.17999999999999999 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 0.12 110.07 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 0.16 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 110.213 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 0.22 109.763 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56000000000000005 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 0.47999999999999998 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 0.37 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 1.8300000000000001 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.31 111.32 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 2.8799999999999999 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.8500000000000001 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 0.23999999999999999 111.299 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 0.27000000000000002 110.289 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.4500000000000002 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.20000000000000001 111.467 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 1.95 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.5499999999999998 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 0.20000000000000001 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 1.6399999999999999 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.14999999999999999 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.4399999999999999 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 0.17999999999999999 109.903 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 0.11 110.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.17999999999999999 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 0.92000000000000004 111.03 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.70999999999999996 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 0.26000000000000001 112.654 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 0.32000000000000001 112.438 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 1.95 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.48999999999999999 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.8899999999999999 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 2.5600000000000001 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.22 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.25 112.12 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 0.19 110.609 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6000000000000001 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.17000000000000001 110.992 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.818 HG23 HG21 ' A' ' 56' ' ' ILE . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 0.17000000000000001 110.406 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 1.8100000000000001 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 0.16 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.17999999999999999 111.531 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 2.79 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' CG1' ' A' ' 18' ' ' VAL . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 0.27000000000000002 110.056 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67000000000000004 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.20000000000000001 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.1000000000000001 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 0.14999999999999999 110.689 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.2799999999999998 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 44' ' ' ILE . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 0.12 110.038 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.17000000000000001 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 0.14999999999999999 110.225 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.23999999999999999 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.28000000000000003 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 110.141 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.504 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.4500000000000002 111.836 -176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.39000000000000001 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.02 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.2200000000000002 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.28000000000000003 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 1.6899999999999999 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 0.20999999999999999 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 0.20000000000000001 110.87 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.2200000000000002 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 0.17000000000000001 111.227 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 0.19 110.101 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 2.6000000000000001 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 0.20000000000000001 112.733 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.14999999999999999 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 0.17000000000000001 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.2000000000000002 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.19 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.72999999999999998 110.518 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 0.48999999999999999 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 0.20999999999999999 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.33000000000000002 110.894 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 0.16 111.008 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 0.14000000000000001 110.694 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 0.14000000000000001 111.574 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 0.14999999999999999 110.492 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68000000000000005 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 0.93999999999999995 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14000000000000001 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.0800000000000001 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 0.16 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.61 HD11 ' HB1' ' A' ' 85' ' ' ALA . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 0.12 109.321 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 0.16 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 2.5800000000000001 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.83 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 0.32000000000000001 111.235 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 0.14999999999999999 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 1.9099999999999999 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 0.29999999999999999 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.25 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.14999999999999999 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 0.98999999999999999 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.8300000000000001 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 0.28000000000000003 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 0.23999999999999999 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.17000000000000001 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.723 HG21 HG13 ' A' ' 139' ' ' VAL . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 0.10000000000000001 109.041 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.13 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.493 HG23 HG13 ' A' ' 119' ' ' VAL . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.10000000000000001 110.007 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65000000000000002 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 0.13 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 152' ' ' ILE . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 0.70999999999999996 109.377 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.91000000000000003 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 0.25 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.22 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.14000000000000001 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 0.32000000000000001 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 108' ' ' ILE . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.13 110.83 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.17000000000000001 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 0.16 109.79 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.19 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.1599999999999999 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17000000000000001 113.247 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.0899999999999999 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 1.78 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.17999999999999999 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.17999999999999999 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17000000000000001 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 0.14999999999999999 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 0.22 110.256 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 0.12 110.989 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 1.9199999999999999 110.899 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.14000000000000001 110.708 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 0.11 110.634 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 0.14999999999999999 110.314 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.6899999999999999 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 0.14000000000000001 110.834 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.5099999999999998 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 0.97999999999999998 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.13 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 0.11 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.14999999999999999 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.3500000000000001 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.794 HD11 HD12 ' A' ' 175' ' ' LEU . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 0.12 109.671 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 0.13 109.272 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 0.12 109.692 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.13 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.17999999999999999 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 0.17000000000000001 109.931 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.1600000000000001 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76000000000000001 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 0.34999999999999998 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.4100000000000001 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.40000000000000002 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.20000000000000001 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.17000000000000001 109.806 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27000000000000002 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.543 ' HA ' HD12 ' A' ' 166' ' ' ILE . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 0.14000000000000001 112.293 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.1899999999999999 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.703 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.16 111.095 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 0.14000000000000001 110.336 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.0699999999999998 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 165' ' ' MET . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 0.14999999999999999 110.973 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.14999999999999999 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.19 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 0.29999999999999999 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 0.25 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 0.32000000000000001 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 147' ' ' ILE . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 0.22 110.556 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.13 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 0.11 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.12 109.227 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 0.11 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.14999999999999999 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14000000000000001 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.16 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 0.26000000000000001 111.31 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.16 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.2799999999999998 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 0.56000000000000005 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.2999999999999998 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.33000000000000002 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.16 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 0.23999999999999999 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.6699999999999999 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 0.13 111.497 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.19 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 0.20000000000000001 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 0.14000000000000001 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.13 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17000000000000001 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 0.13 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 0.11 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 0.13 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.14000000000000001 110.163 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 0.23000000000000001 110.994 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.3100000000000001 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 0.22 112.575 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27000000000000002 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 1.23 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.52000000000000002 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.25 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 0.25 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.27000000000000002 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.3100000000000001 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.2799999999999998 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 0.22 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.28 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.4300000000000002 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -61.41 -48.96 78.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.38 110.81 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.47 -38.35 89.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.705 -0.68 . . . . 0.45000000000000001 111.195 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.44 -44.49 96.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.234 -0.439 . . . . 2.2799999999999998 111.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -59.86 -37.96 80.78 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.591 0.219 . . . . 2.3999999999999999 111.591 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -77.74 -1.07 29.44 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.162 0.801 . . . . 0.63 113.162 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.13 28.08 62.93 Favored Glycine 0 C--N 1.344 1.013 0 C-N-CA 121.143 -0.551 . . . . 0.65000000000000002 111.745 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.3 t -103.32 116.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.635 -0.506 . . . . 1.03 109.635 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.01 160.84 33.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.103 -0.499 . . . . 3.3900000000000001 110.571 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 62.7 mt -83.89 160.21 21.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.046 -0.524 . . . . 5.1900000000000004 110.437 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -65.03 91.37 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.234 -0.439 . . . . 6.5 110.731 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -150.1 172.54 15.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.026 -0.534 . . . . 8.3699999999999992 110.52 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -102.34 132.41 48.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.058 -0.519 . . . . 9.9600000000000009 110.497 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -103.74 136.95 42.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 10.77 110.536 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -149.3 110.48 4.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.052 -0.522 . . . . 13.300000000000001 110.545 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -134.87 153.37 52.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 14.359999999999999 110.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.052 -0.975 . . . . 16.059999999999999 110.473 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.886 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.96 135.81 50.22 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.181 0.991 . . . . 0.0 111.493 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 57' ' ' ILE . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' CE ' ' A' ' 67' ' ' MET . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.702 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 56' ' ' ILE . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' OE1' HG21 ' A' ' 18' ' ' VAL . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 44' ' ' ILE . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 30' ' ' THR . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.784 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.628 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.543 ' CE ' HD12 ' A' ' 33' ' ' ILE . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ILE . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 121' ' ' THR . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.549 HD11 ' HB1' ' A' ' 85' ' ' ALA . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 139' ' ' VAL . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 119' ' ' VAL . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 108' ' ' ILE . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' HG23 ' A' ' 83' ' ' THR . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 131' ' ' LEU . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 137' ' ' VAL . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.731 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 175' ' ' LEU . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 169' ' ' VAL . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 192' ' ' ALA . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.697 ' HA ' HD12 ' A' ' 166' ' ' ILE . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.724 ' O ' HG23 ' A' ' 169' ' ' VAL . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 165' ' ' MET . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 147' ' ' ILE . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.44 ' HE1' ' CG ' ' A' ' 215' ' ' GLU . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.44 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.44 ' CG ' ' HE1' ' A' ' 186' ' ' MET . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.19 -48.97 79.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.88 -39.66 95.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.218 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.74 -42.69 99.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.309 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.07 -37.42 79.83 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -83.47 4.84 26.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.01 28.04 72.26 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.6 t -99.42 119.84 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.98 -63.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -157.15 126.97 6.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.21 126.56 39.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -156.85 156.77 33.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.78 136.78 52.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.441 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -102.34 135.02 44.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -105.46 141.99 35.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.572 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -119.58 141.17 49.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.588 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG2' HG13 ' A' ' 225' ' ' VAL . 20.4 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.0 12.09 20.17 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.937 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 199' ' ' ALA . 47.8 mtmt -109.99 135.7 50.42 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.218 1.009 . . . . 0.0 111.378 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.64 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.851 HG23 HG21 ' A' ' 56' ' ' ILE . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 18' ' ' VAL . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 50' ' ' ILE . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 18' ' ' VAL . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.851 HG21 HG23 ' A' ' 44' ' ' ILE . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.814 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.64 ' N ' HG22 ' A' ' 34' ' ' THR . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.814 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD22 ' CE1' ' A' ' 79' ' ' PHE . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.803 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 HG13 ' A' ' 119' ' ' VAL . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 152' ' ' ILE . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 131' ' ' LEU . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.815 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.612 HD11 HD12 ' A' ' 175' ' ' LEU . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.457 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.663 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.612 HD12 HD11 ' A' ' 147' ' ' ILE . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.664 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 211' ' ' ILE . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -61.26 -48.84 79.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 4' ' ' ILE . 70.5 mt -62.73 -37.97 88.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.149 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -62.47 -45.18 94.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.267 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -59.89 -37.91 80.74 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -75.66 -4.5 40.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.63 28.06 40.39 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.912 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 1' ' ' MET . 22.9 t -80.0 121.45 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -84.03 150.06 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.846 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.42 162.39 15.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -65.82 114.08 4.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -160.0 -180.0 8.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -102.46 133.71 46.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -65.34 -50.47 65.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -137.31 162.06 34.58 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.55 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -159.11 33.44 0.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.514 -179.688 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG11 ' A' ' 225' ' ' VAL . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.15 19.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.946 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -110.02 135.77 50.32 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 118.22 1.01 . . . . 0.0 111.348 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 61' ' ' ALA . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.836 HG21 HG23 ' A' ' 44' ' ' ILE . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.865 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.673 ' N ' HG22 ' A' ' 34' ' ' THR . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.865 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 121' ' ' THR . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.568 HD11 ' HB1' ' A' ' 85' ' ' ALA . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 79' ' ' PHE . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.704 HG21 HG13 ' A' ' 139' ' ' VAL . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 119' ' ' VAL . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 152' ' ' ILE . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 108' ' ' ILE . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.525 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 175' ' ' LEU . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.592 HD21 ' HG2' ' A' ' 165' ' ' MET . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 166' ' ' ILE . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.592 ' HG2' HD21 ' A' ' 149' ' ' LEU . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 163' ' ' THR . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 165' ' ' MET . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 147' ' ' ILE . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.54 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.553 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.553 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.33 -48.4 81.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.49 -37.66 86.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.07 -45.89 91.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.364 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -59.77 -37.29 78.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -77.21 -2.65 35.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.1 28.06 50.76 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.852 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 1' ' ' MET . 24.7 t -79.98 127.77 39.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.38 129.87 39.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.787 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.6 mt -102.06 140.34 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.472 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -65.3 -37.81 88.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -135.99 154.31 51.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -158.16 -55.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -100.19 143.75 30.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -132.21 90.76 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.511 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -102.65 -52.56 3.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.591 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.547 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.03 20.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.912 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.92 135.82 50.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.245 1.022 . . . . 0.0 111.29 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 17' ' ' ALA . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' GLY . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 57' ' ' ILE . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.759 HG23 HG21 ' A' ' 56' ' ' ILE . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 50' ' ' ILE . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 47' ' ' ILE . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG23 ' A' ' 44' ' ' ILE . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 30' ' ' THR . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.711 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 34' ' ' THR . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.617 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 33' ' ' ILE . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.534 HG22 ' HE3' ' A' ' 73' ' ' LYS . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' HE3' HG22 ' A' ' 69' ' ' ILE . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' A' ' 62' ' ' MET . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.44 HD11 ' HB1' ' A' ' 85' ' ' ALA . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.727 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 119' ' ' VAL . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 152' ' ' ILE . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 108' ' ' ILE . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.749 HG13 HG21 ' A' ' 106' ' ' VAL . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.602 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 169' ' ' VAL . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' MET . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 147' ' ' ILE . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.411 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.571 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.96 -47.82 84.67 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.35 -38.68 90.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.118 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -61.97 -44.81 95.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -59.57 -37.27 78.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -80.12 1.87 26.32 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.48 27.97 62.45 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.922 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.62 117.69 42.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -143.03 173.08 11.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.697 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.5 mt -101.97 143.16 32.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.55 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -129.66 127.0 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.477 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -158.83 152.18 22.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.543 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -108.36 131.87 54.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.573 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.09 32.99 3.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.687 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -127.42 165.82 19.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.553 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -102.27 139.63 37.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.545 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.621 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.13 20.08 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.403 -0.665 . . . . 0.0 112.984 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -109.94 135.75 50.3 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 118.197 0.998 . . . . 0.0 111.563 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 14' ' ' GLY . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 61' ' ' ALA . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 41' ' ' ILE . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.681 ' OE1' HG21 ' A' ' 18' ' ' VAL . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.583 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.634 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.679 HG21 HG23 ' A' ' 44' ' ' ILE . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 33' ' ' ILE . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.605 ' N ' HG22 ' A' ' 34' ' ' THR . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 33' ' ' ILE . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HG2' HD13 ' A' ' 41' ' ' ILE . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.791 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.504 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.598 HD11 ' HB1' ' A' ' 85' ' ' ALA . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.56 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.56 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 119' ' ' VAL . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HG3' HD12 ' A' ' 152' ' ' ILE . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.532 HG13 HG23 ' A' ' 108' ' ' ILE . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 175' ' ' LEU . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.711 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 111' ' ' LYS . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.406 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.608 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 147' ' ' ILE . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.711 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 211' ' ' ILE . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.406 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.553 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB1' ' A' ' 202' ' ' ALA . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -61.39 -48.93 78.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 73.1 mt -62.55 -38.11 88.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.297 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -59.76 -38.07 80.79 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -77.1 -2.05 32.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.11 28.01 54.72 Favored Glycine 0 C--N 1.344 1.003 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.942 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.17 116.96 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -158.56 -51.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.612 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.03 135.82 57.75 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -76.36 162.95 27.46 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.581 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -78.78 117.04 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -139.87 -65.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -137.74 103.78 5.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -133.28 143.53 49.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -102.63 32.08 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.756 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 38.1 m80 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.518 -179.589 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' CG ' HG13 ' A' ' 225' ' ' VAL . 12.7 tpp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.23 19.78 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.915 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -109.96 135.82 50.21 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.168 0.984 . . . . 0.0 111.502 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.659 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 14' ' ' GLY . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 5' ' ' VAL . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 58' ' ' VAL . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.653 HG22 ' N ' ' A' ' 61' ' ' ALA . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 56' ' ' ILE . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.626 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 18' ' ' VAL . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 44' ' ' ILE . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' N ' HG22 ' A' ' 34' ' ' THR . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 72' ' ' ILE . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 69' ' ' ILE . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.73 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.503 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.565 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.509 HG23 HG13 ' A' ' 119' ' ' VAL . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HG3' HD12 ' A' ' 152' ' ' ILE . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 108' ' ' ILE . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.503 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.467 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.693 ' HA ' HD12 ' A' ' 166' ' ' ILE . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 163' ' ' THR . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 165' ' ' MET . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 147' ' ' ILE . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 211' ' ' ILE . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -61.46 -49.28 77.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.45 -37.98 88.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -62.49 -45.73 91.7 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -59.84 -36.74 77.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -78.62 -1.3 33.58 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.16 34.09 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.047 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.563 HG13 ' CG ' ' A' ' 1' ' ' MET . 24.6 t -79.94 131.87 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.78 125.66 25.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.062 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 227' ' ' LEU . 8.9 tt -135.2 115.27 13.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.31 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -116.72 132.47 56.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.632 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.97 146.78 16.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.486 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -124.0 129.9 51.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -135.94 -63.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -133.17 155.96 48.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.445 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -128.91 114.68 16.77 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.8 t60 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.571 -179.934 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.13 12.22 19.76 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.854 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -109.88 135.77 50.24 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.123 0.961 . . . . 0.0 111.528 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 38' ' ' MET . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 67' ' ' MET . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE3' ' O ' ' A' ' 10' ' ' ASP . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 44' ' ' ILE . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 56' ' ' ILE . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.823 HG21 HG23 ' A' ' 44' ' ' ILE . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG21 ' HB1' ' A' ' 71' ' ' ALA . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.542 ' CG ' HD12 ' A' ' 33' ' ' ILE . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' A' ' 41' ' ' ILE . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.721 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 85' ' ' ALA . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.721 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 139' ' ' VAL . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 119' ' ' VAL . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 152' ' ' ILE . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 HD12 ' A' ' 175' ' ' LEU . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.455 HD13 ' HA3' ' A' ' 124' ' ' GLY . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.697 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.671 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 147' ' ' ILE . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.62 ' HA ' HD11 ' A' ' 211' ' ' ILE . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.412 HD13 HG21 ' A' ' 211' ' ' ILE . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -61.49 -48.9 78.97 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.69 -38.24 89.59 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.198 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.52 -44.47 96.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -59.83 -37.65 79.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -78.13 -1.07 30.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.45 28.02 41.32 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.021 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.97 119.22 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -90.05 146.96 23.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.53 141.51 32.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.487 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.75 119.04 38.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -159.97 154.36 23.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -137.22 119.77 16.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.654 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -111.38 110.66 21.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.38 -41.9 88.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.614 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -118.4 130.79 56.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.514 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 63.6 m170 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.493 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 193' ' ' PHE . 10.9 ptp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.68 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HD3' HD11 ' A' ' 28' ' ' ILE . 70.7 mttt -109.94 135.82 50.2 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.022 0.911 . . . . 0.0 111.615 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 220' ' ' LEU . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 61' ' ' ALA . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.725 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 56' ' ' ILE . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' HG21 ' A' ' 18' ' ' VAL . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.741 HG21 HG23 ' A' ' 44' ' ' ILE . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.591 ' SD ' HD12 ' A' ' 33' ' ' ILE . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.691 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.509 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.691 HD22 ' CE1' ' A' ' 79' ' ' PHE . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.687 HG21 HG13 ' A' ' 139' ' ' VAL . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.485 HG23 HG13 ' A' ' 119' ' ' VAL . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.446 ' HG3' HD12 ' A' ' 152' ' ' ILE . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG13 HG23 ' A' ' 108' ' ' ILE . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.511 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.415 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.621 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.511 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.616 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.608 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 165' ' ' MET . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.621 HD12 HD11 ' A' ' 147' ' ' ILE . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 211' ' ' ILE . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.408 ' CG ' ' HB2' ' A' ' 1' ' ' MET . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -61.2 -48.73 80.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 4' ' ' ILE . 72.4 mt -62.72 -38.37 90.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.189 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.46 -43.88 97.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.339 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.67 -37.75 79.6 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -79.64 1.76 25.06 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.66 28.04 48.67 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.052 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.34 121.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -138.82 168.31 20.1 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.73 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 229' ' ' HIS . 15.8 tp -100.13 138.74 36.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.72 -41.6 95.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.683 ' O ' HD23 ' A' ' 227' ' ' LEU . 98.6 m-70 -105.1 111.5 24.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -160.06 90.5 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -145.43 163.0 35.99 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.561 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -158.1 -59.35 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -133.72 149.84 51.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.49 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.606 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptp . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.73 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.643 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -109.99 135.81 50.24 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.108 0.954 . . . . 0.0 111.687 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.623 HG11 ' HB2' ' A' ' 17' ' ' ALA . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.437 HG23 ' OE1' ' A' ' 16' ' ' GLU . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' OE1' HG23 ' A' ' 12' ' ' THR . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.663 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 67' ' ' MET . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 61' ' ' ALA . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.841 HG23 HG21 ' A' ' 56' ' ' ILE . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 ' CG1' ' A' ' 18' ' ' VAL . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.841 HG21 HG23 ' A' ' 44' ' ' ILE . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 71' ' ' ALA . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.574 ' HE3' HD12 ' A' ' 33' ' ' ILE . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.747 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.495 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.648 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.747 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 119' ' ' VAL . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.516 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.762 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.709 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 147' ' ' ILE . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.414 ' HE1' ' CB ' ' A' ' 215' ' ' GLU . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.543 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.414 ' CB ' ' HE1' ' A' ' 186' ' ' MET . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -61.28 -48.66 80.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.82 -39.14 93.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.58 -43.15 99.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.309 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.81 -38.74 82.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.592 0.234 . . . . 0.0 111.514 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -79.32 2.0 23.01 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.14 68.78 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.2 t -93.82 116.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -154.99 167.67 29.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.44 125.3 54.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.364 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -96.56 107.81 20.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -160.0 -62.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.51 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -136.38 170.09 16.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -102.99 129.45 49.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.494 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -138.69 118.97 13.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -137.45 154.85 49.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.495 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.898 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.91 135.81 50.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.204 1.002 . . . . 0.0 111.414 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 220' ' ' LEU . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.64 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 5' ' ' VAL . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 56' ' ' ILE . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 18' ' ' VAL . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 44' ' ' ILE . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.793 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.624 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 33' ' ' ILE . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.806 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.806 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.579 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.579 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.731 HG21 HG13 ' A' ' 139' ' ' VAL . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.454 HG23 HG13 ' A' ' 119' ' ' VAL . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.449 ' HG3' HD12 ' A' ' 152' ' ' ILE . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' ILE . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 106' ' ' VAL . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 HD12 ' A' ' 175' ' ' LEU . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.5 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 166' ' ' ILE . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.673 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 165' ' ' MET . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 147' ' ' ILE . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.715 ' HB ' HD12 ' A' ' 148' ' ' LEU . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.95 -48.2 82.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 4' ' ' ILE . 73.3 mt -62.39 -38.39 89.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.233 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.08 -44.99 95.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.438 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -59.86 -37.29 78.88 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -79.18 0.61 27.67 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 73.59 28.0 66.31 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.726 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.36 121.86 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -136.76 -63.91 0.6 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 227' ' ' LEU . 6.9 tt -154.12 110.19 3.25 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -131.09 145.21 51.92 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -158.33 -54.02 0.07 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -126.91 122.0 33.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.026 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -160.08 112.11 2.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.538 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -124.18 144.29 50.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.502 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -135.17 137.01 42.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.465 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.58 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 225' ' ' VAL . 21.5 ptp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 119.888 -0.101 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.14 12.13 19.76 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.753 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.92 135.9 50.06 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 118.005 0.903 . . . . 0.0 111.619 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 7' ' ' ILE . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 57' ' ' ILE . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.528 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 61' ' ' ALA . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.721 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.735 HG23 HG21 ' A' ' 56' ' ' ILE . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.578 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 30' ' ' THR . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.405 ' HB2' HD12 ' A' ' 80' ' ' ILE . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.63 ' N ' HG22 ' A' ' 34' ' ' THR . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 59' ' ' CYS . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 121' ' ' THR . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.62 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.62 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.624 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 146' ' ' GLU . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 HG13 ' A' ' 119' ' ' VAL . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HG3' HD12 ' A' ' 152' ' ' ILE . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 108' ' ' ILE . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.811 ' O ' HG23 ' A' ' 139' ' ' VAL . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 132' ' ' LEU . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 106' ' ' VAL . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.547 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 105' ' ' VAL . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 178' ' ' ILE . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 111' ' ' LYS . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.601 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 163' ' ' THR . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.721 ' HB ' HD12 ' A' ' 148' ' ' LEU . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 1' ' ' MET . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -61.09 -48.48 81.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 4' ' ' ILE . 32.7 mt -62.56 -39.03 92.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -62.73 -44.02 97.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -37.08 78.2 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -80.12 2.05 25.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.11 28.21 58.79 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.85 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 1' ' ' MET . 23.7 t -79.98 146.65 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -63.99 125.44 24.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.1 tp -119.07 142.09 48.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.9 146.91 54.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -65.47 118.33 9.27 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.591 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -124.24 145.02 49.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.459 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -104.16 130.31 51.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.554 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.06 88.73 0.83 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.22 -34.56 7.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.629 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HB2' ' CG ' ' A' ' 193' ' ' PHE . 22.6 ptm . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.16 12.07 19.73 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.677 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -109.89 135.85 50.11 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.116 0.958 . . . . 0.0 111.749 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 17' ' ' ALA . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.653 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' HB ' ' A' ' 57' ' ' ILE . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 61' ' ' ALA . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 56' ' ' ILE . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.714 ' OE1' HG21 ' A' ' 18' ' ' VAL . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 18' ' ' VAL . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 80' ' ' ILE . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.561 ' HB2' HD12 ' A' ' 80' ' ' ILE . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 34' ' ' THR . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.69 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 59' ' ' CYS . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.493 HG23 ' HB ' ' A' ' 121' ' ' THR . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.712 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 95' ' ' LEU . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.712 HD11 ' HB1' ' A' ' 85' ' ' ALA . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.603 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 146' ' ' GLU . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.782 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG13 ' A' ' 119' ' ' VAL . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 152' ' ' ILE . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 108' ' ' ILE . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 126' ' ' LYS . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 122' ' ' TYR . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.778 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.782 HG13 HG21 ' A' ' 106' ' ' VAL . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HB2' HG22 ' A' ' 105' ' ' VAL . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 175' ' ' LEU . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 169' ' ' VAL . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' A' ' 111' ' ' LYS . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.711 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.681 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.611 HD12 HD11 ' A' ' 147' ' ' ILE . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 211' ' ' ILE . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.406 ' CG ' ' HB2' ' A' ' 1' ' ' MET . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.27 -46.81 88.51 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 225' ' ' VAL . 72.7 mt -62.86 -40.15 96.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.036 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -61.53 -43.83 98.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.504 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -59.55 -36.13 75.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -85.56 7.57 22.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.21 28.02 29.15 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.371 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 220' ' ' LEU . 39.9 t -79.89 162.29 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 225' ' ' VAL . 36.2 m120 -52.22 128.15 24.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.9 -178.57 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -151.73 -176.12 5.49 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.382 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -66.08 138.83 58.02 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.454 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -87.5 102.18 14.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.627 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.09 -39.73 86.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -106.54 -178.74 3.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.52 166.34 18.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.514 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.543 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.49 12.29 47.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.389 -0.673 . . . . 0.0 112.745 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -109.85 135.82 50.13 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.163 0.982 . . . . 0.0 111.596 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 21' ' ' TYR . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.515 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.712 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 56' ' ' ILE . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.641 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 44' ' ' ILE . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.78 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.579 ' N ' HG22 ' A' ' 34' ' ' THR . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' HD13 ' A' ' 41' ' ' ILE . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.461 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' CE1' ' A' ' 79' ' ' PHE . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 119' ' ' VAL . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 152' ' ' ILE . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.58 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 108' ' ' ILE . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.57 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 137' ' ' VAL . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 175' ' ' LEU . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.706 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 169' ' ' VAL . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 111' ' ' LYS . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.707 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.668 ' HA ' HD12 ' A' ' 166' ' ' ILE . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 163' ' ' THR . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 165' ' ' MET . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 147' ' ' ILE . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.707 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HA ' HD11 ' A' ' 211' ' ' ILE . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.71 -46.89 88.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.34 -38.9 91.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.193 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -61.85 -44.75 96.21 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.448 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -59.73 -37.1 78.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -81.52 3.61 24.26 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.08 62.18 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 118.343 0.519 . . . . 0.0 112.049 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.59 125.97 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -84.4 132.18 34.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 227' ' ' LEU . 6.7 mp -82.66 164.94 20.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.522 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.24 -33.58 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -90.7 172.09 8.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -97.86 161.1 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.604 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -123.99 170.28 10.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.457 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.55 157.12 43.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -128.94 133.82 47.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.511 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.498 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 119.844 -0.122 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.07 12.16 19.94 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.961 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -109.9 135.77 50.25 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.207 1.003 . . . . 0.0 111.428 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.689 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 44' ' ' ILE . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 56' ' ' ILE . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.57 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.529 HD11 HG13 ' A' ' 18' ' ' VAL . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 44' ' ' ILE . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' N ' HG22 ' A' ' 34' ' ' THR . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 69' ' ' ILE . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 69' ' ' ILE . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.729 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.507 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.536 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.561 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.561 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 146' ' ' GLU . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.746 HG21 HG13 ' A' ' 139' ' ' VAL . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 119' ' ' VAL . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 152' ' ' ILE . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 108' ' ' ILE . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.507 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 131' ' ' LEU . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 137' ' ' VAL . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.785 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' HG22 ' A' ' 105' ' ' VAL . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 175' ' ' LEU . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 169' ' ' VAL . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.484 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.7 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.669 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 163' ' ' THR . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 147' ' ' ILE . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.7 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.643 ' HA ' HD11 ' A' ' 211' ' ' ILE . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.512 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.643 HD11 ' HA ' ' A' ' 185' ' ' LYS . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 211' ' ' ILE . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -61.04 -48.26 82.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.54 -38.86 91.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.144 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.33 -44.2 97.05 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.273 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.58 -36.52 76.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -83.13 5.65 21.89 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.96 27.99 35.94 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.316 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.95 150.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -63.97 153.53 36.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.29 177.14 5.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.582 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.24 174.55 2.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.539 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -65.4 142.6 58.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -65.46 94.83 0.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.62 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -69.02 158.15 35.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.535 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.22 165.75 17.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -102.49 142.61 33.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.56 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.635 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.05 12.2 19.99 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.37 -0.683 . . . . 0.0 112.876 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -110.02 135.85 50.2 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.211 1.006 . . . . 0.0 111.299 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.7 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.639 ' OE1' HG21 ' A' ' 18' ' ' VAL . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.609 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.827 HG21 HG23 ' A' ' 44' ' ' ILE . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.775 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HD12 ' A' ' 80' ' ' ILE . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.627 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.575 ' HG2' HD13 ' A' ' 41' ' ' ILE . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 59' ' ' CYS . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 86' ' ' VAL . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.519 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.651 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.614 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 146' ' ' GLU . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.795 HG21 HG13 ' A' ' 139' ' ' VAL . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 119' ' ' VAL . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 108' ' ' ILE . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 137' ' ' VAL . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.795 HG13 HG21 ' A' ' 106' ' ' VAL . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HB2' HG22 ' A' ' 105' ' ' VAL . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 175' ' ' LEU . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 169' ' ' VAL . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.641 ' HA ' HD12 ' A' ' 166' ' ' ILE . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 169' ' ' VAL . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 163' ' ' THR . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 165' ' ' MET . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.635 HD12 HD11 ' A' ' 147' ' ' ILE . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' A' ' 211' ' ' ILE . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.413 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.654 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -61.08 -48.47 81.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 69.9 mt -62.59 -38.17 89.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.203 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -45.95 90.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.72 -36.5 76.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -79.22 -1.2 35.29 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.55 28.17 33.47 Favored Glycine 0 C--N 1.344 1.004 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.985 175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 226' ' ' ASN . 25.5 t -79.91 159.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.432 ' N ' HG12 ' A' ' 225' ' ' VAL . 76.4 m-20 -59.99 127.76 33.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.576 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.855 HD13 ' CE1' ' A' ' 229' ' ' HIS . 58.3 mt -73.07 159.84 32.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.583 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -104.15 32.06 4.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.855 ' CE1' HD13 ' A' ' 227' ' ' LEU . 14.8 p80 -142.25 32.83 1.52 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.745 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -147.78 162.44 39.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -91.04 136.81 32.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -65.15 -35.99 82.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.659 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -95.86 124.63 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.532 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtm . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.19 12.16 19.61 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.788 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.84 135.83 50.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.02 0.91 . . . . 0.0 111.678 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG13 ' HB ' ' A' ' 12' ' ' THR . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 8' ' ' VAL . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.699 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.763 HG23 HG21 ' A' ' 56' ' ' ILE . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.601 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.763 HG21 HG23 ' A' ' 44' ' ' ILE . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.764 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 69' ' ' ILE . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.821 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.582 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.821 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 HG13 ' A' ' 139' ' ' VAL . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 119' ' ' VAL . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HG3' HD12 ' A' ' 152' ' ' ILE . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 108' ' ' ILE . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.818 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.588 HD11 HD12 ' A' ' 175' ' ' LEU . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 165' ' ' MET . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.724 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.7 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 147' ' ' ILE . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.705 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.724 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.403 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.93 -45.5 94.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 4' ' ' ILE . 68.0 mt -63.82 -44.88 91.92 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.365 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -66.16 -35.01 79.34 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.521 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -60.54 -38.83 85.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.426 0.155 . . . . 0.0 111.405 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -83.69 6.18 21.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.86 28.15 72.28 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.42 116.93 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -154.9 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.23 129.5 51.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.84 104.39 8.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.5 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -146.13 149.72 34.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.404 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -64.82 -36.03 83.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -102.77 136.08 43.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -137.99 -48.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.719 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -130.69 161.9 30.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.612 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.237 0.401 0 CA-C-O 121.247 0.546 . . . . 1.68 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 0.18 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 0.12 110.07 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 0.16 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 0.23 110.213 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 0.22 109.763 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 0.48 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 0.37 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 1.83 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.31 111.32 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 2.88 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.85 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 0.24 111.299 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 0.27 110.289 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.45 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.2 111.467 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 1.95 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.55 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 0.2 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 1.64 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.15 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.44 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 0.18 109.903 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 0.11 110.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.18 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 0.92 111.03 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.71 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 0.26 112.654 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 0.32 112.438 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 1.95 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.49 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.89 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 2.56 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.22 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.25 112.12 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 0.19 110.609 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.17 110.992 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.818 HG23 HG21 ' A' ' 56' ' ' ILE . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 0.17 110.406 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 1.81 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 0.16 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.18 111.531 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 2.79 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' CG1' ' A' ' 18' ' ' VAL . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 0.27 110.056 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.2 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.1 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 0.15 110.689 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.28 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 44' ' ' ILE . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 0.12 110.038 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.17 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 0.15 110.225 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.24 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 0.33 110.141 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.504 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.45 111.836 -176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.39 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.02 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.22 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.28 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 1.69 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 0.21 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 0.2 110.87 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.22 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 0.17 111.227 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 0.19 110.101 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 2.6 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 0.2 112.733 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.15 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 0.17 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.2 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.19 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.83 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.73 110.518 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 0.49 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 0.21 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.33 110.894 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 0.16 111.008 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 0.14 110.694 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 0.14 111.574 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 0.15 110.492 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 0.94 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.08 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 0.16 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.61 HD11 ' HB1' ' A' ' 85' ' ' ALA . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 0.12 109.321 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 0.16 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 2.58 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.83 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 0.32 111.235 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 0.15 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 0.3 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.25 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.15 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 0.99 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.83 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 0.28 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 0.24 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.17 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.723 HG21 HG13 ' A' ' 139' ' ' VAL . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 0.1 109.041 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.13 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.493 HG23 HG13 ' A' ' 119' ' ' VAL . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.1 110.007 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 0.13 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 152' ' ' ILE . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 0.71 109.377 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.91 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 0.25 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.22 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.14 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 0.32 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 108' ' ' ILE . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.13 110.83 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.17 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 0.16 109.79 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.19 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.16 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17 113.247 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.09 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 1.78 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.18 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.18 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 0.15 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 0.22 110.256 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 0.12 110.989 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 1.92 110.899 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.14 110.708 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 0.11 110.634 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 0.15 110.314 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.69 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 0.14 110.834 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.51 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 0.98 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.13 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 0.11 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.15 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.35 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.794 HD11 HD12 ' A' ' 175' ' ' LEU . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 0.12 109.671 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 0.13 109.272 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 0.12 109.692 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.13 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 0.17 109.931 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.16 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 0.35 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.41 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.4 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.2 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.17 109.806 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.543 ' HA ' HD12 ' A' ' 166' ' ' ILE . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 0.14 112.293 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.19 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.703 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.16 111.095 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.07 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.35 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 165' ' ' MET . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 0.15 110.973 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.15 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.19 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 0.3 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 0.25 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 0.32 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 147' ' ' ILE . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 0.22 110.556 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.13 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 0.11 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.12 109.227 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 0.11 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.15 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.16 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 0.26 111.31 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.16 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.28 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 0.56 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.3 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.33 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.16 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 0.24 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.67 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 0.13 111.497 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.19 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 0.2 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 0.14 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.13 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 0.13 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 0.11 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 0.13 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.14 110.163 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 0.23 110.994 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.31 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 0.22 112.575 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 1.23 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.52 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.25 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 0.25 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.27 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.31 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.28 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 0.22 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.28 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.43 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.38 110.81 179.661 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.282 0.563 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 57' ' ' ILE . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' CE ' ' A' ' 67' ' ' MET . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.702 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 56' ' ' ILE . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' OE1' HG21 ' A' ' 18' ' ' VAL . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 44' ' ' ILE . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 30' ' ' THR . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.784 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.628 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.543 ' CE ' HD12 ' A' ' 33' ' ' ILE . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ILE . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 121' ' ' THR . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.549 HD11 ' HB1' ' A' ' 85' ' ' ALA . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 139' ' ' VAL . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 119' ' ' VAL . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 108' ' ' ILE . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' HG23 ' A' ' 83' ' ' THR . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 131' ' ' LEU . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 137' ' ' VAL . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.731 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 175' ' ' LEU . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 169' ' ' VAL . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 192' ' ' ALA . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.697 ' HA ' HD12 ' A' ' 166' ' ' ILE . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.724 ' O ' HG23 ' A' ' 169' ' ' VAL . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 165' ' ' MET . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 147' ' ' ILE . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.44 ' HE1' ' CG ' ' A' ' 215' ' ' GLU . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.44 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.44 ' CG ' ' HE1' ' A' ' 186' ' ' MET . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 199' ' ' ALA . 47.8 mtmt . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.25 0.548 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.584 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.64 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.851 HG23 HG21 ' A' ' 56' ' ' ILE . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 18' ' ' VAL . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 50' ' ' ILE . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 18' ' ' VAL . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.851 HG21 HG23 ' A' ' 44' ' ' ILE . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.814 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.64 ' N ' HG22 ' A' ' 34' ' ' THR . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.814 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD22 ' CE1' ' A' ' 79' ' ' PHE . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.803 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 HG13 ' A' ' 119' ' ' VAL . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 152' ' ' ILE . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 131' ' ' LEU . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.815 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.612 HD11 HD12 ' A' ' 175' ' ' LEU . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.457 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.663 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.612 HD12 HD11 ' A' ' 147' ' ' ILE . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.664 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 211' ' ' ILE . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 121.268 0.556 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 61' ' ' ALA . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.836 HG21 HG23 ' A' ' 44' ' ' ILE . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.865 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.673 ' N ' HG22 ' A' ' 34' ' ' THR . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.865 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 121' ' ' THR . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.568 HD11 ' HB1' ' A' ' 85' ' ' ALA . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 79' ' ' PHE . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.704 HG21 HG13 ' A' ' 139' ' ' VAL . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 119' ' ' VAL . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 152' ' ' ILE . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 108' ' ' ILE . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.525 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 175' ' ' LEU . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.592 HD21 ' HG2' ' A' ' 165' ' ' MET . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 166' ' ' ILE . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.592 ' HG2' HD21 ' A' ' 149' ' ' LEU . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 163' ' ' THR . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 165' ' ' MET . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 147' ' ' ILE . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.54 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.553 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.553 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.216 0.532 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 17' ' ' ALA . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' GLY . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 57' ' ' ILE . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.759 HG23 HG21 ' A' ' 56' ' ' ILE . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 50' ' ' ILE . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 47' ' ' ILE . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG23 ' A' ' 44' ' ' ILE . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 30' ' ' THR . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.711 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 34' ' ' THR . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.617 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 33' ' ' ILE . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.534 HG22 ' HE3' ' A' ' 73' ' ' LYS . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' HE3' HG22 ' A' ' 69' ' ' ILE . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' A' ' 62' ' ' MET . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.44 HD11 ' HB1' ' A' ' 85' ' ' ALA . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.727 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 119' ' ' VAL . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 152' ' ' ILE . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 108' ' ' ILE . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.749 HG13 HG21 ' A' ' 106' ' ' VAL . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.602 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 169' ' ' VAL . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' MET . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 147' ' ' ILE . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.411 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.571 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.261 0.553 . . . . 0.0 111.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 14' ' ' GLY . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 61' ' ' ALA . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 41' ' ' ILE . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.681 ' OE1' HG21 ' A' ' 18' ' ' VAL . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.583 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.634 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.679 HG21 HG23 ' A' ' 44' ' ' ILE . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 33' ' ' ILE . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.605 ' N ' HG22 ' A' ' 34' ' ' THR . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 33' ' ' ILE . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HG2' HD13 ' A' ' 41' ' ' ILE . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.791 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.504 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.598 HD11 ' HB1' ' A' ' 85' ' ' ALA . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.56 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.56 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 119' ' ' VAL . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HG3' HD12 ' A' ' 152' ' ' ILE . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.532 HG13 HG23 ' A' ' 108' ' ' ILE . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 175' ' ' LEU . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.711 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 111' ' ' LYS . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.406 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.608 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 147' ' ' ILE . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.711 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 211' ' ' ILE . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.406 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.553 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB1' ' A' ' 202' ' ' ALA . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt . . . . . 0 N--CA 1.468 0.469 0 CA-C-O 121.31 0.576 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.659 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 14' ' ' GLY . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.62 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 5' ' ' VAL . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 58' ' ' VAL . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.653 HG22 ' N ' ' A' ' 61' ' ' ALA . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 56' ' ' ILE . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.626 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 18' ' ' VAL . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 44' ' ' ILE . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.653 ' N ' HG22 ' A' ' 34' ' ' THR . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 72' ' ' ILE . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 69' ' ' ILE . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.73 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.503 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.565 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.509 HG23 HG13 ' A' ' 119' ' ' VAL . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HG3' HD12 ' A' ' 152' ' ' ILE . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 108' ' ' ILE . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.503 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.467 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.693 ' HA ' HD12 ' A' ' 166' ' ' ILE . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 163' ' ' THR . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 165' ' ' MET . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 147' ' ' ILE . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 211' ' ' ILE . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.257 0.551 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 38' ' ' MET . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 67' ' ' MET . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE3' ' O ' ' A' ' 10' ' ' ASP . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 44' ' ' ILE . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 56' ' ' ILE . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.823 HG21 HG23 ' A' ' 44' ' ' ILE . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.715 HG21 ' HB1' ' A' ' 71' ' ' ALA . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.621 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.542 ' CG ' HD12 ' A' ' 33' ' ' ILE . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' A' ' 41' ' ' ILE . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.721 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 85' ' ' ALA . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.721 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 139' ' ' VAL . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 119' ' ' VAL . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 152' ' ' ILE . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.79 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 HD12 ' A' ' 175' ' ' LEU . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.455 HD13 ' HA3' ' A' ' 124' ' ' GLY . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.697 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.671 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 147' ' ' ILE . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.62 ' HA ' HD11 ' A' ' 211' ' ' ILE . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.412 HD13 HG21 ' A' ' 211' ' ' ILE . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HD3' HD11 ' A' ' 28' ' ' ILE . 70.7 mttt . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.205 0.526 . . . . 0.0 111.615 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 61' ' ' ALA . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.725 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 56' ' ' ILE . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' HG21 ' A' ' 18' ' ' VAL . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.741 HG21 HG23 ' A' ' 44' ' ' ILE . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.654 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.591 ' SD ' HD12 ' A' ' 33' ' ' ILE . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.691 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.509 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.691 HD22 ' CE1' ' A' ' 79' ' ' PHE . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.687 HG21 HG13 ' A' ' 139' ' ' VAL . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.485 HG23 HG13 ' A' ' 119' ' ' VAL . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.446 ' HG3' HD12 ' A' ' 152' ' ' ILE . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG13 HG23 ' A' ' 108' ' ' ILE . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.511 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.415 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.621 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.511 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.616 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.608 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 165' ' ' MET . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.621 HD12 HD11 ' A' ' 147' ' ' ILE . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 211' ' ' ILE . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 121.279 0.561 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.623 HG11 ' HB2' ' A' ' 17' ' ' ALA . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.437 HG23 ' OE1' ' A' ' 16' ' ' GLU . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' OE1' HG23 ' A' ' 12' ' ' THR . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.623 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.663 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 67' ' ' MET . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 61' ' ' ALA . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.841 HG23 HG21 ' A' ' 56' ' ' ILE . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 ' CG1' ' A' ' 18' ' ' VAL . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.841 HG21 HG23 ' A' ' 44' ' ' ILE . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 71' ' ' ALA . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.574 ' HE3' HD12 ' A' ' 33' ' ' ILE . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.747 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.495 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.648 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.747 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 119' ' ' VAL . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.516 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.762 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.709 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 147' ' ' ILE . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.414 ' HE1' ' CB ' ' A' ' 215' ' ' GLU . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.543 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.414 ' CB ' ' HE1' ' A' ' 186' ' ' MET . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.274 0.559 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.64 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 5' ' ' VAL . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 56' ' ' ILE . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 18' ' ' VAL . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 44' ' ' ILE . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.793 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.624 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 33' ' ' ILE . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.806 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.806 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.579 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.579 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.731 HG21 HG13 ' A' ' 139' ' ' VAL . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.454 HG23 HG13 ' A' ' 119' ' ' VAL . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.449 ' HG3' HD12 ' A' ' 152' ' ' ILE . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' ILE . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 106' ' ' VAL . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 HD12 ' A' ' 175' ' ' LEU . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.5 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 166' ' ' ILE . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.673 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 165' ' ' MET . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 147' ' ' ILE . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.715 ' HB ' HD12 ' A' ' 148' ' ' LEU . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.169 0.509 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 7' ' ' ILE . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 57' ' ' ILE . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.528 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 61' ' ' ALA . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.721 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.735 HG23 HG21 ' A' ' 56' ' ' ILE . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.578 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 30' ' ' THR . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.742 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.405 ' HB2' HD12 ' A' ' 80' ' ' ILE . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.63 ' N ' HG22 ' A' ' 34' ' ' THR . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 59' ' ' CYS . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 121' ' ' THR . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.62 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.62 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.624 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 146' ' ' GLU . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 HG13 ' A' ' 119' ' ' VAL . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HG3' HD12 ' A' ' 152' ' ' ILE . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 108' ' ' ILE . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.811 ' O ' HG23 ' A' ' 139' ' ' VAL . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 132' ' ' LEU . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 106' ' ' VAL . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.547 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 105' ' ' VAL . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 178' ' ' ILE . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 111' ' ' LYS . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.601 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 163' ' ' THR . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.721 ' HB ' HD12 ' A' ' 148' ' ' LEU . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--O 1.237 0.402 0 CA-C-O 121.248 0.547 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 17' ' ' ALA . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.653 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' HB ' ' A' ' 57' ' ' ILE . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 61' ' ' ALA . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 56' ' ' ILE . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.714 ' OE1' HG21 ' A' ' 18' ' ' VAL . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 18' ' ' VAL . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 80' ' ' ILE . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.561 ' HB2' HD12 ' A' ' 80' ' ' ILE . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 34' ' ' THR . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.69 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 59' ' ' CYS . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.493 HG23 ' HB ' ' A' ' 121' ' ' THR . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.712 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 95' ' ' LEU . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.712 HD11 ' HB1' ' A' ' 85' ' ' ALA . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.603 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 146' ' ' GLU . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.782 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG13 ' A' ' 119' ' ' VAL . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 152' ' ' ILE . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 108' ' ' ILE . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 126' ' ' LYS . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 122' ' ' TYR . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.778 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.782 HG13 HG21 ' A' ' 106' ' ' VAL . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HB2' HG22 ' A' ' 105' ' ' VAL . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 175' ' ' LEU . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 169' ' ' VAL . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' A' ' 111' ' ' LYS . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.711 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.681 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.611 HD12 HD11 ' A' ' 147' ' ' ILE . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 211' ' ' ILE . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.415 0.626 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 21' ' ' TYR . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.515 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.712 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 56' ' ' ILE . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.641 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 44' ' ' ILE . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.78 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.579 ' N ' HG22 ' A' ' 34' ' ' THR . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' HD13 ' A' ' 41' ' ' ILE . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.461 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' CE1' ' A' ' 79' ' ' PHE . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 119' ' ' VAL . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 152' ' ' ILE . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.58 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 108' ' ' ILE . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.57 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 131' ' ' LEU . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 137' ' ' VAL . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 175' ' ' LEU . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.706 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 169' ' ' VAL . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 111' ' ' LYS . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.707 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.668 ' HA ' HD12 ' A' ' 166' ' ' ILE . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 163' ' ' THR . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 165' ' ' MET . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 147' ' ' ILE . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.707 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HA ' HD11 ' A' ' 211' ' ' ILE . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 121.27 0.557 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.689 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 44' ' ' ILE . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 56' ' ' ILE . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.57 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.529 HD11 HG13 ' A' ' 18' ' ' VAL . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 44' ' ' ILE . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' N ' HG22 ' A' ' 34' ' ' THR . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 69' ' ' ILE . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 69' ' ' ILE . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.729 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.507 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.536 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.536 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.561 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.561 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 146' ' ' GLU . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.746 HG21 HG13 ' A' ' 139' ' ' VAL . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 119' ' ' VAL . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 152' ' ' ILE . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 108' ' ' ILE . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.507 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 131' ' ' LEU . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 137' ' ' VAL . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.785 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' HG22 ' A' ' 105' ' ' VAL . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 175' ' ' LEU . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 169' ' ' VAL . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.484 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.7 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.669 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 163' ' ' THR . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 147' ' ' ILE . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.7 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.643 ' HA ' HD11 ' A' ' 211' ' ' ILE . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.512 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.643 HD11 ' HA ' ' A' ' 185' ' ' LYS . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 211' ' ' ILE . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.31 0.576 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.7 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.639 ' OE1' HG21 ' A' ' 18' ' ' VAL . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.609 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.827 HG21 HG23 ' A' ' 44' ' ' ILE . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.775 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HD12 ' A' ' 80' ' ' ILE . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.627 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.627 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.575 ' HG2' HD13 ' A' ' 41' ' ' ILE . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 59' ' ' CYS . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 86' ' ' VAL . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.519 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.651 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.614 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 146' ' ' GLU . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.795 HG21 HG13 ' A' ' 139' ' ' VAL . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 119' ' ' VAL . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 108' ' ' ILE . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 137' ' ' VAL . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.795 HG13 HG21 ' A' ' 106' ' ' VAL . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HB2' HG22 ' A' ' 105' ' ' VAL . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 175' ' ' LEU . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 169' ' ' VAL . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.641 ' HA ' HD12 ' A' ' 166' ' ' ILE . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 169' ' ' VAL . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 163' ' ' THR . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 165' ' ' MET . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.635 HD12 HD11 ' A' ' 147' ' ' ILE . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' A' ' 211' ' ' ILE . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.413 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.654 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt . . . . . 0 N--CA 1.466 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 HG13 ' HB ' ' A' ' 12' ' ' THR . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 8' ' ' VAL . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.699 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.763 HG23 HG21 ' A' ' 56' ' ' ILE . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.601 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.763 HG21 HG23 ' A' ' 44' ' ' ILE . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.764 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 69' ' ' ILE . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.821 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.582 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.821 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 HG13 ' A' ' 139' ' ' VAL . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 119' ' ' VAL . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HG3' HD12 ' A' ' 152' ' ' ILE . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 108' ' ' ILE . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.818 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.588 HD11 HD12 ' A' ' 175' ' ' LEU . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 165' ' ' MET . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.724 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.7 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 147' ' ' ILE . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.705 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.724 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.403 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.556 -0.535 . . . . 2.12 109.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.09 19.91 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.332 -0.705 . . . . 0.47 112.867 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -109.98 135.74 50.35 Favored 'General case' 0 C--N 1.347 0.474 0 CA-C-N 118.253 1.026 . . . . 1.68 111.455 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.37 132.94 54.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.362 -0.835 . . . . 0.18 109.113 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.08 132.33 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.07 -0.344 . . . . 0.12 110.07 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.89 135.38 47.44 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.143 -0.48 . . . . 0.16 110.215 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.71 115.03 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.871 0.367 . . . . 0.23 110.213 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.0 104.94 17.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.145 -0.479 . . . . 0.22 109.763 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.14 172.08 12.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.04 -0.527 . . . . 0.56 110.673 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.02 -18.38 45.75 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.12 -0.491 . . . . 0.56 112.218 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.79 -15.06 60.76 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.686 0.624 . . . . 0.48 112.686 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -106.13 144.34 32.98 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.018 0.372 . . . . 0.37 110.323 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -71.7 145.72 48.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.012 -0.54 . . . . 1.83 110.669 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.676 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.99 -36.7 92.66 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.32 -0.712 . . . . 0.31 111.32 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.9 ttm105 -61.91 -41.26 97.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 2.88 110.953 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.42 -44.6 94.15 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.214 -0.448 . . . . 1.85 110.837 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.7 -39.89 90.2 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.361 -0.381 . . . . 0.24 111.299 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.4 t -62.87 -45.09 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.353 -0.385 . . . . 0.27 110.289 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -60.02 -38.37 82.48 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.181 0.515 . . . . 2.02 110.95 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -62.5 -42.52 99.55 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.832 -0.622 . . . . 2.45 111.035 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.609 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -62.73 -32.8 74.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.481 -0.327 . . . . 0.2 111.467 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -64.0 -50.37 68.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 1.95 110.992 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.13 -56.02 5.05 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.217 -0.447 . . . . 2.55 111.991 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.35 -46.99 74.87 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.685 -0.487 . . . . 0.2 109.685 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.6 mttt 58.24 66.38 2.68 Favored Pre-proline 0 CA--C 1.556 1.208 0 CA-C-N 115.804 -0.634 . . . . 1.64 111.728 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.69 174.16 13.13 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.647 1.564 . . . . 0.15 111.594 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -93.78 -40.09 10.39 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.143 -0.48 . . . . 1.44 109.959 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.02 140.87 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.794 -0.639 . . . . 0.18 109.903 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.18 122.81 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.257 -0.429 . . . . 0.11 110.032 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.1 p -107.06 119.03 38.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.18 110.256 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.53 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 11.8 ttm -120.51 136.87 54.64 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.419 -0.355 . . . . 0.92 111.03 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -88.17 127.64 35.43 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.093 -0.503 . . . . 0.71 111.263 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.07 -3.98 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 112.654 0.613 . . . . 0.26 112.654 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.613 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.04 -15.82 5.93 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.409 0.55 . . . . 0.32 112.438 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.6 mtt -114.84 87.07 14.17 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 109.621 -0.511 . . . . 1.95 109.621 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -48.32 -25.78 7.59 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 121.927 1.752 . . . . 0.49 114.067 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -55.28 -23.09 21.29 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.07 0.767 . . . . 1.89 113.07 -176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 19.3 mmt -87.55 -2.02 58.33 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.424 0.898 . . . . 2.56 113.424 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 m120 60.17 52.65 4.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.798 0.808 . . . . 1.22 110.939 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.98 -55.08 32.89 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.848 -0.615 . . . . 0.25 112.12 -176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.9 mt -63.69 -28.36 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.802 0.301 . . . . 0.19 110.609 -177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.58 -45.19 94.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.444 0.64 . . . . 1.6 110.311 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.07 -38.92 90.63 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.17 110.992 176.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.818 HG23 HG21 ' A' ' 56' ' ' ILE . 87.0 mt -57.95 -40.27 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-O 120.882 0.372 . . . . 0.17 110.406 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -61.32 -41.13 96.51 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.056 -0.52 . . . . 1.81 110.776 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.6 mt-10 -61.99 -41.94 98.59 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.886 -0.597 . . . . 1.72 111.361 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.5 mm -62.35 -42.23 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 110.478 -0.193 . . . . 0.16 110.478 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -60.62 -42.64 97.26 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.688 0.28 . . . . 0.18 111.531 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -62.81 -44.64 95.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 2.79 111.089 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' CG1' ' A' ' 18' ' ' VAL . 25.0 mt -64.99 -48.19 85.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.98 -0.555 . . . . 0.27 110.056 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.17 87.06 6.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.129 -0.487 . . . . 0.67 110.043 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.12 -18.89 31.06 Favored 'Trans proline' 0 N--CA 1.506 2.21 0 C-N-CA 121.659 1.572 . . . . 0.2 113.318 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.46 9.1 24.84 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.807 0.669 . . . . 1.1 112.807 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.88 153.06 37.02 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.131 0.423 . . . . 0.15 110.689 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -93.97 101.47 13.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.546 -0.539 . . . . 2.28 109.546 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.818 HG21 HG23 ' A' ' 44' ' ' ILE . 19.8 mt -95.31 131.4 42.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.319 0.58 . . . . 0.12 110.038 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.7 mt -118.99 140.78 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.922 -0.77 . . . . 0.17 108.922 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.759 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.1 t -121.77 131.99 71.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.111 0.482 . . . . 0.15 110.225 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.5 t -98.39 115.73 29.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.745 -0.661 . . . . 0.24 109.986 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -105.67 150.77 25.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.942 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.43 148.14 37.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.626 . . . . 0.33 110.141 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.504 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 23.0 ttt -59.47 120.8 10.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.416 -0.356 . . . . 2.45 111.836 -176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.07 56.1 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.163 -0.798 . . . . 0.39 113.453 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -99.52 77.9 2.13 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 118.446 1.123 . . . . 2.02 110.819 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -63.36 -50.08 71.32 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.719 -0.673 . . . . 2.22 110.791 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.55 -29.9 70.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.28 111.218 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 39.9 mmm -63.98 -41.62 97.47 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.992 0.425 . . . . 1.69 110.336 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.1 t -60.77 -38.74 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 116.25 -0.432 . . . . 0.21 110.317 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.554 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -62.03 -46.93 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.046 0.451 . . . . 0.2 110.87 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.24 -41.33 96.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.131 -0.486 . . . . 2.22 111.172 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.75 -38.1 84.02 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.27 -0.423 . . . . 0.17 111.227 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.07 -43.8 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.082 -0.508 . . . . 0.19 110.101 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -59.52 -32.9 70.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.696 0.284 . . . . 2.6 111.508 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.24 -9.81 54.86 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.733 0.642 . . . . 0.2 112.733 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.23 6.92 29.18 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 119.293 -0.726 . . . . 0.15 112.637 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.72 146.31 51.63 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.296 1.048 . . . . 0.17 110.021 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -108.29 -32.14 7.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.991 -0.55 . . . . 2.2 110.485 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 156.91 21.38 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.098 -0.572 . . . . 0.19 111.807 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.83 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.6 p90 -138.54 150.8 46.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.006 0.431 . . . . 0.73 110.518 176.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mt -109.22 146.63 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 121.36 0.6 . . . . 0.49 111.868 -168.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -134.81 155.86 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.099 -0.955 . . . . 0.21 109.17 171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 30.9 t-20 -137.93 -93.17 0.21 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 120.979 -0.288 . . . . 0.33 110.894 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.8 m -62.85 -33.32 75.01 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.284 0.493 . . . . 0.16 111.008 -175.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.53 -49.78 67.66 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.368 -0.378 . . . . 0.14 110.694 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.61 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.72 -37.09 80.56 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.561 -0.29 . . . . 0.14 111.574 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.6 t -67.4 -46.67 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.426 -0.352 . . . . 0.15 110.492 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -62.33 -37.71 86.7 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.543 0.211 . . . . 0.68 111.476 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -135.52 79.71 47.03 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.448 -0.342 . . . . 0.94 110.443 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.61 -25.1 7.41 Favored 'Trans proline' 0 N--CA 1.508 2.369 0 C-N-CA 121.96 1.774 . . . . 0.14 113.841 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.7 p -56.9 -28.58 62.09 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.083 -0.386 . . . . 1.08 111.864 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.17 -36.48 84.19 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.391 -0.368 . . . . 0.16 111.006 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.61 HD11 ' HB1' ' A' ' 85' ' ' ALA . 43.2 mt -67.55 -44.75 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.321 -0.622 . . . . 0.12 109.321 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.13 -44.38 96.76 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.927 -0.579 . . . . 0.16 111.201 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -62.94 -42.74 99.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.356 -0.384 . . . . 2.58 111.029 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.83 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 26.9 mt -62.31 -41.13 98.27 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.361 -0.382 . . . . 0.32 111.235 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.24 -46.58 86.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.628 -0.26 . . . . 0.15 110.812 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.06 -39.26 91.8 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 1.91 111.675 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.59 -53.98 8.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.554 0.575 . . . . 0.3 112.554 -173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -110.5 2.57 18.9 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.432 0.901 . . . . 0.25 113.432 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.49 131.68 7.42 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.41 -1.076 . . . . 0.15 110.41 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.75 -33.43 66.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.955 0.354 . . . . 0.99 111.955 -177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -67.75 -9.51 44.61 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.755 0.65 . . . . 1.83 112.755 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.81 -10.4 34.22 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.643 0.608 . . . . 0.28 112.643 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.01 121.28 53.99 Favored 'Isoleucine or valine' 0 C--N 1.347 0.47 0 CA-C-N 118.543 0.61 . . . . 0.24 110.309 -176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.4 t -108.25 126.95 64.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.473 -0.566 . . . . 0.17 109.473 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.723 HG21 HG13 ' A' ' 139' ' ' VAL . 28.2 t -100.69 117.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.041 -0.726 . . . . 0.1 109.041 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.91 133.97 42.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.13 110.764 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.493 HG23 HG13 ' A' ' 119' ' ' VAL . 42.2 mt -128.41 115.89 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.1 110.007 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -93.95 114.04 26.16 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.615 -0.883 . . . . 0.65 108.615 172.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.4 159.26 27.92 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.356 0.502 . . . . 0.13 112.356 -171.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 152' ' ' ILE . 45.1 mtpt -142.64 164.39 30.23 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.217 -0.901 . . . . 0.71 109.377 174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.3 mtm-85 -90.23 113.96 25.87 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.011 0.434 . . . . 0.91 110.14 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 42.4 t -133.82 133.53 56.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.891 -0.595 . . . . 0.25 109.599 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.35 29.06 16.24 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.368 0.507 . . . . 2.02 112.368 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.91 10.08 86.33 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 119.765 -0.464 . . . . 0.22 113.532 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -139.42 154.9 47.88 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 117.84 0.82 . . . . 1.5 109.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -76.68 123.02 25.51 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.164 0.29 . . . . 0.14 110.248 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.9 mtp -123.75 142.96 50.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.829 0.347 . . . . 0.32 110.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.493 HG13 HG23 ' A' ' 108' ' ' ILE . 31.5 t -84.47 140.08 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.13 110.83 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.07 138.06 54.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.778 -0.647 . . . . 0.17 109.819 174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.84 179.7 3.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.79 -0.448 . . . . 0.16 109.79 177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.93 52.33 2.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.735 0.779 . . . . 0.19 109.909 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.1 t 60.02 29.53 19.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.659 -0.701 . . . . 1.16 111.553 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.56 14.69 80.93 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.693 -0.504 . . . . 0.17 113.247 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -84.48 -33.6 23.57 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 117.833 0.817 . . . . 2.09 112.105 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -125.93 137.43 53.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.875 0.369 . . . . 1.78 111.431 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -81.73 139.75 34.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.017 -0.538 . . . . 0.18 110.591 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.4 p -94.12 -30.72 14.5 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.366 -0.379 . . . . 0.18 111.177 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.58 -18.08 57.46 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 121.151 -0.547 . . . . 0.17 111.856 -176.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.7 mt -68.92 132.1 33.29 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 117.788 0.794 . . . . 0.15 109.29 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.07 142.19 50.85 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 0.22 110.256 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.6 tp -61.23 -37.87 84.6 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.03 -0.532 . . . . 0.12 110.989 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.499 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.0 mtp180 -61.59 -49.51 76.33 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.097 0.475 . . . . 1.92 110.899 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.78 -38.13 79.78 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.672 -0.695 . . . . 0.63 110.932 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -66.17 -43.43 86.95 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 120.681 -0.408 . . . . 0.14 110.708 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.7 -40.82 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.485 0.184 . . . . 0.11 110.634 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.9 t -63.25 -43.51 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 120.941 -0.304 . . . . 0.15 110.314 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -62.46 -41.39 98.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.343 -0.39 . . . . 1.69 111.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.6 t -61.45 -40.25 85.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.591 -0.277 . . . . 0.14 110.834 -177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.94 -49.73 66.92 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.69 -0.404 . . . . 0.17 110.407 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -60.13 -33.17 71.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.724 0.297 . . . . 2.51 111.546 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.91 -20.09 65.06 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.269 0.47 . . . . 0.98 112.269 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.26 9.73 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.013 -0.613 . . . . 0.13 112.01 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.56 131.81 49.25 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.313 0.557 . . . . 0.11 110.605 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.18 92.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.952 -0.859 . . . . 0.15 110.952 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.93 167.22 27.27 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.397 -0.401 . . . . 1.35 110.96 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.794 HD11 HD12 ' A' ' 175' ' ' LEU . 37.8 mt -129.34 135.3 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 109.671 -0.492 . . . . 0.12 109.671 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.4 tp -104.63 107.03 17.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.272 -0.64 . . . . 0.13 109.272 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -85.34 108.85 18.01 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 123.484 0.49 . . . . 0.12 109.692 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.2 m -112.63 128.55 56.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.13 109.638 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.8 t -103.63 109.89 21.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.234 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.8 mt -71.34 -33.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 109.931 -0.396 . . . . 0.17 109.931 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.31 -0.404 . . . . 0.19 111.266 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -97.91 -21.39 16.9 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.241 0.459 . . . . 2.16 112.241 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -56.26 125.35 21.45 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.925 0.393 . . . . 0.76 112.032 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.17 -0.96 88.91 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-O 119.276 -0.736 . . . . 0.37 113.405 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.7 p -80.18 -39.14 29.88 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 118.395 1.098 . . . . 0.35 110.466 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.1 mttp 59.63 35.23 22.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.189 -0.459 . . . . 2.41 111.232 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.1 p -125.57 23.15 7.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.092 -0.504 . . . . 0.4 111.828 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.03 146.21 8.08 Favored Glycine 0 C--N 1.339 0.711 0 N-CA-C 111.117 -0.793 . . . . 0.2 111.117 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.719 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 53.5 m-85 -67.91 160.21 28.97 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.806 -0.442 . . . . 0.17 109.806 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -75.66 72.73 2.62 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.593 0.711 . . . . 0.27 110.343 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.543 ' HA ' HD12 ' A' ' 166' ' ' ILE . 75.7 p -56.07 -27.62 54.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.113 -0.494 . . . . 0.14 112.293 -176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -65.05 -52.69 54.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.975 0.416 . . . . 2.19 110.228 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.703 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.6 ttm -62.46 -36.18 81.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.015 -0.539 . . . . 0.16 111.095 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.3 mt -62.93 -51.29 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 110.336 -0.246 . . . . 0.14 110.336 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -62.54 -37.79 87.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.857 0.361 . . . . 3.07 110.992 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -65.75 -39.57 91.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.35 111.748 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 165' ' ' MET . 43.2 t -75.49 -37.23 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.815 -0.175 . . . . 0.15 110.973 -177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.95 -52.27 19.83 Favored Pre-proline 0 CA--C 1.558 1.265 0 N-CA-C 113.789 1.033 . . . . 0.15 113.789 -175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -66.91 -9.96 26.73 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.459 1.439 . . . . 0.19 114.386 -173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.6 mt -100.19 -5.78 27.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.105 0.78 . . . . 0.3 113.105 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.14 141.96 28.02 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.581 0.628 . . . . 0.25 112.16 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.4 p -100.04 18.34 18.78 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.666 -0.697 . . . . 0.32 111.622 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 147' ' ' ILE . 21.1 mt -94.62 167.23 13.6 Favored Pre-proline 0 C--N 1.347 0.491 0 CA-C-O 119.357 -0.354 . . . . 0.22 110.556 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -70.17 133.77 25.59 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.368 1.379 . . . . 0.13 111.109 173.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.99 120.66 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 120.921 0.391 . . . . 0.11 110.132 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.5 mt -99.88 112.87 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.227 -0.657 . . . . 0.12 109.227 174.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.59 131.58 35.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.726 0.298 . . . . 0.11 110.755 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -135.96 127.82 29.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.057 -0.52 . . . . 0.15 111.338 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.09 126.57 3.42 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.493 -0.643 . . . . 0.14 111.493 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.14 -16.12 57.33 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 119.406 -0.663 . . . . 0.16 113.078 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.719 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.3 113.49 2.93 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.988 0.894 . . . . 0.26 111.31 -176.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.22 -32.27 0.63 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 116.046 -0.524 . . . . 0.16 112.83 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -146.5 168.53 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 117.61 0.705 . . . . 2.28 110.612 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.9 mtt -54.01 -36.57 63.11 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.625 0.602 . . . . 0.56 112.625 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -34.13 73.79 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.579 -0.282 . . . . 2.3 111.342 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -69.52 -35.11 75.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.33 110.116 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -63.14 -48.18 79.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.024 0.44 . . . . 0.16 110.654 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.3 tp -61.31 -39.19 89.57 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.997 -0.547 . . . . 0.24 111.144 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.66 -45.58 92.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.872 0.368 . . . . 1.67 111.054 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.88 -39.12 88.04 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.402 -0.363 . . . . 0.13 111.497 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.81 -43.92 87.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.033 -0.531 . . . . 0.19 110.753 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.61 -31.81 70.97 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.854 0.359 . . . . 0.2 111.221 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.73 -7.59 40.71 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.736 0.643 . . . . 0.14 112.736 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.06 36.22 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.12 -0.822 . . . . 0.13 113.251 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.93 146.07 48.05 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.354 1.077 . . . . 0.13 110.02 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.73 -27.38 15.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.17 111.157 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.77 153.19 37.81 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.095 -0.335 . . . . 0.13 110.095 175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.82 129.66 55.35 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.952 0.406 . . . . 0.11 111.048 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.2 141.87 35.5 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.972 -0.558 . . . . 0.13 111.1 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -156.35 134.86 11.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.93 -0.577 . . . . 0.14 110.163 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.97 -49.36 1.73 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.486 -0.324 . . . . 0.23 110.994 -178.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.2 m -61.57 -46.09 91.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.319 -0.4 . . . . 1.31 111.375 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.2 m -58.4 -22.22 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 112.575 0.583 . . . . 0.22 112.575 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -91.86 -49.92 6.0 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 120.972 -0.291 . . . . 0.27 111.02 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -59.8 -34.55 73.19 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.884 0.327 . . . . 1.23 111.884 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.95 10.26 34.14 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.13 0.789 . . . . 0.52 113.13 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 57.06 49.06 14.39 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.345 0.521 . . . . 3.25 112.008 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -95.94 -46.08 6.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.107 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.6 mt -115.27 137.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 116.074 -0.512 . . . . 0.25 109.861 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -81.2 124.18 29.07 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.814 -0.63 . . . . 0.31 109.898 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.98 -53.2 48.4 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 121.434 -0.413 . . . . 0.27 112.527 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -59.93 -47.46 85.69 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 111.89 0.33 . . . . 3.31 111.89 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -60.8 -33.96 73.79 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.712 0.291 . . . . 2.28 111.337 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 18.3 tp -60.71 -44.56 96.45 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.226 0.536 . . . . 0.22 110.804 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -61.85 -42.09 98.62 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.812 -0.631 . . . . 1.28 110.818 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.25 -35.17 76.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.049 -0.523 . . . . 2.43 111.28 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -61.41 -48.96 78.83 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.188 0.518 . . . . 0.38 110.81 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.2 mt -62.47 -38.35 89.5 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.705 -0.68 . . . . 0.45 111.195 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.44 -44.49 96.3 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.234 -0.439 . . . . 2.28 111.309 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -59.86 -37.96 80.78 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.591 0.219 . . . . 2.4 111.591 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -77.74 -1.07 29.44 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.162 0.801 . . . . 0.63 113.162 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.13 28.08 62.93 Favored Glycine 0 C--N 1.344 1.013 0 C-N-CA 121.143 -0.551 . . . . 0.65 111.745 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.3 t -103.32 116.9 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 109.635 -0.506 . . . . 1.03 109.635 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -160.01 160.84 33.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.103 -0.499 . . . . 3.39 110.571 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 62.7 mt -83.89 160.21 21.17 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.046 -0.524 . . . . 5.19 110.437 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -65.03 91.37 0.09 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.234 -0.439 . . . . 6.5 110.731 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -150.1 172.54 15.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.026 -0.534 . . . . 8.37 110.52 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -102.34 132.41 48.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.058 -0.519 . . . . 9.96 110.497 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -103.74 136.95 42.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.157 -0.474 . . . . 10.77 110.536 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -149.3 110.48 4.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.052 -0.522 . . . . 13.3 110.545 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -134.87 153.37 52.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.088 -0.505 . . . . 14.36 110.565 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 118.052 -0.975 . . . . 16.06 110.473 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.886 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -109.96 135.81 50.22 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.181 0.991 . . . . 0.0 111.493 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.0 mm -108.51 132.7 55.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.056 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.96 131.35 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -106.17 135.09 48.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.11 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.5 mt -112.66 115.49 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.842 0.354 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.99 105.04 17.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.812 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -88.89 177.05 6.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.589 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -59.44 -18.83 42.72 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 -14.98 60.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -111.09 138.89 46.96 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 118.03 0.377 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -70.68 149.55 46.87 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.94 -36.19 91.77 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -62.01 -41.85 98.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.809 0.338 . . . . 0.0 110.931 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -63.53 -44.07 95.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.826 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.95 -39.95 91.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.336 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.6 t -63.18 -45.65 97.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.264 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.05 -38.09 81.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.172 0.511 . . . . 0.0 111.004 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -62.57 -42.99 99.89 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.054 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.15 -32.15 73.46 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.648 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -64.66 -50.78 65.71 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.744 0.307 . . . . 0.0 110.939 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.17 -56.02 5.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.891 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.6 tp -64.22 -47.08 81.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.5 mttt 58.11 64.67 3.65 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.689 -174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.22 174.18 12.49 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 121.654 1.569 . . . . 0.0 111.767 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.91 -40.22 9.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.897 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.5 mt -119.96 139.18 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.781 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -131.58 122.11 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.034 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 57' ' ' ILE . 62.8 p -107.51 120.73 43.01 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.353 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 12.7 ttm -121.83 137.43 54.78 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.013 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -88.54 126.84 35.46 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.265 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.543 HD12 ' CE ' ' A' ' 67' ' ' MET . 6.2 pt -112.96 -1.65 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.5 p -56.98 -16.44 6.95 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.446 0.566 . . . . 0.0 112.507 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.5 mtp -114.76 87.11 14.07 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.18 -26.4 5.36 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.978 1.785 . . . . 0.0 114.285 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.21 -24.32 41.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.2 ttp -81.68 -5.28 57.95 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.6 m120 61.25 50.09 5.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.723 0.773 . . . . 0.0 110.671 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.1 -55.05 33.01 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.145 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.702 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.7 mt -63.2 -28.4 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.783 0.292 . . . . 0.0 110.613 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -62.87 -44.78 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.415 0.626 . . . . 0.0 110.268 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.51 -39.06 89.63 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 56' ' ' ILE . 82.6 mt -58.63 -40.64 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 120.908 0.385 . . . . 0.0 110.296 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -60.87 -40.36 92.68 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.05 0.452 . . . . 0.0 110.901 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' OE1' HG21 ' A' ' 18' ' ' VAL . 55.9 mt-10 -62.32 -42.24 99.21 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.93 -41.57 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.04 -43.48 98.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.657 0.265 . . . . 0.0 111.425 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -62.56 -43.55 98.53 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.1 mt -65.23 -48.9 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.007 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -146.19 87.17 6.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.975 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.18 -18.7 30.76 Favored 'Trans proline' 0 N--CA 1.506 2.238 0 C-N-CA 121.599 1.533 . . . . 0.0 113.42 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -88.46 9.07 24.9 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.97 153.05 38.72 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 118.152 0.433 . . . . 0.0 110.708 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -94.11 100.28 12.41 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.825 HG21 HG23 ' A' ' 44' ' ' ILE . 16.0 mt -95.16 130.65 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 121.137 0.494 . . . . 0.0 109.9 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 30' ' ' THR . 65.3 mt -117.94 140.39 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.784 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.4 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 110.204 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.7 t -99.15 120.42 39.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.845 177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.7 p -109.63 149.34 29.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.031 -176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.628 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.53 148.06 41.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.045 178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 50.8 ttp -59.15 120.44 9.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.862 0.363 . . . . 0.0 111.854 -176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 -0.03 56.12 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.21 -0.772 . . . . 0.0 113.473 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -98.18 77.85 2.44 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 118.454 1.127 . . . . 0.0 110.858 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -63.92 -50.03 70.3 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.704 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.53 -30.64 70.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.263 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.543 ' CE ' HD12 ' A' ' 33' ' ' ILE . 79.8 mmm -63.74 -41.27 98.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.025 0.441 . . . . 0.0 110.42 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.98 -39.0 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.333 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.6 mm -61.8 -45.92 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.947 0.404 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 81.8 mt-10 -61.28 -42.21 98.26 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.784 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.65 -38.18 84.0 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.308 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 69' ' ' ILE . 23.3 mt -65.36 -45.09 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.137 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -59.46 -32.26 70.07 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.511 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.44 -8.85 54.1 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.16 30.59 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.779 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.7 149.89 49.87 Favored 'General case' 0 C--N 1.349 0.57 0 CA-C-N 118.339 1.07 . . . . 0.0 110.033 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.77 -28.38 7.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.973 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.94 150.91 18.91 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.936 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.5 p90 -134.0 144.47 48.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.037 0.446 . . . . 0.0 110.781 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -108.53 149.34 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-O 121.418 0.628 . . . . 0.0 112.086 -168.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.19 157.22 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.214 171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.89 -95.43 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.942 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.521 HG23 ' HB ' ' A' ' 121' ' ' THR . 24.0 m -62.37 -33.11 74.1 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 118.565 0.62 . . . . 0.0 110.938 -174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.84 -46.97 79.68 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.87 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.41 -40.58 94.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.481 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 t -65.91 -44.84 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.566 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.54 -38.35 89.67 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.555 0.217 . . . . 0.0 111.406 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -136.44 80.06 40.25 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.377 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.55 -24.66 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.386 0 C-N-CA 121.964 1.776 . . . . 0.0 113.88 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.6 t -56.96 -28.61 62.43 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.045 -0.409 . . . . 0.0 111.867 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.12 -35.57 81.19 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.998 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.549 HD11 ' HB1' ' A' ' 85' ' ' ALA . 47.6 mt -67.97 -45.69 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 m -62.08 -43.68 98.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.209 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -63.55 -44.57 93.77 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.653 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 17.2 mt -62.89 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.142 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.8 -48.11 78.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.479 0.18 . . . . 0.0 110.719 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -61.74 -38.77 89.17 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.06 -54.09 8.59 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -111.71 5.91 19.49 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.85 129.34 6.65 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.21 -33.13 67.19 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.689 -0.3 . . . . 0.0 111.74 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -67.8 -9.57 45.4 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.38 -5.99 35.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.457 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.0 t -103.09 121.33 54.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.559 0 CA-C-N 118.667 0.667 . . . . 0.0 110.161 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.5 t -108.18 127.2 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.709 HG21 HG13 ' A' ' 139' ' ' VAL . 25.4 t -101.71 117.86 47.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.35 133.52 42.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 119' ' ' VAL . 46.4 mt -127.58 115.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.962 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.56 114.01 25.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.91 159.07 29.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -171.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.437 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.0 mtpt -141.85 163.92 31.58 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.388 174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mtm-85 -90.01 113.98 25.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.163 173.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.2 t -133.37 133.02 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.673 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.43 29.56 17.17 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.66 10.03 86.04 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-O 119.715 -0.492 . . . . 0.0 113.525 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.4 mt-10 -139.54 155.24 47.63 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.862 0.831 . . . . 0.0 109.158 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.73 124.93 28.4 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.21 0.319 . . . . 0.0 110.387 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.6 mtp -125.29 144.19 50.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.778 0.323 . . . . 0.0 110.908 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 108' ' ' ILE . 26.0 t -85.95 139.16 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.771 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.04 138.07 54.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.871 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' HG23 ' A' ' 83' ' ' THR . 22.0 p -113.52 179.99 3.8 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.66 52.32 2.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.739 0.78 . . . . 0.0 109.96 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.1 t 60.07 29.49 19.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.48 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.87 14.54 80.73 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.228 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -84.36 -33.68 23.77 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 117.9 0.85 . . . . 0.0 112.066 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.6 tttt -125.17 138.97 54.14 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.862 0.363 . . . . 0.0 111.481 -175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.81 139.43 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.69 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.8 p -91.74 -33.08 15.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.67 -17.81 56.98 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.763 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 76.8 mt -69.54 132.15 33.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 CA-C-N 117.708 0.754 . . . . 0.0 109.107 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 131' ' ' LEU . 27.1 mt -72.28 142.92 48.89 Favored 'General case' 0 CA--C 1.521 -0.16 0 O-C-N 123.4 0.438 . . . . 0.0 110.299 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.34 -34.33 75.1 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 137' ' ' VAL . 12.5 mtt180 -62.65 -52.59 62.71 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.621 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.99 -38.1 85.43 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.122 -176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.731 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.1 t-105 -65.9 -43.99 86.59 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.791 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.9 t -60.84 -40.8 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.402 -0.186 . . . . 0.0 110.573 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.07 -43.46 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.334 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.73 -41.58 99.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.185 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.34 -39.5 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.89 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -65.96 -50.66 63.57 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.293 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -60.05 -32.54 71.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.781 0.324 . . . . 0.0 111.58 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -67.96 -20.21 65.03 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 26.12 9.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.109 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.4 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.62 131.83 49.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 117.33 0.565 . . . . 0.0 110.606 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.79 -45.84 93.31 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -149.88 166.25 30.11 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.789 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 175' ' ' LEU . 36.5 mt -128.03 135.49 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.4 tp -104.41 106.97 17.67 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 169' ' ' VAL . 33.3 tp -85.28 108.88 17.98 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.8 m -112.27 126.73 55.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.601 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 t -101.54 109.94 21.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.142 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.1 mt -71.98 -34.62 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -64.68 -30.8 71.83 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.225 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -96.38 -21.65 17.65 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -56.84 125.12 21.04 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.894 0.378 . . . . 0.0 111.909 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 0.2 88.81 Favored Glycine 0 CA--C 1.541 1.667 0 CA-C-O 119.235 -0.759 . . . . 0.0 113.344 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -79.93 -39.1 30.99 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.41 1.105 . . . . 0.0 110.491 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 59.76 36.1 22.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.172 0.511 . . . . 0.0 111.16 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -126.47 23.13 6.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.822 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.56 148.9 9.09 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 192' ' ' ALA . 48.1 m-85 -67.97 160.49 28.56 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -75.91 73.58 2.82 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.586 0.708 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.697 ' HA ' HD12 ' A' ' 166' ' ' ILE . 66.6 p -56.81 -28.1 60.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.233 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -65.26 -53.39 44.89 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 110.313 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.724 ' O ' HG23 ' A' ' 169' ' ' VAL . 53.1 ttm -62.38 -36.06 81.09 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.141 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.3 mt -63.05 -51.23 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.419 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -62.35 -38.64 90.29 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -66.15 -38.19 87.51 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.87 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 165' ' ' MET . 45.3 t -75.48 -37.06 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 121.311 -0.156 . . . . 0.0 110.815 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.68 -52.31 18.6 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.8 -9.87 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.323 0 C-N-CA 121.439 1.426 . . . . 0.0 114.422 -174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 79.0 mt -101.93 -3.29 28.08 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.22 139.94 26.2 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.573 0.624 . . . . 0.0 112.101 -174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 78.3 p -99.05 18.3 17.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.475 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 147' ' ' ILE . 16.3 mt -96.18 167.11 12.99 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.368 -0.348 . . . . 0.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -69.73 134.2 27.47 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.335 1.357 . . . . 0.0 111.193 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.1 121.07 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.978 0.418 . . . . 0.0 110.073 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -99.98 112.24 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.192 174.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.96 131.44 35.16 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.681 0.276 . . . . 0.0 110.83 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.7 t -136.68 129.57 30.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.383 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.06 127.43 3.53 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.91 60.56 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.333 -0.704 . . . . 0.0 113.276 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.32 126.81 28.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.294 1.047 . . . . 0.0 111.326 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.76 -32.42 0.07 OUTLIER Glycine 0 CA--C 1.541 1.703 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.549 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -142.04 166.86 23.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.077 0.938 . . . . 0.0 110.249 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.44 ' HE1' ' CG ' ' A' ' 215' ' ' GLU . 44.9 mtt -55.45 -33.3 63.48 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.65 -33.78 73.32 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.29 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -67.49 -37.48 82.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.172 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.65 -48.17 80.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.001 0.429 . . . . 0.0 110.752 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.38 -39.64 91.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.14 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.91 -44.97 94.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.114 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.437 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.0 -38.33 85.66 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.821 0.344 . . . . 0.0 111.351 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.65 -44.21 87.03 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.726 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.9 mt -60.44 -32.04 71.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.5 -8.02 43.24 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.07 36.24 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.207 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.27 146.27 47.33 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 118.317 1.058 . . . . 0.0 109.986 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.42 -28.33 15.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.077 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.4 152.54 38.32 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.091 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.64 128.83 55.31 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.968 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.58 141.31 38.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.44 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.17 139.2 16.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.089 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.02 -47.63 1.78 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.01 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.7 t -60.92 -47.84 84.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.59 -176.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.44 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.7 m -58.24 -22.75 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -92.07 -49.68 6.08 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.083 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -59.79 -35.37 74.53 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -93.19 9.82 34.43 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 35.5 ttt85 57.14 49.02 14.29 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.317 0.508 . . . . 0.0 111.985 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -94.89 -46.14 6.99 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.097 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.21 139.54 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.751 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.7 133.85 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.195 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.05 49.46 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.7 -50.08 75.23 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.44 ' CG ' ' HE1' ' A' ' 186' ' ' MET . 30.7 tp10 -58.66 -36.02 73.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.834 0.35 . . . . 0.0 111.538 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.98 -45.89 91.65 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 110.799 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -61.95 -41.57 98.13 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.966 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.36 -37.15 82.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.244 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.19 -48.97 79.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.138 0.494 . . . . 0.0 110.864 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.88 -39.66 95.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.218 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -62.74 -42.69 99.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.309 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.07 -37.42 79.83 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -83.47 4.84 26.08 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 70.01 28.04 72.26 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.669 -0.573 . . . . 0.0 111.669 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.6 t -99.42 119.84 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -159.98 -63.89 0.07 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.507 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -157.15 126.97 6.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.503 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -94.21 126.56 39.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.49 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -156.85 156.77 33.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.59 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -114.78 136.78 52.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.441 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -102.34 135.02 44.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.591 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -105.46 141.99 35.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.572 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -119.58 141.17 49.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.5 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.588 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG2' HG13 ' A' ' 225' ' ' VAL . 20.4 ttt . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.0 12.09 20.17 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.937 -177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 199' ' ' ALA . 47.8 mtmt -109.99 135.7 50.42 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 118.218 1.009 . . . . 0.0 111.378 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -108.19 132.01 57.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.037 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.49 131.77 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 123.225 0.328 . . . . 0.0 110.15 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.3 tp -106.16 134.84 48.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.09 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.8 mt -110.65 118.3 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 120.831 0.348 . . . . 0.0 110.194 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.584 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.2 t -115.13 104.99 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.653 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -95.37 177.1 5.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.561 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -59.61 -17.97 37.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.95 -14.92 60.69 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -114.31 145.06 42.26 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 118.028 0.376 . . . . 0.0 110.273 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.23 150.66 38.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.74 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.23 -39.0 96.57 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -61.57 -40.56 95.17 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -63.42 -44.18 95.36 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.57 -40.0 90.06 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.375 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.0 t -63.44 -45.7 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.264 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.88 -37.92 80.73 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -62.94 -42.87 99.94 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.999 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.612 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.0 t80 -62.43 -31.67 72.41 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.521 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -64.5 -51.31 63.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.722 0.296 . . . . 0.0 110.881 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -75.09 -56.08 5.09 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.842 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.0 -47.03 81.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.012 0.434 . . . . 0.0 109.864 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 58.26 65.05 3.35 Favored Pre-proline 0 CA--C 1.558 1.271 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.662 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -74.39 174.18 12.99 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.657 1.571 . . . . 0.0 111.842 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -95.33 -39.23 10.14 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.063 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -120.32 140.48 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.91 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -130.6 123.49 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.055 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.2 p -107.99 119.46 39.54 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.285 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 ttm -121.73 136.45 54.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.14 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -88.76 126.35 35.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.236 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.493 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.05 -1.05 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.64 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.4 p -56.97 -15.77 5.61 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.491 0.587 . . . . 0.0 112.483 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -114.84 87.15 14.34 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.29 -19.21 33.78 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.463 1.442 . . . . 0.0 113.441 -170.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.64 -23.43 41.28 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 80.5 mtp -91.34 4.26 52.84 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 59.13 53.72 5.32 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.573 0.701 . . . . 0.0 111.269 178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.86 -52.25 54.06 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.847 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.2 mt -63.66 -28.02 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 121.063 -0.255 . . . . 0.0 110.578 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.95 -44.87 94.86 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.315 0.579 . . . . 0.0 110.256 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.43 -38.64 87.89 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.0 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.851 HG23 HG21 ' A' ' 56' ' ' ILE . 89.9 mt -58.41 -40.37 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 120.988 0.423 . . . . 0.0 110.401 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -61.22 -40.08 92.65 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.885 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' OE1' HG21 ' A' ' 18' ' ' VAL . 41.3 mt-10 -61.84 -42.09 98.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.249 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 50' ' ' ILE . 44.7 mm -62.09 -42.18 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.496 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.605 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -61.19 -42.39 98.49 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.667 0.27 . . . . 0.0 111.436 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.57 -44.28 96.72 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.102 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.474 HD11 ' CG1' ' A' ' 18' ' ' VAL . 16.0 mt -64.95 -49.06 81.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.95 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.17 87.35 6.66 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.92 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.09 -18.8 30.48 Favored 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 121.641 1.561 . . . . 0.0 113.38 -177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -88.45 9.01 25.1 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.612 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.84 153.04 35.22 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.129 0.422 . . . . 0.0 110.718 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -93.68 103.18 15.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.61 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.851 HG21 HG23 ' A' ' 44' ' ' ILE . 21.4 mt -96.74 128.98 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 121.191 0.519 . . . . 0.0 109.82 -177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.05 139.88 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.814 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.83 132.0 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 19.0 t -98.94 119.13 37.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.873 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.4 p -106.78 151.87 24.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.969 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.64 ' N ' HG22 ' A' ' 34' ' ' THR . . . -73.75 148.08 42.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.162 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 6.5 ptm -56.64 114.11 1.91 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 7.86 52.08 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.351 -0.694 . . . . 0.0 113.555 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -101.42 77.92 1.82 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 118.343 1.072 . . . . 0.0 110.773 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -63.29 -49.94 72.05 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.791 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.69 -29.46 69.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.324 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 37.5 mtt -63.93 -42.85 97.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.025 0.441 . . . . 0.0 110.394 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.75 -38.15 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.635 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.3 mm -62.63 -47.81 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -60.9 -40.65 93.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.09 0.472 . . . . 0.0 111.181 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.814 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.59 -39.95 89.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.4 mt -65.56 -42.89 94.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.228 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -59.46 -32.13 69.95 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -78.38 1.65 21.28 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.12 0.1 31.48 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 119.236 -0.758 . . . . 0.0 113.024 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.78 146.28 54.96 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.371 1.085 . . . . 0.0 110.324 176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -113.82 -27.55 7.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.953 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.86 147.86 17.81 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.762 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -130.7 142.67 50.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 110.859 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.3 mt -110.16 151.89 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.374 0.607 . . . . 0.0 112.104 -169.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.49 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.3 m -137.31 158.76 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.114 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.4 t-20 -138.1 -93.74 0.2 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.949 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.1 m -63.02 -33.63 75.84 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 118.286 0.494 . . . . 0.0 110.876 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.1 -48.25 74.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.826 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.594 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.96 -38.48 86.05 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.589 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.6 t -66.56 -46.11 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.356 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.64 -38.19 89.3 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.602 0.239 . . . . 0.0 111.421 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -135.42 80.0 46.91 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.336 -178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -48.52 -24.76 6.8 Favored 'Trans proline' 0 N--CA 1.51 2.443 0 C-N-CA 121.931 1.754 . . . . 0.0 113.884 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -57.0 -28.81 62.78 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 122.088 -0.383 . . . . 0.0 111.749 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.3 tp -63.92 -35.72 81.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.958 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.594 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.0 mt -67.65 -44.56 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 m -62.35 -44.87 95.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.142 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.08 -43.0 99.75 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD22 ' CE1' ' A' ' 79' ' ' PHE . 35.4 mt -62.43 -40.0 95.14 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.48 -47.84 80.12 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.818 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.93 -38.3 87.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.725 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.33 -54.17 9.01 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.31 5.32 18.21 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -174.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.88 130.18 6.93 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.15 -32.79 66.75 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.612 -0.346 . . . . 0.0 111.722 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -67.79 -9.41 43.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.66 -4.75 33.09 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.467 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.6 t -103.06 121.23 54.01 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 CA-C-N 118.69 0.677 . . . . 0.0 110.159 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.6 t -108.34 128.6 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.803 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -103.15 118.73 50.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.82 133.12 43.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 HG13 ' A' ' 119' ' ' VAL . 43.0 mt -127.82 115.89 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.965 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.04 114.03 26.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.7 158.62 29.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HG3' HD12 ' A' ' 152' ' ' ILE . 52.9 mtpt -141.71 164.5 30.03 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.342 173.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -90.77 113.98 26.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.97 0.414 . . . . 0.0 110.222 174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.2 t -133.95 134.21 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.645 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.45 29.05 16.38 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.77 10.0 86.19 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.565 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -140.04 155.86 46.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.849 0.824 . . . . 0.0 109.151 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -77.04 124.49 27.87 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.176 0.298 . . . . 0.0 110.355 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.4 mtp -125.06 143.31 50.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.76 0.314 . . . . 0.0 110.94 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 30.1 t -84.37 139.67 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.869 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -121.01 136.25 55.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.891 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -112.29 178.93 4.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.94 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 64.06 52.4 2.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.717 0.77 . . . . 0.0 109.822 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t 60.12 29.97 19.47 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.541 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.6 14.24 81.46 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-O 119.646 -0.53 . . . . 0.0 113.287 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -83.92 -33.99 24.59 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 117.897 0.848 . . . . 0.0 112.092 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -125.89 137.79 53.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.926 0.393 . . . . 0.0 111.47 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -82.64 139.44 33.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.0 p -94.1 -30.76 14.49 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.85 -18.34 56.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.863 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.05 130.96 34.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 CA-C-N 117.69 0.745 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 131' ' ' LEU . 22.9 mt -71.59 143.23 49.92 Favored 'General case' 0 CA--C 1.521 -0.167 0 O-C-N 123.457 0.473 . . . . 0.0 110.373 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.777 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.4 tp -61.42 -35.66 78.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.482 ' O ' HG23 ' A' ' 137' ' ' VAL . 41.2 mtp180 -62.36 -51.27 68.27 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.658 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -67.51 -38.09 83.77 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.15 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.815 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.4 t-105 -65.97 -43.35 88.11 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.789 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -61.04 -42.34 92.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.42 -44.67 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.376 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.3 -42.46 99.38 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.12 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.7 t -61.78 -38.08 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 -177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.49 -49.56 68.61 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.348 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -60.17 -33.17 71.83 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.745 0.307 . . . . 0.0 111.535 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -68.01 -18.54 64.74 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.14 9.83 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.193 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.27 131.7 48.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.358 0.579 . . . . 0.0 110.331 176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.01 -47.68 79.67 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.45 166.09 28.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.882 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.612 HD11 HD12 ' A' ' 175' ' ' LEU . 58.6 mt -129.63 133.65 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.3 tp -102.4 106.96 17.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.14 108.85 17.89 Favored 'General case' 0 C--N 1.333 -0.141 0 O-C-N 123.462 0.476 . . . . 0.0 109.761 177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.6 m -112.13 128.17 56.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.9 t -102.9 109.96 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.278 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.457 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.3 mt -71.7 -34.4 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -65.5 -30.6 71.39 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 55.1 mmt-85 -94.54 -22.34 18.28 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -56.39 123.47 14.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.98 88.22 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-O 119.293 -0.726 . . . . 0.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.5 p -80.27 -39.06 29.62 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 118.387 1.093 . . . . 0.0 110.525 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 59.32 34.55 22.96 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.2 p -125.6 23.06 7.49 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.838 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 118.33 148.83 8.6 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.664 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.9 m-85 -67.9 160.66 28.05 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -75.6 72.42 2.56 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.559 0.695 . . . . 0.0 110.422 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.663 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.6 p -57.55 -28.04 63.18 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.983 -177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -65.06 -53.4 46.29 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.016 0.436 . . . . 0.0 110.285 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.643 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.6 ttm -62.69 -36.34 82.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.663 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.5 mt -63.11 -51.13 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.39 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -62.68 -37.36 86.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.791 0.329 . . . . 0.0 111.032 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -66.13 -40.21 90.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.791 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.97 -36.18 31.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 121.286 -0.166 . . . . 0.0 110.986 -177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.14 -52.32 20.85 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.24 -9.87 26.68 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 121.41 1.406 . . . . 0.0 114.411 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 29.5 mt -96.77 -10.61 26.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.18 145.45 30.46 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 118.506 0.594 . . . . 0.0 112.283 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.4 p -100.96 18.45 19.61 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.59 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.612 HD12 HD11 ' A' ' 147' ' ' ILE . 68.3 mt -91.11 167.13 16.65 Favored Pre-proline 0 C--N 1.347 0.484 0 CA-C-O 119.415 -0.326 . . . . 0.0 110.512 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -71.57 133.28 21.98 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.43 1.42 . . . . 0.0 111.167 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 75.7 mt -104.96 121.72 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.161 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.1 mt -101.2 112.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.214 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.57 132.09 34.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.862 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.1 t -136.6 124.89 23.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.263 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.67 4.2 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 174.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.17 -19.23 52.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.762 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.664 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.46 127.56 32.34 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 117.866 0.833 . . . . 0.0 111.661 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -143.88 -32.37 0.09 OUTLIER Glycine 0 CA--C 1.542 1.774 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.325 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 211' ' ' ILE . 26.4 mtpt -144.86 169.67 17.6 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.983 0.891 . . . . 0.0 110.072 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 63.1 mtt -54.19 -34.4 60.46 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -61.17 -34.17 74.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.337 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -68.41 -36.04 78.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.173 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -62.82 -47.81 81.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.078 0.466 . . . . 0.0 110.704 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.24 -39.79 91.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.092 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -62.54 -44.77 95.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.097 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.33 88.68 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.416 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -66.03 -43.96 86.08 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.754 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.5 -31.99 71.01 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.859 0.361 . . . . 0.0 111.294 177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.69 -7.8 42.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.07 7.06 36.21 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-O 119.149 -0.806 . . . . 0.0 113.286 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.73 145.6 48.7 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 118.29 1.045 . . . . 0.0 110.017 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -94.58 -27.21 16.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.253 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . . . -148.25 152.22 36.8 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.72 128.65 54.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.894 0.378 . . . . 0.0 111.003 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.86 140.85 38.25 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.027 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.17 134.09 13.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.234 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -46.02 1.85 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.909 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.4 m -61.56 -46.18 90.98 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.383 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.3 m -58.64 -22.44 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.98 -50.88 5.62 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.911 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -59.94 -34.25 72.99 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -93.84 10.89 31.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 57.18 49.02 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.336 0.516 . . . . 0.0 112.086 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -97.07 -46.03 6.33 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.055 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.46 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.3 mt -119.79 137.68 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.9 132.97 35.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.099 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.02 -51.64 58.05 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -58.31 -53.07 62.4 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -58.68 -34.36 71.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.752 0.311 . . . . 0.0 111.591 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.1 tp -61.84 -45.62 93.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.073 0.463 . . . . 0.0 110.772 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -61.98 -41.2 97.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.862 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -61.31 -37.09 81.98 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.314 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -61.26 -48.84 79.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.097 0.475 . . . . 0.0 110.806 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.461 HD11 HD11 ' A' ' 4' ' ' ILE . 70.5 mt -62.73 -37.97 88.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.149 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -62.47 -45.18 94.24 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.267 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -59.89 -37.91 80.74 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -75.66 -4.5 40.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.63 28.06 40.39 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.912 177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' A' ' 1' ' ' MET . 22.9 t -80.0 121.45 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -84.03 150.06 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.846 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.3 mp -111.42 162.39 15.12 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -65.82 114.08 4.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.544 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -160.0 -180.0 8.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -102.46 133.71 46.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.519 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -65.34 -50.47 65.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.593 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -137.31 162.06 34.58 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.55 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -159.11 33.44 0.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.656 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.514 -179.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG11 ' A' ' 225' ' ' VAL . 64.6 mtt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.15 19.81 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.946 -177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -110.02 135.77 50.32 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 118.22 1.01 . . . . 0.0 111.348 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.5 mm -109.12 131.73 59.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.252 -0.886 . . . . 0.0 108.997 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -117.27 131.19 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.03 133.25 49.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.098 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.5 mt -111.73 110.94 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.763 0.316 . . . . 0.0 110.209 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.5 t -115.11 104.88 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.82 177.05 8.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.688 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -18.03 44.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.97 60.77 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -108.75 138.98 44.2 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.03 0.377 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -70.21 149.89 47.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.72 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -34.66 88.73 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 54.9 ttt85 -62.08 -42.58 99.35 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.836 0.35 . . . . 0.0 110.859 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -63.31 -43.53 97.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.684 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.81 -40.77 93.95 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.912 0.387 . . . . 0.0 111.362 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.3 t -63.11 -44.93 99.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.352 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.98 -39.07 84.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.231 0.538 . . . . 0.0 110.985 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -62.45 -41.6 98.87 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.968 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.674 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.4 t80 -62.67 -33.07 74.32 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.655 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.19 -50.04 69.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.014 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -76.09 -56.01 5.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.077 -176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.2 -47.21 71.57 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp 58.22 65.98 2.89 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.657 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.61 174.15 13.12 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.646 1.564 . . . . 0.0 111.824 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.15 -40.65 10.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.108 0.48 . . . . 0.0 109.838 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.94 141.05 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.785 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.96 123.53 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.068 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.7 p -105.4 119.15 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.271 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 41.4 tpp -118.99 132.32 56.06 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.821 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -85.54 126.45 33.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.332 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.528 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.96 -3.41 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.673 HG22 ' N ' ' A' ' 61' ' ' ALA . 62.4 p -56.87 -16.21 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.431 0.559 . . . . 0.0 112.416 -176.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 mtt -114.78 86.99 13.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -48.8 -25.63 8.59 Favored 'Trans proline' 0 N--CA 1.507 2.286 0 C-N-CA 121.829 1.686 . . . . 0.0 113.995 -174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -55.61 -22.87 24.45 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.0 mmt -88.91 0.01 56.98 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 59.98 53.91 4.46 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.707 0.765 . . . . 0.0 110.945 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.39 -55.01 33.05 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.077 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.0 mt -63.73 -27.79 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.8 0.3 . . . . 0.0 110.601 -176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.81 -45.16 93.95 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.474 0.654 . . . . 0.0 110.246 176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.81 88.77 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.969 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -58.78 -41.09 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 120.897 0.379 . . . . 0.0 110.295 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -60.97 -40.57 93.88 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.909 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.2 mt-10 -62.38 -41.28 98.51 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.282 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.5 mm -62.05 -41.75 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.77 -42.32 97.27 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.752 0.311 . . . . 0.0 111.542 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -62.66 -44.29 96.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.095 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 24.5 mt -64.93 -48.99 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.107 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -146.13 87.16 6.75 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.004 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.14 -18.76 30.66 Favored 'Trans proline' 0 N--CA 1.506 2.226 0 C-N-CA 121.625 1.55 . . . . 0.0 113.399 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -88.34 9.02 24.74 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.674 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.18 152.98 38.36 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.149 0.431 . . . . 0.0 110.68 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -94.09 100.23 12.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.836 HG21 HG23 ' A' ' 44' ' ' ILE . 16.7 mt -94.94 129.35 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.083 0.468 . . . . 0.0 109.977 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.3 mt -116.39 142.06 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.865 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.83 131.99 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.097 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.4 t -101.33 111.96 24.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.934 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.0 p -103.37 148.83 25.4 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.673 ' N ' HG22 ' A' ' 34' ' ' THR . . . -69.26 148.08 50.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.042 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.7 mtm -58.96 119.85 8.0 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 0.02 56.17 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.249 -0.75 . . . . 0.0 113.536 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -96.36 77.91 3.02 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.385 1.092 . . . . 0.0 110.883 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -63.69 -50.13 70.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.734 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.94 -29.9 69.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.275 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.9 mmt -63.62 -42.68 98.16 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.055 0.455 . . . . 0.0 110.396 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.4 t -60.0 -38.52 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.584 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.485 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.8 mm -62.13 -47.43 93.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.777 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.19 96.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.163 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.865 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.17 87.95 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.238 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.28 -44.32 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.221 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.5 -32.02 69.9 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.76 0.314 . . . . 0.0 111.596 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.76 35.88 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.17 2.67 31.51 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.883 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.97 150.66 48.3 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 118.378 1.089 . . . . 0.0 110.166 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.83 -27.57 6.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.034 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.87 147.57 17.69 Favored Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.975 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.585 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.2 p90 -131.46 142.48 50.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.727 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -109.07 151.44 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.407 0.622 . . . . 0.0 111.983 -169.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.28 158.42 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.183 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -138.05 -95.94 0.19 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 119.412 -0.328 . . . . 0.0 110.939 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 121' ' ' THR . 23.3 m -62.37 -34.35 76.53 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.693 0.679 . . . . 0.0 110.949 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.14 84.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.933 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.63 -41.27 97.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.464 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.05 -44.8 95.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.491 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -62.34 -38.61 90.18 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.413 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -135.67 80.01 45.28 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.372 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -48.56 -24.79 6.93 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 122.074 1.849 . . . . 0.0 113.852 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -56.98 -28.53 62.45 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 122.013 -0.429 . . . . 0.0 111.809 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.84 -36.59 84.41 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.957 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.568 HD11 ' HB1' ' A' ' 85' ' ' ALA . 59.4 mt -67.79 -44.63 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 m -62.11 -44.02 97.56 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.209 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -63.27 -43.99 96.39 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CE1' ' A' ' 79' ' ' PHE . 25.2 mt -62.68 -39.45 94.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.183 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.57 80.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.528 0.204 . . . . 0.0 110.727 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.85 -38.77 89.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.725 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -73.95 -54.14 8.57 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -111.61 4.85 18.96 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.25 129.93 6.84 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -57.04 -32.89 66.66 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.659 -0.318 . . . . 0.0 111.828 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -67.89 -9.27 43.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.14 -6.2 35.5 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.46 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.2 t -103.09 121.05 53.81 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.621 0.646 . . . . 0.0 110.231 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 99.3 t -107.87 127.22 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.704 HG21 HG13 ' A' ' 139' ' ' VAL . 25.7 t -102.77 118.76 50.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.79 134.16 42.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.855 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 119' ' ' VAL . 43.5 mt -128.39 115.91 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.031 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -93.42 115.63 28.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.05 156.62 34.51 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.455 ' HG3' HD12 ' A' ' 152' ' ' ILE . 47.5 mtpt -140.74 165.58 27.11 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.454 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -90.44 115.49 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 110.401 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.6 t -133.16 132.34 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.585 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.36 28.95 16.1 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 176.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.35 10.0 85.67 Favored Glycine 0 CA--C 1.54 1.605 0 CA-C-O 119.68 -0.511 . . . . 0.0 113.641 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -135.96 155.01 50.9 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.867 0.834 . . . . 0.0 109.107 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -76.42 124.22 27.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.7 mtp -125.82 143.74 50.94 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.84 0.352 . . . . 0.0 110.888 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 108' ' ' ILE . 29.5 t -83.97 139.75 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.862 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -121.05 137.79 54.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.873 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.525 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.22 179.43 3.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 64.07 52.29 2.05 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 0.0 109.884 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.3 m 60.03 29.93 19.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.496 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.38 14.47 81.46 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.635 -0.536 . . . . 0.0 113.248 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -84.26 -33.7 23.98 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.83 0.815 . . . . 0.0 112.103 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -126.22 136.75 53.2 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.831 0.348 . . . . 0.0 111.516 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.22 140.31 34.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.7 p -94.07 -31.65 14.12 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.236 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.95 56.11 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.919 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.84 133.31 32.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 CA-C-N 117.712 0.756 . . . . 0.0 109.233 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.8 mt -71.85 144.44 49.08 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 123.377 0.423 . . . . 0.0 110.244 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.7 tp -61.77 -38.43 87.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.943 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 58.9 mtp85 -61.38 -50.34 73.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.9 0.381 . . . . 0.0 110.923 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.9 -38.24 85.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.185 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.91 -42.78 84.86 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.874 -178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.56 -40.94 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.381 -0.199 . . . . 0.0 110.573 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.6 -44.53 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.25 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.44 -42.13 99.23 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.188 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.3 t -61.49 -38.59 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.828 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -65.82 -50.67 63.82 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.334 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.06 -33.24 71.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.734 0.302 . . . . 0.0 111.561 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -67.85 -19.05 65.0 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.11 26.12 9.81 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.261 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -64.33 131.75 48.19 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 117.324 0.562 . . . . 0.0 110.477 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.48 -47.21 86.49 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -147.8 166.0 28.86 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.903 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 175' ' ' LEU . 58.5 mt -128.52 133.89 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.709 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.29 106.99 17.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.592 HD21 ' HG2' ' A' ' 165' ' ' MET . 31.3 tp -85.57 108.85 18.15 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 123.439 0.462 . . . . 0.0 109.855 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.8 m -111.56 127.68 55.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.526 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -101.49 110.0 21.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.269 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.5 mt -73.44 -34.72 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -65.12 -30.16 71.07 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.268 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -100.11 -18.65 16.85 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.58 124.78 19.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.907 0.384 . . . . 0.0 111.972 178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.1 1.5 88.56 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 119.299 -0.723 . . . . 0.0 113.431 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.9 p -79.92 -39.03 31.19 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 118.373 1.086 . . . . 0.0 110.592 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 46.0 mttp 59.54 33.95 22.3 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.5 p -121.64 23.13 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.703 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 117.05 147.36 8.59 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.683 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 31.8 m-85 -67.87 158.01 33.59 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.93 72.06 2.77 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.58 0.705 . . . . 0.0 110.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.517 ' HA ' HD12 ' A' ' 166' ' ' ILE . 67.4 p -57.17 -28.12 62.51 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.044 -176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.97 -53.01 44.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 120.968 0.413 . . . . 0.0 110.23 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.592 ' HG2' HD21 ' A' ' 149' ' ' LEU . 57.0 ttm -60.49 -36.32 78.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 163' ' ' THR . 90.2 mt -63.66 -51.51 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.228 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -62.29 -34.07 75.87 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.89 0.376 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -65.87 -43.69 87.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.595 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 165' ' ' MET . 32.2 t -76.82 -34.75 23.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.148 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.1 -52.3 20.67 Favored Pre-proline 0 CA--C 1.559 1.296 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.98 -9.87 26.5 Favored 'Trans proline' 0 N--CA 1.507 2.292 0 C-N-CA 121.422 1.415 . . . . 0.0 114.428 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.71 -10.46 26.84 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 146.65 30.87 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 118.523 0.601 . . . . 0.0 112.243 -173.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -101.97 18.47 20.57 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.522 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 147' ' ' ILE . 86.0 mt -89.9 167.15 17.9 Favored Pre-proline 0 C--N 1.348 0.506 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.466 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.19 132.83 20.13 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.467 1.445 . . . . 0.0 111.066 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -105.1 121.83 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.167 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.709 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.9 111.93 32.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.63 132.08 34.71 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.779 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.7 t -136.87 125.67 24.04 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 131.32 4.13 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.49 -18.79 52.82 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.62 -0.545 . . . . 0.0 112.752 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.683 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.14 128.31 36.15 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.929 0.864 . . . . 0.0 111.699 -176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.64 -32.39 0.07 OUTLIER Glycine 0 CA--C 1.542 1.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.362 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.54 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.7 mttm -143.68 169.02 18.52 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.032 0.916 . . . . 0.0 110.125 175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.6 mtp -54.98 -34.45 63.37 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -61.04 -33.91 74.04 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.204 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -67.87 -35.94 79.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.235 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -62.79 -48.02 80.95 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.099 0.476 . . . . 0.0 110.685 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.11 -39.58 90.54 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.086 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -62.56 -44.85 95.31 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.54 88.69 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.791 0.329 . . . . 0.0 111.416 -178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.98 -43.32 88.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.853 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.29 -32.59 71.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.841 0.353 . . . . 0.0 111.386 177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.4 -6.93 39.2 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.13 7.08 36.02 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.171 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.49 145.44 49.19 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.345 1.073 . . . . 0.0 109.911 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -94.53 -27.12 16.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.235 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.8 153.26 37.88 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.96 129.39 55.14 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.998 0.428 . . . . 0.0 111.097 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 7' ' ' ILE . . . -106.06 138.68 41.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.906 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.553 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.37 137.89 18.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.271 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.01 -48.7 1.74 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.043 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.3 p -61.83 -45.71 92.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.405 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.553 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.46 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.25 -49.73 6.02 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.099 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -59.91 -33.3 71.68 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -99.52 20.42 13.9 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 47.72 49.09 16.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -94.43 -46.11 7.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.954 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.0 mt -116.68 136.95 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.83 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.58 131.62 35.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.94 -51.8 57.08 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.977 -0.449 . . . . 0.0 111.977 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -57.45 -53.24 60.35 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -58.66 -34.74 71.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.881 0.372 . . . . 0.0 111.622 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.6 tp -61.51 -45.51 93.92 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.123 0.487 . . . . 0.0 110.773 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.0 mmtt -62.05 -41.37 98.07 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.851 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -61.23 -37.17 82.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.292 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -61.33 -48.4 81.5 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.117 0.484 . . . . 0.0 110.759 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.49 -37.66 86.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -62.07 -45.89 91.53 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.364 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -59.77 -37.29 78.64 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -77.21 -2.65 35.65 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.1 28.06 50.76 Favored Glycine 0 C--N 1.344 1.0 0 C-N-CA 121.15 -0.548 . . . . 0.0 111.852 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 1' ' ' MET . 24.7 t -79.98 127.77 39.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.38 129.87 39.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.787 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.6 mt -102.06 140.34 36.47 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.472 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -65.3 -37.81 88.29 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.603 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -135.99 154.31 51.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -158.16 -55.33 0.07 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -100.19 143.75 30.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -132.21 90.76 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.511 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -102.65 -52.56 3.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.591 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 71.6 m80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.547 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.03 20.23 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 119.351 -0.694 . . . . 0.0 112.912 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -109.92 135.82 50.18 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.245 1.022 . . . . 0.0 111.29 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.7 mm -109.14 132.02 58.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.019 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.8 t -117.19 132.25 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.6 tp -105.89 132.17 52.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.921 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.2 mt -112.41 110.99 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.799 0.333 . . . . 0.0 110.114 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 17' ' ' ALA . 28.7 t -114.99 104.98 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.655 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -83.12 177.1 8.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.753 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -59.5 -18.62 41.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -106.07 145.02 31.97 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 117.936 0.335 . . . . 0.0 110.368 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -75.57 147.71 39.44 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.16 -37.37 93.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -61.34 -41.06 96.42 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.948 0.404 . . . . 0.0 111.056 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.29 -44.94 93.62 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.802 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.45 -39.29 87.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.413 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' GLY . 43.5 t -62.91 -44.79 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 110.25 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -60.03 -39.6 86.46 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.075 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -62.65 -41.27 98.96 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.983 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.67 -34.12 76.46 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.137 0.273 . . . . 0.0 111.538 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -63.87 -49.26 73.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.095 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -77.53 -56.05 4.86 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.973 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.77 -47.16 73.04 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.5 mttt 57.61 66.08 3.11 Favored Pre-proline 0 CA--C 1.559 1.302 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.722 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.8 174.15 13.2 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 121.626 1.55 . . . . 0.0 111.841 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.01 -41.03 10.21 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.123 0.487 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.3 mt -119.97 139.36 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.793 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -132.34 123.38 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.111 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.544 HG22 ' HB ' ' A' ' 57' ' ' ILE . 25.6 p -106.66 119.12 38.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.4 tpp -118.98 133.4 55.85 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.827 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -84.93 125.2 32.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.585 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.0 pt -111.18 -1.68 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.566 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.3 p -58.55 -13.81 6.57 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 118.424 0.557 . . . . 0.0 112.402 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.7 ttt -114.76 87.01 13.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.18 -22.9 16.29 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 C-N-CA 121.611 1.54 . . . . 0.0 113.651 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -53.91 -23.33 12.42 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.5 ptp -99.04 6.8 46.45 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 58.34 58.99 3.18 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.638 0.733 . . . . 0.0 111.45 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.89 -51.56 57.85 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.798 -176.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.693 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.8 mt -64.07 -27.8 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.511 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.14 -44.37 95.74 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.279 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.24 -37.72 84.11 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.018 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.759 HG23 HG21 ' A' ' 56' ' ' ILE . 86.2 mt -59.42 -40.8 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 120.88 0.372 . . . . 0.0 110.246 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -61.06 -39.53 90.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.086 0.47 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -61.98 -43.38 98.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.203 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' HA ' HD12 ' A' ' 50' ' ' ILE . 46.2 mm -61.92 -41.58 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.572 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.595 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.11 -43.19 99.26 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.742 0.306 . . . . 0.0 111.466 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -62.67 -43.82 97.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.063 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 47' ' ' ILE . 16.5 mt -64.88 -49.06 81.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.959 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -146.08 87.58 6.63 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.978 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.98 -18.77 29.54 Favored 'Trans proline' 0 N--CA 1.506 2.209 0 C-N-CA 121.619 1.546 . . . . 0.0 113.395 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.65 9.04 25.59 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.21 153.06 38.27 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.134 0.424 . . . . 0.0 110.839 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -93.57 100.22 12.53 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG23 ' A' ' 44' ' ' ILE . 25.4 mt -94.68 130.9 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.212 0.529 . . . . 0.0 110.128 -177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 30' ' ' THR . 66.3 mt -117.01 140.97 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.711 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.4 t -121.85 132.48 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.365 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.9 t -98.92 115.59 29.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.975 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 62.1 p -102.86 155.91 18.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.566 ' N ' HG22 ' A' ' 34' ' ' THR . . . -83.1 148.07 27.72 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.156 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.617 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.74 120.3 8.7 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.07 0.06 56.11 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-O 119.178 -0.79 . . . . 0.0 113.486 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -99.8 77.96 2.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.421 1.11 . . . . 0.0 110.97 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.94 -50.06 70.13 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.721 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.37 -30.73 70.71 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.203 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.585 ' SD ' HD12 ' A' ' 33' ' ' ILE . 30.4 ttm -64.09 -41.2 97.38 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.289 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.21 -38.09 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-O 120.997 0.427 . . . . 0.0 110.333 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.534 HG22 ' HE3' ' A' ' 73' ' ' LYS . 24.4 mm -62.13 -46.21 96.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HB3' HD13 ' A' ' 41' ' ' ILE . 83.4 mt-10 -60.75 -42.22 96.99 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.226 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.711 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.62 -38.42 84.67 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.245 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.3 mt -65.18 -43.53 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.183 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' HE3' HG22 ' A' ' 69' ' ' ILE . 97.9 mttt -59.42 -33.13 70.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.782 0.325 . . . . 0.0 111.655 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.03 -10.45 57.59 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 8.5 27.21 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.305 -0.72 . . . . 0.0 112.585 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.28 146.88 50.29 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 118.271 1.036 . . . . 0.0 110.01 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -106.83 -32.84 7.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.443 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.84 158.93 22.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.762 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.5 p90 -140.24 152.81 46.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.969 0.414 . . . . 0.0 110.651 175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.7 mt -105.91 144.91 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.012 -168.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.85 154.17 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.207 170.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.496 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.3 t-20 -137.91 -93.73 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.982 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -63.11 -34.97 78.74 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.347 0.521 . . . . 0.0 110.918 -174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.617 ' HB2' ' HE2' ' A' ' 62' ' ' MET . . . -64.99 -48.12 75.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.817 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.07 -38.49 86.42 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.554 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.4 t -66.7 -46.06 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.346 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.54 -37.95 88.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.455 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -135.1 79.96 49.01 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.525 -177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -48.81 -24.49 7.1 Favored 'Trans proline' 0 N--CA 1.508 2.376 0 C-N-CA 121.904 1.736 . . . . 0.0 113.883 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 m -56.98 -28.83 62.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.062 -0.398 . . . . 0.0 111.863 -178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.4 tp -64.38 -35.68 81.68 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.898 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.44 HD11 ' HB1' ' A' ' 85' ' ' ALA . 42.4 mt -67.81 -45.79 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.07 -43.62 98.45 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -63.24 -43.46 97.99 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.727 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 55.1 mt -62.42 -40.53 96.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.18 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.99 83.72 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.751 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -62.04 -38.67 89.62 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.652 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -74.43 -54.1 8.24 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -112.66 4.89 17.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.48 131.93 7.51 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -56.97 -32.85 66.48 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 122.64 -0.329 . . . . 0.0 111.873 -178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -67.89 -8.98 41.05 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.29 -9.88 34.62 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.98 119.72 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.563 0.619 . . . . 0.0 110.227 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.2 t -108.07 126.29 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.749 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -99.97 116.96 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.25 132.86 43.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.721 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.497 HG23 HG13 ' A' ' 119' ' ' VAL . 41.3 mt -127.08 115.87 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -93.83 114.0 26.16 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 173.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.34 156.61 32.23 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' A' ' 152' ' ' ILE . 33.7 mtpt -140.49 163.2 33.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.334 174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.0 mtt85 -88.57 120.86 30.35 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.847 0.356 . . . . 0.0 110.268 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.6 t -144.46 137.59 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.61 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.52 29.26 16.81 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.3 10.15 84.36 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-O 119.722 -0.488 . . . . 0.0 113.504 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -141.08 158.65 43.62 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.775 0.788 . . . . 0.0 109.244 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -77.6 123.48 26.68 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.253 0.345 . . . . 0.0 110.331 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 mtp -123.33 142.14 51.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.799 0.333 . . . . 0.0 111.085 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 108' ' ' ILE . 33.9 t -83.98 140.13 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.694 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -121.01 140.97 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.03 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.9 p -115.71 179.65 3.91 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.884 176.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 64.16 52.24 2.01 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.84 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.6 t 60.14 29.47 19.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.557 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.25 14.76 81.26 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.183 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -83.88 -34.22 24.62 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.824 0.812 . . . . 0.0 111.947 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -125.46 137.93 53.99 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.86 0.362 . . . . 0.0 111.461 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -82.02 139.59 34.41 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.674 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.0 p -94.05 -30.83 14.49 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.235 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.29 -17.9 57.86 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.891 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 79.8 mt -68.92 131.01 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 117.714 0.757 . . . . 0.0 109.296 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.52 142.62 53.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.98 0.419 . . . . 0.0 110.316 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.9 tp -61.25 -39.32 89.92 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.003 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.515 ' O ' HG23 ' A' ' 137' ' ' VAL . 29.6 mtp180 -61.08 -48.58 81.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.032 0.444 . . . . 0.0 111.019 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.46 -38.12 80.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.967 -175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.738 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.0 t-105 -66.72 -42.52 86.19 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.718 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.0 t -60.68 -41.19 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.321 -0.237 . . . . 0.0 110.576 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.2 -44.12 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.357 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -62.43 -41.86 99.03 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.195 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.749 HG13 HG21 ' A' ' 106' ' ' VAL . 51.8 t -61.15 -39.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.921 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -65.79 -50.32 65.14 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.391 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.91 -33.09 71.41 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -68.0 -20.01 64.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.308 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.12 9.8 Favored Glycine 0 C--N 1.344 0.975 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.055 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.2 131.83 49.73 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.351 0.575 . . . . 0.0 110.716 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.43 -45.76 94.16 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -151.39 167.1 28.99 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.372 -0.414 . . . . 0.0 111.044 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.602 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.76 134.73 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.718 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.5 tp -104.74 106.99 17.72 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 HG21 ' A' ' 169' ' ' VAL . 30.8 tp -85.31 108.9 18.01 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 123.513 0.508 . . . . 0.0 109.827 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.0 m -112.06 128.15 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.611 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -101.42 109.83 21.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.309 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.493 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -72.49 -35.07 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -63.68 -30.99 72.03 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.169 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -92.21 -25.38 18.68 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -54.99 122.9 11.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.11 -1.03 88.97 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.341 -0.7 . . . . 0.0 113.481 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.5 p -83.14 -35.19 25.76 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.335 1.068 . . . . 0.0 110.589 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 61.4 38.51 16.05 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.322 0.582 . . . . 0.0 110.713 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.4 p -118.81 23.1 11.64 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.802 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 100.87 160.58 27.64 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 79.1 m-85 -67.96 156.04 38.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -75.7 72.81 2.65 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.572 0.701 . . . . 0.0 110.008 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.642 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.3 p -55.65 -27.9 52.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.23 -51.09 63.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.995 0.426 . . . . 0.0 110.27 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.598 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.4 ttm -61.65 -35.42 77.9 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.062 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.46 -51.82 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.322 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.1 mtt-85 -62.63 -34.23 76.63 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -66.45 -41.93 88.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.772 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' MET . 38.6 t -76.06 -35.97 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.98 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -44.65 -52.3 18.5 Favored Pre-proline 0 CA--C 1.559 1.316 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -66.77 -9.95 26.47 Favored 'Trans proline' 0 N--CA 1.508 2.352 0 C-N-CA 121.459 1.439 . . . . 0.0 114.472 -174.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.7 mt -100.64 -5.61 26.41 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.22 142.9 28.84 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.604 0.638 . . . . 0.0 112.136 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -100.99 18.88 18.53 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.508 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.602 HD12 HD11 ' A' ' 147' ' ' ILE . 48.2 mt -93.63 167.13 14.48 Favored Pre-proline 0 C--N 1.347 0.47 0 CA-C-O 119.352 -0.356 . . . . 0.0 110.537 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.8 132.66 22.09 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.379 1.386 . . . . 0.0 111.117 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.58 121.46 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.949 0.404 . . . . 0.0 110.159 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.718 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -100.53 111.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.313 174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.87 132.44 34.2 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.7 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.3 t -137.63 129.21 28.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.602 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.85 126.78 3.73 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.38 -19.86 46.8 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.941 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.12 115.43 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 117.869 0.834 . . . . 0.0 111.701 -175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -125.17 -32.15 0.81 Allowed Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.659 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.559 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.3 mttm -143.34 166.08 25.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.456 0.628 . . . . 0.0 110.666 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 39.8 mtt -54.38 -35.6 62.99 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -60.02 -33.77 72.46 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.866 0.365 . . . . 0.0 111.315 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.411 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 42.0 m170 -70.76 -32.94 70.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.404 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -63.27 -47.94 80.25 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.072 0.463 . . . . 0.0 110.418 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -61.04 -39.58 90.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -62.36 -45.11 94.67 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.103 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.85 -39.15 88.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.367 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.63 -43.7 88.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.789 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.43 -32.31 71.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.822 0.344 . . . . 0.0 111.323 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.39 -7.01 39.7 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.04 36.17 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-O 119.123 -0.821 . . . . 0.0 113.243 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.65 146.0 48.56 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.375 1.088 . . . . 0.0 109.937 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -95.01 -27.98 15.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.149 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.2 153.56 39.99 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.29 127.61 53.88 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.844 0.354 . . . . 0.0 111.037 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.89 139.35 41.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.007 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.571 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -151.02 139.87 20.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.2 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -50.05 1.71 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.956 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -62.01 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.368 -177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.571 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.6 m -58.05 -24.24 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -91.84 -50.74 5.57 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.012 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -59.97 -33.3 71.76 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.9 11.5 33.6 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 57.12 49.0 14.38 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -96.17 -46.08 6.6 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.101 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.1 mt -120.17 137.58 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.755 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -80.49 132.74 35.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.058 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.18 -51.39 59.45 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -57.94 -53.54 57.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -58.46 -34.75 71.22 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.91 0.386 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.7 tp -61.73 -45.15 95.19 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.516 . . . . 0.0 110.792 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.8 -40.68 96.06 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.884 178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -61.19 -37.58 83.48 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.282 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.96 -47.82 84.67 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.231 0.539 . . . . 0.0 110.814 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 74.3 mt -62.35 -38.68 90.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.118 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -61.97 -44.81 95.97 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -59.57 -37.27 78.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -80.12 1.87 26.32 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.48 27.97 62.45 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.922 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.0 t -97.62 117.69 42.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -143.03 173.08 11.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.697 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 61.5 mt -101.97 143.16 32.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.55 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -129.66 127.0 39.67 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.477 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -158.83 152.18 22.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.543 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -108.36 131.87 54.31 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.573 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -102.09 32.99 3.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.687 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -127.42 165.82 19.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.553 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -102.27 139.63 37.63 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.545 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.621 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.13 20.08 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-O 119.403 -0.665 . . . . 0.0 112.984 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -109.94 135.75 50.3 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 118.197 0.998 . . . . 0.0 111.563 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.36 132.94 53.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.212 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.01 129.9 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -104.54 135.1 46.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.984 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.4 mt -111.95 116.46 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.925 0.393 . . . . 0.0 110.233 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.7 t -115.0 104.91 17.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.7 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -94.29 177.05 6.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.603 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.66 -18.01 38.56 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.07 60.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -114.19 145.03 42.24 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.981 0.355 . . . . 0.0 110.207 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -76.8 151.48 35.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.92 -35.33 90.28 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.404 -0.678 . . . . 0.0 111.404 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -61.94 -42.79 99.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.908 0.385 . . . . 0.0 110.874 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -63.28 -43.49 97.76 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.83 -40.01 91.18 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.311 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 14' ' ' GLY . 40.1 t -63.0 -46.14 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.27 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -60.06 -38.82 83.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.216 0.531 . . . . 0.0 111.021 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -62.61 -42.66 99.71 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.087 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.634 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.4 t80 -63.28 -31.89 73.16 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.274 0.359 . . . . 0.0 111.581 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -64.5 -51.5 62.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.758 0.313 . . . . 0.0 110.919 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -75.0 -56.1 5.08 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.911 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.32 -47.15 77.54 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp 57.9 64.98 3.58 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.662 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.85 174.17 11.59 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 121.608 1.539 . . . . 0.0 111.754 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.37 -39.56 10.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.826 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -123.24 140.63 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.865 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.5 t -129.61 124.63 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.014 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 77.6 p -108.38 119.45 39.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.224 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 15.2 ttm -123.01 137.28 54.99 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.162 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.19 126.29 35.07 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.362 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.0 pt -113.06 -1.72 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 177.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.605 HG22 ' N ' ' A' ' 61' ' ' ALA . 64.6 p -56.99 -15.93 5.98 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.469 0.577 . . . . 0.0 112.509 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.1 mtt -114.79 87.0 13.95 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.1 -25.39 9.1 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.818 1.679 . . . . 0.0 113.972 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -55.32 -23.4 23.44 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 24.5 tpp -89.13 1.69 55.25 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.71 51.88 5.94 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.643 0.735 . . . . 0.0 111.077 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.77 -54.8 34.58 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.855 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.714 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.7 mt -62.99 -27.25 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.783 0.291 . . . . 0.0 110.687 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.84 -45.59 91.88 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.383 0.611 . . . . 0.0 110.198 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.94 -38.78 89.75 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.081 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.714 HD12 ' HA ' ' A' ' 41' ' ' ILE . 90.6 mt -58.12 -40.09 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-O 120.933 0.396 . . . . 0.0 110.373 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.74 -41.07 97.17 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.784 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.681 ' OE1' HG21 ' A' ' 18' ' ' VAL . 23.4 mt-10 -62.14 -40.66 96.7 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.289 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.39 -43.64 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.583 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.39 -39.93 89.08 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.724 0.297 . . . . 0.0 111.533 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -62.93 -45.2 93.62 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.082 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.4 mt -65.41 -49.03 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.986 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.15 87.99 6.46 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.992 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.86 -17.88 32.07 Favored 'Trans proline' 0 N--CA 1.507 2.277 0 C-N-CA 121.515 1.477 . . . . 0.0 113.404 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.68 9.04 25.68 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.634 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.78 153.05 38.94 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.219 0.463 . . . . 0.0 110.781 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -93.1 101.83 14.14 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.679 HG21 HG23 ' A' ' 44' ' ' ILE . 22.0 mt -96.17 129.47 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.144 0.497 . . . . 0.0 109.989 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.27 138.15 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 33' ' ' ILE . 21.1 t -121.9 131.97 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.146 -176.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.1 t -97.99 115.85 29.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.204 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.1 p -103.08 153.7 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.794 -177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.605 ' N ' HG22 ' A' ' 34' ' ' THR . . . -79.13 148.08 32.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.223 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.9 mtm -59.58 120.66 9.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.898 -175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.04 0.1 56.14 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.244 -0.753 . . . . 0.0 113.511 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -101.46 77.96 1.82 Allowed 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.42 1.11 . . . . 0.0 110.911 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -63.04 -49.26 75.28 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.892 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.92 -29.72 69.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.235 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 33' ' ' ILE . 10.3 ttm -64.1 -42.22 97.0 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 110.313 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.25 -38.54 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.055 0.455 . . . . 0.0 110.551 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.9 mm -62.5 -48.04 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.775 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' HG2' HD13 ' A' ' 41' ' ' ILE . 46.1 tt0 -61.08 -40.48 93.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.98 -38.84 87.41 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.136 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' ILE . 26.5 mt -65.47 -43.55 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.158 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -59.48 -31.83 69.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.842 0.353 . . . . 0.0 111.543 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.74 -7.69 46.73 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 3.9 31.12 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-O 119.292 -0.727 . . . . 0.0 112.734 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.08 146.97 52.14 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 118.37 1.085 . . . . 0.0 110.048 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -108.37 -32.42 7.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.477 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.02 154.64 20.35 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.791 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 23.9 p90 -135.69 149.82 49.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.366 176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 mt -108.55 147.22 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.368 0.604 . . . . 0.0 111.986 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 15.9 m -134.47 157.66 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.073 171.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.537 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.2 t-20 -138.33 -93.13 0.2 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.97 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.504 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.7 m -62.74 -33.6 75.47 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 118.257 0.481 . . . . 0.0 110.972 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.89 -49.52 67.78 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.767 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.598 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.67 -36.32 78.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.598 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.36 -48.05 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.433 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -62.61 -37.74 87.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.349 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -132.37 78.65 67.55 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.03 -24.99 11.74 Favored 'Trans proline' 0 N--CA 1.508 2.35 0 C-N-CA 121.799 1.666 . . . . 0.0 113.427 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -57.06 -30.0 63.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.815 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.47 -36.36 83.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.058 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.598 HD11 ' HB1' ' A' ' 85' ' ' ALA . 60.5 mt -67.49 -44.95 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.95 -43.83 98.02 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.205 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -62.73 -43.21 99.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.049 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.791 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 28.0 mt -62.39 -41.05 98.35 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.56 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.07 -46.35 87.87 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.819 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -62.15 -39.42 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.659 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.51 -54.04 8.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -110.19 1.73 18.89 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.34 133.75 8.16 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.56 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.6 m -55.94 -34.24 65.46 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.585 -0.362 . . . . 0.0 111.89 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.79 -9.38 43.75 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.0 -10.66 32.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.6 t -103.11 121.18 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 118.547 0.612 . . . . 0.0 110.294 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.64 128.15 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.3 t -101.18 117.68 46.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.92 131.89 44.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.532 HG23 HG13 ' A' ' 119' ' ' VAL . 41.6 mt -127.09 115.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.963 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.31 113.95 25.94 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.2 156.95 31.3 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.495 ' HG3' HD12 ' A' ' 152' ' ' ILE . 32.4 mtpt -140.34 163.48 32.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.268 173.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.4 mtt85 -88.8 120.53 30.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.891 0.377 . . . . 0.0 110.219 173.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.0 t -144.04 137.54 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.604 -176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.72 29.24 17.05 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.83 10.01 83.37 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.748 -0.474 . . . . 0.0 113.505 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -140.81 158.94 43.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.823 0.811 . . . . 0.0 109.107 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -78.0 124.84 28.51 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.245 0.34 . . . . 0.0 110.376 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.7 mtp -124.7 142.67 51.23 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.045 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.532 HG13 HG23 ' A' ' 108' ' ' ILE . 36.0 t -83.98 140.03 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.704 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -121.06 137.99 54.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.982 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.09 179.61 3.91 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.741 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 63.81 52.32 2.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.653 0.74 . . . . 0.0 109.916 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.3 m 60.03 30.01 19.53 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.416 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.34 14.64 81.29 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 119.698 -0.501 . . . . 0.0 113.223 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -83.87 -34.3 24.63 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.915 0.857 . . . . 0.0 112.04 -177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -126.04 137.64 53.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.839 0.352 . . . . 0.0 111.488 -174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -82.16 139.61 34.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -93.99 -31.16 14.37 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.242 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.37 -18.16 56.8 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.897 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.9 mt -69.53 131.4 34.07 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 CA-C-N 117.691 0.745 . . . . 0.0 109.252 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.8 mt -70.37 143.05 52.03 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 121.024 0.44 . . . . 0.0 110.249 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.48 -37.03 82.13 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.91 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 137' ' ' VAL . 24.3 mtp180 -62.35 -50.31 72.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -67.2 -38.16 84.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.237 -175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.7 t-105 -66.22 -43.13 87.57 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.784 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.86 -42.08 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.474 0.178 . . . . 0.0 110.638 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.49 -44.58 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.339 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -62.49 -42.61 99.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.754 0.311 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.65 -37.8 78.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.862 -177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.6 -49.94 66.91 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.231 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.12 -32.32 70.89 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.824 0.345 . . . . 0.0 111.593 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -67.9 -19.88 65.05 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.16 25.96 9.91 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.464 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.29 131.72 49.28 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.417 0.608 . . . . 0.0 110.617 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.14 -46.55 90.78 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -150.07 166.68 29.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.985 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.789 HD11 HD12 ' A' ' 175' ' ' LEU . 39.2 mt -129.7 134.25 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.711 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.2 tp -102.92 107.0 17.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.3 tp -85.3 108.88 18.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.6 m -112.36 128.69 56.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.597 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.0 t -102.05 109.89 21.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.2 177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.495 HD12 ' HG3' ' A' ' 111' ' ' LYS . 41.1 mt -73.13 -35.32 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -63.35 -30.83 71.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.379 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -102.59 -18.06 15.43 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -56.35 125.11 20.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.117 0.417 . . . . 0.0 112.076 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -0.89 88.94 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-O 119.225 -0.764 . . . . 0.0 113.371 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.4 p -80.22 -36.04 35.34 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 118.403 1.102 . . . . 0.0 110.568 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 60.7 36.21 19.53 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.21 0.529 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -120.95 23.18 10.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.752 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.406 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 109.37 151.07 13.9 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 67.5 m-85 -67.94 156.74 36.56 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -75.14 73.4 2.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.553 0.692 . . . . 0.0 110.036 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.608 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -56.27 -27.37 54.99 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.96 -0.563 . . . . 0.0 112.278 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -65.1 -50.81 64.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.062 0.458 . . . . 0.0 110.212 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.6 ttm -62.26 -36.41 81.94 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.003 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.608 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.1 mt -63.03 -51.19 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.359 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -62.6 -36.57 83.17 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.027 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.05 -40.28 90.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.741 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 165' ' ' MET . 41.4 t -75.46 -37.0 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.835 -0.166 . . . . 0.0 110.974 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.79 -52.2 19.42 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.95 -9.91 26.61 Favored 'Trans proline' 0 N--CA 1.508 2.375 0 C-N-CA 121.439 1.426 . . . . 0.0 114.408 -174.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 65.0 mt -100.38 -5.32 27.43 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.79 27.83 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 118.569 0.622 . . . . 0.0 112.15 -174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 82.2 p -99.92 18.64 17.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.53 174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.789 HD12 HD11 ' A' ' 147' ' ' ILE . 19.9 mt -94.79 167.18 13.59 Favored Pre-proline 0 C--N 1.347 0.476 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.384 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.22 133.76 25.46 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 121.396 1.398 . . . . 0.0 111.245 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.8 mt -104.7 121.52 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.948 0.404 . . . . 0.0 110.065 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.711 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -101.01 112.23 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.233 175.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.91 132.18 34.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.771 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t -136.4 126.93 26.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.382 -178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.08 128.33 3.77 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.78 45.63 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 119.564 -0.575 . . . . 0.0 112.934 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.14 112.52 2.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 117.836 0.818 . . . . 0.0 111.622 -176.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -124.64 -32.2 0.84 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' HD11 ' A' ' 211' ' ' ILE . 1.5 mptp? -143.26 166.5 24.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.384 0.592 . . . . 0.0 110.462 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.77 -35.27 63.63 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.61 -33.72 73.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.287 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.406 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.6 m170 -70.42 -32.53 70.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.453 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -63.07 -48.89 76.69 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.173 0.511 . . . . 0.0 110.407 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.8 tp -61.02 -39.33 89.36 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.111 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -62.43 -44.82 95.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.108 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.75 -39.07 87.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 111.342 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -65.53 -43.71 89.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.732 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.35 -32.45 71.27 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.841 0.353 . . . . 0.0 111.348 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.88 -7.41 39.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 7.11 36.16 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.089 -0.839 . . . . 0.0 113.212 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.95 146.01 48.06 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.377 1.088 . . . . 0.0 109.913 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.67 -27.79 15.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.127 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.65 152.29 37.61 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.11 128.79 54.63 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.996 0.427 . . . . 0.0 110.974 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.91 143.16 35.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.004 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.546 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -152.75 141.18 20.69 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.266 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.553 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.99 -50.0 1.71 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.961 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.8 m -62.03 -48.61 79.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.446 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.546 HG22 ' HB1' ' A' ' 202' ' ' ALA . 26.8 m -56.86 -23.17 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -91.56 -50.53 5.72 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.93 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -59.74 -34.43 72.94 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -93.61 9.7 35.75 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 56.5 mtp85 57.25 49.01 14.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.373 0.533 . . . . 0.0 112.021 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -96.13 -46.08 6.61 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.968 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.29 136.32 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.783 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.58 132.35 35.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.029 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.92 -51.6 58.22 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.943 -0.463 . . . . 0.0 111.943 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.25 -53.06 62.53 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -58.86 -34.8 72.02 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.768 0.318 . . . . 0.0 111.568 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.0 tp -61.69 -44.94 95.98 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.039 0.447 . . . . 0.0 110.762 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -62.04 -41.81 98.51 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.876 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.31 -36.32 79.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.269 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -61.39 -48.93 78.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.134 0.493 . . . . 0.0 110.82 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 73.1 mt -62.55 -38.11 88.77 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.161 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.297 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -59.76 -38.07 80.79 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -77.1 -2.05 32.25 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 79.11 28.01 54.72 Favored Glycine 0 C--N 1.344 1.003 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.942 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.9 t -104.17 116.96 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -158.56 -51.25 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.612 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 15.7 tp -59.03 135.82 57.75 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -76.36 162.95 27.46 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.581 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -78.78 117.04 19.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 44.8 m170 -139.87 -65.19 0.47 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.509 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -137.74 103.78 5.11 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -133.28 143.53 49.13 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.526 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -102.63 32.08 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.756 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.518 -179.589 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' CG ' HG13 ' A' ' 225' ' ' VAL . 12.7 tpp . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.12 12.23 19.78 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.915 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -109.96 135.82 50.21 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.168 0.984 . . . . 0.0 111.502 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.29 132.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.142 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.3 t -118.68 130.73 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.2 tp -105.16 135.87 45.73 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.078 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -113.05 116.95 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.948 0.404 . . . . 0.0 110.14 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.2 t -114.98 106.73 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.826 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -90.66 177.05 6.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.613 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -60.51 -17.45 45.52 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.395 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -14.99 60.74 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.91 139.67 48.36 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 117.992 0.36 . . . . 0.0 110.316 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -71.72 149.47 45.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.659 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.12 -35.27 90.55 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -61.59 -42.55 99.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.016 0.436 . . . . 0.0 110.899 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -63.31 -43.13 98.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.721 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.0 -38.93 87.77 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.331 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 14' ' ' GLY . 49.1 t -62.58 -45.99 97.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.815 0.341 . . . . 0.0 110.219 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -59.91 -38.68 83.0 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.236 0.541 . . . . 0.0 111.077 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.72 -42.78 99.83 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.034 178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.62 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.0 t80 -62.6 -32.82 73.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.574 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.3 ttmm -64.46 -50.34 67.89 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 110.963 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -75.57 -56.12 5.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.969 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.4 tp -66.45 -47.17 74.02 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm 58.02 66.22 2.85 Favored Pre-proline 0 CA--C 1.557 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.678 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.64 174.2 13.05 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.649 1.566 . . . . 0.0 111.715 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.63 -40.77 10.09 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.899 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.539 ' HB ' HG22 ' A' ' 5' ' ' VAL . 41.0 mt -120.09 140.37 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.872 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.6 t -130.7 121.53 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.057 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -107.1 119.0 38.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.253 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 8.9 ttm -119.84 136.43 54.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.009 -178.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -88.06 123.35 32.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.285 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 58' ' ' VAL . 6.1 pt -107.75 -5.49 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.653 HG22 ' N ' ' A' ' 61' ' ' ALA . 63.3 p -57.03 -15.77 5.79 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.4 0.545 . . . . 0.0 112.439 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.2 tpp -114.77 87.08 14.03 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -25.52 8.77 Favored 'Trans proline' 0 N--CA 1.506 2.228 0 C-N-CA 121.773 1.649 . . . . 0.0 114.058 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.35 -22.42 19.27 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.9 mmt -88.46 -2.56 58.67 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.18 53.43 4.48 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.742 0.782 . . . . 0.0 110.849 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.04 -55.19 32.28 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.175 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.708 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.7 mt -64.1 -27.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.677 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.76 -45.64 91.73 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.386 0.612 . . . . 0.0 110.218 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.35 -38.09 88.19 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.961 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.73 HG23 HG21 ' A' ' 56' ' ' ILE . 85.5 mt -58.38 -40.09 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 120.858 0.361 . . . . 0.0 110.291 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -61.13 -40.67 94.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.829 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.39 -42.71 99.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.339 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.7 mm -61.83 -41.97 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.626 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.4 mmt -61.05 -43.08 99.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 111.454 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -62.61 -43.54 98.55 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.154 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.528 HD11 HG13 ' A' ' 18' ' ' VAL . 22.7 mt -65.31 -49.2 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.925 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -146.2 87.34 6.65 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.008 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -18.85 30.13 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 121.559 1.506 . . . . 0.0 113.359 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -88.37 9.07 24.7 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -74.81 153.05 38.91 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.095 0.407 . . . . 0.0 110.704 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -94.18 100.27 12.39 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.73 HG21 HG23 ' A' ' 44' ' ' ILE . 15.7 mt -95.71 133.41 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.27 141.7 39.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.8 t -121.78 131.97 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.225 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -99.14 112.04 24.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.15 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.4 p -102.18 149.53 24.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.784 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.653 ' N ' HG22 ' A' ' 34' ' ' THR . . . -72.83 147.98 44.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.203 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 79.5 mtm -59.39 120.72 9.86 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.939 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.07 56.18 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -101.64 77.89 1.79 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-N 118.395 1.098 . . . . 0.0 110.898 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -62.76 -45.7 91.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.884 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.13 -31.3 71.01 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.345 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.0 mmt -64.05 -41.09 97.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.278 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.4 t -59.6 -39.26 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.569 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 72' ' ' ILE . 20.1 mm -62.64 -47.1 94.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.752 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.09 -41.28 96.37 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.285 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.09 -38.64 86.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.185 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 69' ' ' ILE . 20.6 mt -65.31 -44.15 94.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.166 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -59.52 -32.49 70.35 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.782 0.325 . . . . 0.0 111.521 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.96 -7.58 47.12 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.2 2.83 31.46 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.33 147.81 52.48 Favored 'General case' 0 C--N 1.35 0.608 0 CA-C-N 118.344 1.072 . . . . 0.0 109.987 175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -107.38 -33.28 7.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.469 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.39 158.14 22.0 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.919 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.73 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.14 151.68 46.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.6 mt -108.15 144.52 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.799 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.38 157.27 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.253 171.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -137.28 -95.97 0.21 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 119.445 -0.312 . . . . 0.0 110.774 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.503 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.2 m -62.2 -33.01 73.74 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.617 0.644 . . . . 0.0 111.123 -174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.69 -47.76 77.22 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.881 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.28 -40.4 93.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.541 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.8 t -65.62 -45.33 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.456 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -62.45 -38.16 88.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.472 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -135.54 79.98 46.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.419 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.51 -24.94 6.98 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 122.012 1.808 . . . . 0.0 113.803 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -28.79 62.62 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.103 -0.373 . . . . 0.0 111.828 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.14 -36.07 82.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.849 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 85' ' ' ALA . 61.1 mt -67.79 -45.86 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.1 m -61.64 -43.94 97.91 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.278 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -63.19 -43.44 98.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.024 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.73 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.8 mt -62.73 -40.32 96.84 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.175 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.31 -46.98 84.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.75 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.14 -39.43 92.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.643 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.2 m -74.16 -54.04 8.61 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -111.44 3.6 18.27 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 133.49 8.08 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.565 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 4.1 m -56.05 -34.56 66.02 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.527 -0.396 . . . . 0.0 111.911 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -67.81 -9.41 44.16 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.87 -10.47 33.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.1 t -103.14 120.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 CA-C-N 118.531 0.605 . . . . 0.0 110.203 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.6 t -108.22 127.81 64.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.848 HG21 HG13 ' A' ' 139' ' ' VAL . 24.4 t -100.87 117.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.62 131.59 44.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.657 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.509 HG23 HG13 ' A' ' 119' ' ' VAL . 44.4 mt -126.47 115.91 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.92 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.91 114.11 26.26 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.59 155.99 33.87 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.454 ' HG3' HD12 ' A' ' 152' ' ' ILE . 5.0 mtpm? -139.32 163.14 33.26 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.32 173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -88.26 116.06 26.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 110.396 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -134.68 133.87 54.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.656 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 57.26 28.97 15.99 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.01 86.47 Favored Glycine 0 CA--C 1.54 1.634 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.638 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -138.77 156.86 47.01 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 117.833 0.816 . . . . 0.0 109.358 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -76.91 124.85 28.34 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.4 mtp -126.12 143.66 51.04 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.808 0.337 . . . . 0.0 110.955 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.509 HG13 HG23 ' A' ' 108' ' ' ILE . 32.0 t -84.09 139.75 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.765 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.04 137.18 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.86 174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.503 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -112.32 179.66 3.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 63.69 52.39 2.23 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.698 0.761 . . . . 0.0 109.956 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.8 t 59.91 29.79 19.35 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.82 14.65 80.63 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.636 -0.535 . . . . 0.0 113.221 176.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.85 -33.24 22.89 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 117.827 0.813 . . . . 0.0 112.087 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -126.44 136.59 52.85 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.858 0.361 . . . . 0.0 111.421 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -81.53 140.03 34.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.655 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 65.3 p -94.04 -31.62 14.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.163 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.14 -17.7 56.67 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.18 -0.533 . . . . 0.0 111.943 -176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -70.53 132.63 33.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.442 0 CA-C-N 117.726 0.763 . . . . 0.0 109.221 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.8 mt -71.0 143.46 50.78 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.975 0.416 . . . . 0.0 110.195 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.1 tp -61.71 -36.77 81.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 137' ' ' VAL . 31.2 mtp180 -62.13 -50.96 69.81 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.83 -38.2 85.95 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.1 t-105 -66.26 -43.05 87.57 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.822 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.773 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -61.1 -41.72 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.19 -44.45 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.318 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.81 -42.75 99.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.191 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.848 HG13 HG21 ' A' ' 106' ' ' VAL . 46.2 t -61.65 -37.18 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.708 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -66.24 -52.02 51.86 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.388 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -61.87 -29.09 69.95 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.393 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -67.94 -20.22 65.05 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.19 9.78 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.184 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.473 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.08 131.85 49.93 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.349 0.575 . . . . 0.0 110.654 176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.27 91.82 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -150.85 166.19 31.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.034 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.645 HD11 HD12 ' A' ' 175' ' ' LEU . 57.2 mt -128.23 134.3 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.3 tp -103.51 106.96 17.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.563 HD13 HG21 ' A' ' 169' ' ' VAL . 32.7 tp -84.74 108.85 17.65 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.1 m -111.72 126.0 54.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.438 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.5 t -100.33 109.89 22.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.126 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.467 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.9 mt -72.36 -36.76 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -63.71 -30.87 71.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.168 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -93.81 -22.3 18.75 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -57.07 123.71 16.16 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.899 0.38 . . . . 0.0 111.937 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.13 3.29 87.59 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-O 119.269 -0.739 . . . . 0.0 113.339 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -80.04 -39.07 30.61 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 118.366 1.083 . . . . 0.0 110.563 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 11.0 tttp 59.94 35.38 21.65 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.111 0.482 . . . . 0.0 111.097 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.1 p -126.82 23.18 6.7 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.924 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 115.07 152.31 10.2 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.716 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.2 m-85 -67.96 161.04 27.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -75.91 72.22 2.77 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.506 0.67 . . . . 0.0 110.278 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.693 ' HA ' HD12 ' A' ' 166' ' ' ILE . 71.3 p -57.18 -29.86 64.02 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.24 -53.0 42.22 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.9 0.381 . . . . 0.0 110.209 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.617 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.55 -35.56 76.33 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.258 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 163' ' ' THR . 61.1 mt -63.57 -51.75 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.256 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -61.84 -36.1 80.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 111.126 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -66.01 -41.15 91.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.774 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 165' ' ' MET . 39.0 t -76.1 -35.66 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.082 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.75 -52.23 19.12 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.63 -9.94 26.21 Favored 'Trans proline' 0 N--CA 1.507 2.289 0 C-N-CA 121.394 1.396 . . . . 0.0 114.413 -173.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.3 mt -101.69 -3.3 28.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.16 141.29 27.33 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.65 0.659 . . . . 0.0 112.108 -175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 76.9 p -100.43 18.59 18.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.481 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.645 HD12 HD11 ' A' ' 147' ' ' ILE . 19.8 mt -95.15 167.14 13.44 Favored Pre-proline 0 C--N 1.347 0.488 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.486 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.12 133.87 25.9 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.367 1.378 . . . . 0.0 111.212 173.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.4 mt -105.2 121.8 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 110.13 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.63 111.92 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.269 174.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.41 131.6 34.79 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.816 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -136.63 128.01 28.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.333 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 126.37 3.41 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.58 -16.73 56.16 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.525 -0.597 . . . . 0.0 113.078 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.716 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.67 125.33 23.44 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.919 0.86 . . . . 0.0 111.493 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.25 -32.31 0.18 Allowed Glycine 0 CA--C 1.541 1.706 0 CA-C-O 119.483 -0.62 . . . . 0.0 113.472 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.564 ' HA ' HD11 ' A' ' 211' ' ' ILE . 42.9 mttm -145.2 170.19 16.73 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.064 0.932 . . . . 0.0 110.472 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 51.2 mtt -54.1 -36.41 63.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.72 -33.86 73.52 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.796 0.332 . . . . 0.0 111.346 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -69.82 -35.08 74.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.194 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -63.41 -47.9 80.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.936 0.398 . . . . 0.0 110.54 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.08 -39.38 89.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -62.56 -45.58 92.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.128 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.16 88.27 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.391 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.61 -44.13 87.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.797 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.64 -32.14 71.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.801 0.334 . . . . 0.0 111.251 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.96 -7.37 40.08 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.03 7.14 36.16 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.163 -0.798 . . . . 0.0 113.235 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.83 145.74 48.44 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.32 1.06 . . . . 0.0 110.015 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.12 -26.71 15.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.291 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.69 152.14 36.13 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.67 128.72 55.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.005 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.34 138.8 40.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.097 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.67 139.34 17.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.953 178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.07 -49.72 1.71 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.046 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.5 p -61.24 -46.55 89.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.516 -176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.471 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -58.75 -24.05 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -176.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -91.82 -50.18 5.87 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.053 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -59.93 -34.57 73.4 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.41 11.07 31.9 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 25.8 mmm-85 57.14 49.01 14.31 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.261 0.482 . . . . 0.0 112.047 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -95.58 -46.06 6.8 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.047 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.4 mt -116.32 138.42 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.798 176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -81.17 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.092 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.71 57.57 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -57.73 -52.47 65.3 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -58.85 -34.51 71.67 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.82 0.343 . . . . 0.0 111.549 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.8 tp -61.44 -45.66 93.34 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.06 0.457 . . . . 0.0 110.812 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -62.39 -42.13 99.19 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.773 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -61.04 -35.97 78.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -61.46 -49.28 77.43 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.094 0.473 . . . . 0.0 110.829 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.45 -37.98 88.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.237 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -62.49 -45.73 91.7 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.328 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -59.84 -36.74 77.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -78.62 -1.3 33.58 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.16 34.09 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.047 175.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.563 HG13 ' CG ' ' A' ' 1' ' ' MET . 24.6 t -79.94 131.87 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -63.78 125.66 25.08 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.062 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 227' ' ' LEU . 8.9 tt -135.2 115.27 13.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.31 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -116.72 132.47 56.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.632 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -159.97 146.78 16.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.486 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -124.0 129.9 51.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -135.94 -63.03 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.518 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -133.17 155.96 48.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.445 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -128.91 114.68 16.77 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.478 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.8 t60 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.571 -179.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.13 12.22 19.76 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 119.385 -0.675 . . . . 0.0 112.854 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -109.88 135.77 50.24 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.123 0.961 . . . . 0.0 111.528 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.1 mm -106.94 133.05 52.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.16 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.1 t -117.8 130.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.79 135.07 46.85 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.122 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -111.03 115.62 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.903 0.382 . . . . 0.0 110.173 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.6 t -115.02 105.01 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.685 178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -92.68 177.06 6.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.607 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' O ' ' HE3' ' A' ' 38' ' ' MET . 2.0 m-20 -59.52 -18.64 42.03 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.84 -15.03 60.74 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -112.54 137.72 50.35 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.022 0.374 . . . . 0.0 110.23 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -68.01 147.83 51.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.711 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -39.01 96.3 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.81 -39.88 90.63 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.002 0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.48 -41.09 98.57 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.652 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.19 -40.06 92.51 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.348 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.2 t -62.52 -46.28 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.942 0.401 . . . . 0.0 110.333 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -59.95 -38.24 81.87 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.194 0.521 . . . . 0.0 111.036 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -62.47 -43.96 97.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.047 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.649 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.5 t80 -62.58 -32.46 73.45 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.29 0.369 . . . . 0.0 111.548 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.16 -49.86 70.43 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.0 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -77.17 -56.14 4.82 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.902 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.08 -47.09 78.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.828 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.9 mttt 57.44 65.61 3.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.792 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.19 174.13 12.97 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.627 1.551 . . . . 0.0 111.719 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -94.26 -39.3 10.59 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.775 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.4 mt -121.09 140.23 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.82 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.7 t -131.12 123.44 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.047 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.9 p -107.79 119.09 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.208 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.499 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 23.7 ttm -121.58 135.44 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.109 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -87.81 125.25 34.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' CG ' ' A' ' 67' ' ' MET . 6.2 pt -113.04 1.16 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.3 p -56.97 -16.02 6.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.447 0.567 . . . . 0.0 112.494 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.0 mtt -114.82 87.11 14.21 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -55.87 -20.52 29.51 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 121.472 1.448 . . . . 0.0 113.422 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -56.75 -23.36 42.29 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE3' ' O ' ' A' ' 10' ' ' ASP . 85.7 mtp -88.69 4.54 46.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 59.51 48.98 9.06 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.56 0.695 . . . . 0.0 111.246 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -51.32 59.54 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.914 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.718 ' HA ' HD12 ' A' ' 44' ' ' ILE . 55.9 mt -63.76 -28.95 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.747 0.273 . . . . 0.0 110.482 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -63.19 -44.74 94.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.269 0.557 . . . . 0.0 110.303 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -60.68 -37.21 80.83 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.029 176.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.823 HG23 HG21 ' A' ' 56' ' ' ILE . 87.3 mt -59.26 -40.97 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 120.884 0.373 . . . . 0.0 110.218 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -60.76 -38.78 86.38 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.092 0.473 . . . . 0.0 110.868 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.96 -43.17 99.41 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.833 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 mm -61.69 -42.13 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 116.754 -0.203 . . . . 0.0 110.486 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.598 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.9 mmt -61.12 -41.63 97.05 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.5 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -62.61 -44.31 96.61 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.8 mt -65.19 -49.57 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.989 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -146.11 87.76 6.55 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.985 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.42 -18.29 30.78 Favored 'Trans proline' 0 N--CA 1.506 2.258 0 C-N-CA 121.542 1.495 . . . . 0.0 113.386 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -88.56 9.09 25.15 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.649 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.59 153.04 37.58 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 118.131 0.423 . . . . 0.0 110.711 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 100.0 mttt -93.35 101.13 13.36 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.823 HG21 HG23 ' A' ' 44' ' ' ILE . 25.2 mt -95.65 129.12 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -115.44 139.51 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.715 HG21 ' HB1' ' A' ' 71' ' ' ALA . 17.3 t -121.84 131.95 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.234 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.15 120.12 37.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.037 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.4 p -108.47 150.14 27.82 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.621 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.5 148.02 39.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.109 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -56.83 118.97 5.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.96 0.06 56.24 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.536 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -97.27 77.98 2.7 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 118.443 1.122 . . . . 0.0 110.931 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.51 -49.93 71.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.25 70.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.243 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.542 ' CG ' HD12 ' A' ' 33' ' ' ILE . 2.2 tpt -64.32 -41.37 96.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.919 0.39 . . . . 0.0 110.342 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.8 t -60.04 -38.0 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.019 0.438 . . . . 0.0 110.309 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 24.0 mm -62.37 -46.59 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.721 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' HB3' HD13 ' A' ' 41' ' ' ILE . 61.5 mt-10 -60.71 -41.41 95.18 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.08 0.467 . . . . 0.0 111.191 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.81 -39.14 87.86 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.256 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.1 mt -65.28 -42.65 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.262 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -59.31 -33.44 71.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.766 0.317 . . . . 0.0 111.573 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -70.68 -7.54 45.31 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 4.41 30.86 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.673 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.12 148.95 51.19 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 118.379 1.089 . . . . 0.0 110.244 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -109.52 -32.31 7.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.434 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.92 157.14 22.07 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.03 -0.605 . . . . 0.0 111.756 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.721 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.6 p90 -138.43 151.65 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 110.475 176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -108.06 145.55 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.334 0.588 . . . . 0.0 111.982 -168.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.5 m -131.88 157.68 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.11 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -137.36 -95.31 0.21 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 119.442 -0.313 . . . . 0.0 110.771 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.541 HG23 ' HB ' ' A' ' 121' ' ' THR . 19.6 m -62.46 -33.02 74.0 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.444 0.565 . . . . 0.0 111.045 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.03 -47.34 77.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.884 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -40.06 91.9 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.534 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 135' ' ' TRP . 21.6 t -65.66 -46.31 89.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.52 -38.03 88.37 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.636 0.255 . . . . 0.0 111.396 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -134.18 79.82 54.93 Favored Pre-proline 0 CA--C 1.549 0.908 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.12 -24.79 11.71 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 121.827 1.684 . . . . 0.0 113.318 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.99 -29.56 63.38 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.077 -0.389 . . . . 0.0 111.845 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.44 -35.99 82.26 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.992 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 85' ' ' ALA . 56.8 mt -67.96 -45.79 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 m -61.78 -43.43 98.87 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.253 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.32 -43.64 97.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.033 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.721 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 54.4 mt -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.242 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.96 83.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.782 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.19 -39.32 92.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.656 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.42 -54.13 8.21 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -110.62 3.02 18.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 -173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.54 132.15 7.58 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -57.04 -32.84 66.61 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.76 -9.39 43.62 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.67 -8.96 36.35 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.12 120.61 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.635 0.652 . . . . 0.0 110.102 -177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 97.7 t -108.47 127.41 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.832 HG21 HG13 ' A' ' 139' ' ' VAL . 24.0 t -101.08 117.97 47.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.54 132.35 44.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.654 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 119' ' ' VAL . 44.7 mt -127.05 115.86 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.001 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.97 113.95 26.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.72 158.26 30.51 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -170.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 152' ' ' ILE . 31.5 mtpt -141.54 163.85 31.8 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.5 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -90.5 113.97 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.937 0.398 . . . . 0.0 110.187 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -133.68 133.77 56.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.67 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.49 28.95 16.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.06 86.28 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-O 119.699 -0.5 . . . . 0.0 113.553 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -139.6 155.47 47.43 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 117.812 0.806 . . . . 0.0 109.136 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 124.64 28.05 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.24 0.338 . . . . 0.0 110.346 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.9 mtp -125.11 143.68 50.8 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.87 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.55 139.65 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.785 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -121.03 136.22 55.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.885 174.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.541 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -111.95 179.08 4.11 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.818 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.93 52.34 2.12 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.721 0.772 . . . . 0.0 109.942 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.4 t 60.18 29.96 19.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.513 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.46 81.19 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.217 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -84.51 -33.67 23.48 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 117.938 0.869 . . . . 0.0 112.063 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -126.12 137.1 53.57 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.878 0.371 . . . . 0.0 111.486 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -81.98 139.66 34.43 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.639 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.5 p -94.14 -30.83 14.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.295 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.07 -18.28 56.93 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.86 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.51 131.27 34.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.427 0 CA-C-N 117.714 0.757 . . . . 0.0 109.181 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 131' ' ' LEU . 17.2 mt -71.08 143.33 50.7 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 123.371 0.42 . . . . 0.0 110.255 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.8 -35.63 78.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.905 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.9 mtp180 -62.53 -51.32 67.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.695 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.15 -38.12 84.96 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.08 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.79 ' O ' HG23 ' A' ' 139' ' ' VAL . 13.2 t-105 -65.95 -43.83 86.8 Favored 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.735 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.7 t -60.84 -41.69 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.517 0.199 . . . . 0.0 110.587 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.51 -44.64 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.312 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -62.51 -42.59 99.61 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.203 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.832 HG13 HG21 ' A' ' 106' ' ' VAL . 47.0 t -61.68 -37.88 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.89 -177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.53 -50.14 66.32 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.217 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -60.25 -32.22 70.95 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.731 0.3 . . . . 0.0 111.448 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -67.91 -19.55 65.01 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.07 26.18 9.79 Favored Glycine 0 C--N 1.343 0.93 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.172 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.69 131.72 48.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 117.36 0.58 . . . . 0.0 110.618 176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.06 -46.34 91.5 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -150.01 166.77 28.69 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.458 -0.371 . . . . 0.0 110.95 -176.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.639 HD11 HD12 ' A' ' 175' ' ' LEU . 57.9 mt -129.21 135.07 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.71 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.1 tp -104.33 107.4 18.31 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.564 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.0 tp -85.35 108.8 17.99 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.569 0.543 . . . . 0.0 109.87 177.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.2 m -111.31 127.07 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.558 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.9 t -100.58 109.88 22.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.361 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.455 HD13 ' HA3' ' A' ' 124' ' ' GLY . 41.5 mt -73.06 -35.27 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -65.04 -30.74 71.73 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.176 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -94.99 -21.54 18.53 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -57.1 122.7 12.99 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.941 0.401 . . . . 0.0 111.892 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.12 4.01 87.02 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.39 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -81.25 -38.34 27.08 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 118.299 1.05 . . . . 0.0 110.574 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 69.7 tttt 60.61 36.89 19.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 0.0 110.891 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 59.9 p -125.73 23.11 7.4 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.851 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.405 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.1 155.95 13.94 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.697 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 41.2 m-85 -68.0 161.18 27.21 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -75.92 72.26 2.78 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.495 0.664 . . . . 0.0 110.279 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.671 ' HA ' HD12 ' A' ' 166' ' ' ILE . 70.8 p -57.3 -28.76 63.33 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.035 -176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -65.39 -53.46 42.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.905 0.383 . . . . 0.0 110.244 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 54.7 ttm -61.99 -35.76 79.48 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.15 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.8 mt -63.49 -51.95 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.295 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -62.42 -36.16 81.5 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -66.65 -40.61 88.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.825 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 40.8 t -76.66 -34.9 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.01 -177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.99 -52.22 20.16 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 113.742 1.016 . . . . 0.0 113.742 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.96 -9.9 26.59 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.436 1.424 . . . . 0.0 114.379 -174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.8 -4.59 27.71 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 141.45 27.48 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.582 0.628 . . . . 0.0 112.1 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.8 p -99.66 18.32 18.35 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.618 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 147' ' ' ILE . 20.9 mt -94.89 167.21 13.47 Favored Pre-proline 0 C--N 1.348 0.538 0 CA-C-O 119.383 -0.341 . . . . 0.0 110.411 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -70.39 133.93 25.52 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.38 1.386 . . . . 0.0 111.218 173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.9 mt -104.63 121.55 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.087 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.71 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.7 mt -100.81 112.1 32.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.286 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 131.88 34.92 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.808 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.0 t -136.78 126.5 25.53 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.493 -178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.03 128.26 3.65 Favored Glycine 0 N--CA 1.465 0.632 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.6 -18.44 53.19 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.981 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.55 125.29 23.27 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 117.824 0.812 . . . . 0.0 111.538 -176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.94 -32.24 0.24 Allowed Glycine 0 CA--C 1.541 1.675 0 CA-C-O 119.59 -0.561 . . . . 0.0 113.364 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.62 ' HA ' HD11 ' A' ' 211' ' ' ILE . 96.2 mttt -145.28 169.86 17.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.986 0.893 . . . . 0.0 110.443 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 34.1 mtt -54.19 -36.13 63.1 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.96 -33.77 73.72 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.697 0.284 . . . . 0.0 111.266 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.405 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -70.27 -33.75 71.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.227 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -63.56 -48.87 75.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.116 0.484 . . . . 0.0 110.56 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.7 tp -60.92 -38.87 87.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.11 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -62.75 -45.79 91.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.047 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.79 -38.61 85.91 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.909 0.385 . . . . 0.0 111.416 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.73 -44.06 87.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.764 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.3 mt -60.56 -32.08 71.17 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.756 0.312 . . . . 0.0 111.217 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.76 -7.69 41.76 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.17 7.08 35.9 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 119.161 -0.8 . . . . 0.0 113.19 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.05 145.8 48.02 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 118.357 1.079 . . . . 0.0 109.918 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -94.72 -27.75 15.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.217 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.78 150.68 35.8 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.19 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.34 127.61 54.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.854 0.359 . . . . 0.0 110.815 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.06 139.49 39.08 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.031 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.491 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -155.33 137.15 14.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.28 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.96 -45.7 1.86 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.937 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 20.3 t -61.1 -49.01 79.03 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.473 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.2 m -57.74 -21.99 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -91.45 -51.2 5.39 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.03 -34.21 73.07 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.32 10.22 32.97 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 57.24 49.06 13.99 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.359 0.527 . . . . 0.0 112.013 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -96.05 -46.1 6.63 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.965 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.62 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -119.02 137.1 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.743 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.65 132.85 35.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.989 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.83 -52.76 51.33 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -57.68 -53.32 59.49 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -58.79 -34.36 71.39 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.868 0.366 . . . . 0.0 111.526 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.412 HD13 HG21 ' A' ' 211' ' ' ILE . 20.4 tp -61.85 -45.1 95.26 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.103 0.478 . . . . 0.0 110.864 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -62.32 -40.78 97.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.764 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.14 -37.08 81.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.272 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -61.49 -48.9 78.97 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.104 0.478 . . . . 0.0 110.768 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.1 mt -62.69 -38.24 89.59 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.198 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -62.52 -44.47 96.29 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.305 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -59.83 -37.65 79.81 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -78.13 -1.07 30.77 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.45 28.02 41.32 Favored Glycine 0 C--N 1.343 0.942 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.021 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.7 t -79.97 119.22 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -90.05 146.96 23.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 60.7 mt -99.53 141.51 32.22 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.487 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.75 119.04 38.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.605 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -159.97 154.36 23.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -137.22 119.77 16.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.654 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -111.38 110.66 21.22 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.462 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -66.38 -41.9 88.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.614 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -118.4 130.79 56.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.514 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 63.6 m170 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.493 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB2' ' CG ' ' A' ' 193' ' ' PHE . 10.9 ptp . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.74 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.527 -0.596 . . . . 0.0 112.68 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.502 ' HD3' HD11 ' A' ' 28' ' ' ILE . 70.7 mttt -109.94 135.82 50.2 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.022 0.911 . . . . 0.0 111.615 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 220' ' ' LEU . 44.7 mm -107.95 123.69 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.888 176.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 20.0 t -112.88 131.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.816 0.341 . . . . 0.0 110.423 -177.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.1 tp -105.68 133.47 50.37 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.819 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.3 mt -110.47 118.01 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.945 0.402 . . . . 0.0 110.314 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 17' ' ' ALA . 24.4 t -115.0 104.99 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.692 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -93.86 177.1 6.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.451 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -59.04 -18.59 36.11 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.9 -14.96 60.71 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -114.44 144.95 42.49 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.058 0.39 . . . . 0.0 110.381 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -74.62 150.66 39.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.954 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.641 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.43 -39.98 98.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -61.32 -39.41 90.41 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -63.81 -45.35 90.03 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.36 -39.4 87.08 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 111.335 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.4 t -63.26 -46.02 96.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.251 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -60.02 -37.64 80.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.214 0.531 . . . . 0.0 110.981 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.79 -42.85 99.89 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.089 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.9 t80 -62.46 -32.97 73.93 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.202 0.314 . . . . 0.0 111.482 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -64.06 -50.04 69.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.756 0.312 . . . . 0.0 111.072 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.34 -56.08 4.96 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.018 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.03 -47.13 78.5 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 58.59 66.46 2.51 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.726 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.51 174.28 12.93 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.585 1.523 . . . . 0.0 110.971 173.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -98.52 -31.67 11.85 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.419 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.7 mt -121.41 138.49 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.3 t -130.81 124.35 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.033 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.3 p -108.47 119.0 38.24 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.243 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -122.09 136.09 54.88 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 111.146 -177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -87.11 125.85 34.4 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.118 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' SD ' ' A' ' 67' ' ' MET . 6.2 pt -113.03 0.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 61' ' ' ALA . 68.6 p -61.28 -11.97 11.7 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 33.2 mtt -114.72 87.08 13.91 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.04 -26.14 7.34 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.91 1.74 . . . . 0.0 114.149 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -55.27 -23.53 23.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.078 0.769 . . . . 0.0 113.078 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.3 ttm -86.66 -10.09 54.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 61.74 54.08 3.03 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.787 0.803 . . . . 0.0 110.372 -175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -48.86 83.75 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.027 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.725 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.33 -28.96 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.335 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -62.46 -43.91 97.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 175.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.4 -40.29 93.84 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.004 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.741 HG23 HG21 ' A' ' 56' ' ' ILE . 84.2 mt -57.86 -41.08 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 120.95 0.405 . . . . 0.0 110.33 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -61.24 -41.47 96.95 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.91 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.576 ' OE1' HG21 ' A' ' 18' ' ' VAL . 3.5 tt0 -62.79 -40.56 97.72 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.207 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mm -61.74 -41.96 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.56 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.68 -40.57 92.66 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.476 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -62.88 -44.4 96.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.107 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 69.0 mt -65.39 -49.9 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.935 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.11 87.82 6.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.875 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.12 -17.59 32.57 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.508 1.472 . . . . 0.0 113.433 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -88.38 8.99 25.0 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.18 153.01 36.47 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-N 118.243 0.474 . . . . 0.0 110.627 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -94.9 102.94 14.81 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.741 HG21 HG23 ' A' ' 44' ' ' ILE . 12.4 mt -96.06 128.0 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.179 0.514 . . . . 0.0 109.732 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -114.01 137.4 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.85 132.0 71.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.365 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.27 120.02 37.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.844 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.3 p -106.41 151.78 24.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.654 ' N ' HG22 ' A' ' 34' ' ' THR . . . -74.51 146.3 42.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.152 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 44.3 ttm -59.62 119.85 8.35 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.954 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.04 56.11 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.583 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -101.78 77.84 1.76 Allowed 'General case' 0 C--N 1.348 0.501 0 CA-C-N 118.377 1.089 . . . . 0.0 110.66 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.99 -48.38 79.07 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.914 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.59 -30.74 70.01 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.347 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.591 ' SD ' HD12 ' A' ' 33' ' ' ILE . 4.3 ttt -64.09 -42.12 97.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.079 0.466 . . . . 0.0 110.281 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.1 t -59.38 -38.52 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.663 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.6 -47.76 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.712 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.92 -40.72 94.24 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.201 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.05 -39.25 89.11 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.6 mt -65.99 -43.33 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.19 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -59.56 -31.36 69.35 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.784 0.326 . . . . 0.0 111.503 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.83 -1.69 23.33 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.26 2.28 31.35 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 119.235 -0.758 . . . . 0.0 112.857 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.61 146.79 54.11 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 118.42 1.11 . . . . 0.0 110.162 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -112.3 -28.96 7.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.768 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.93 149.61 18.53 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.715 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.691 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.3 p90 -132.63 143.76 49.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.14 0.495 . . . . 0.0 110.781 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.0 mt -109.36 150.82 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.416 0.626 . . . . 0.0 112.041 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 12.1 m -137.32 157.52 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.16 171.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.473 ' O ' HG23 ' A' ' 86' ' ' VAL . 31.1 t-20 -138.7 -93.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.966 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.509 HG23 ' HB ' ' A' ' 121' ' ' THR . 22.2 m -62.76 -33.7 75.7 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.323 0.511 . . . . 0.0 110.923 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.582 ' HB2' ' HG3' ' A' ' 62' ' ' MET . . . -65.29 -48.68 72.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.782 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.95 -37.68 83.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.557 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.4 t -66.89 -47.04 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.433 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.72 -37.37 86.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.764 -0.198 . . . . 0.0 111.363 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -136.04 79.97 43.02 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.253 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -48.29 -24.81 6.33 Favored 'Trans proline' 0 N--CA 1.509 2.401 0 C-N-CA 121.954 1.77 . . . . 0.0 113.88 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.84 -28.44 61.62 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.033 -0.417 . . . . 0.0 111.961 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.6 tp -64.74 -35.22 80.37 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.937 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.528 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.2 mt -67.7 -45.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -62.26 -44.43 96.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.193 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -62.93 -43.0 99.98 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.039 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.691 HD22 ' CE1' ' A' ' 79' ' ' PHE . 34.4 mt -61.99 -40.23 94.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.167 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 101' ' ' SER . . . -63.56 -48.11 78.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.722 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.73 -37.53 84.59 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.69 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -73.49 -54.09 9.06 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.89 8.44 15.94 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.96 129.67 6.78 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HB1' ' A' ' 96' ' ' ALA . 1.8 p -57.9 -32.4 67.7 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.582 -0.364 . . . . 0.0 111.743 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -67.8 -9.72 46.7 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -98.6 -4.44 34.0 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 13.2 t -103.04 120.57 53.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 118.669 0.668 . . . . 0.0 110.167 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -108.72 128.0 64.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.687 HG21 HG13 ' A' ' 139' ' ' VAL . 26.1 t -103.12 117.94 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -99.02 134.62 41.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.798 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.485 HG23 HG13 ' A' ' 119' ' ' VAL . 42.5 mt -128.2 115.89 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.957 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -93.27 114.69 27.21 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.35 156.43 33.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.138 0.494 . . . . 0.0 112.284 -170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.446 ' HG3' HD12 ' A' ' 152' ' ' ILE . 49.0 mtpt -140.45 164.53 29.89 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.35 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -89.57 116.64 27.87 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.286 0.366 . . . . 0.0 110.267 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.38 133.57 52.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.689 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.21 29.07 16.08 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.71 9.98 86.12 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.716 -0.491 . . . . 0.0 113.568 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -138.34 155.73 48.28 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 117.807 0.803 . . . . 0.0 109.284 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -76.82 123.94 26.98 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.219 0.325 . . . . 0.0 110.372 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.9 mtp -125.08 143.24 51.02 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.895 0.379 . . . . 0.0 111.047 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG13 HG23 ' A' ' 108' ' ' ILE . 31.4 t -83.99 139.67 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.863 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -121.03 137.93 54.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.791 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.509 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.35 179.44 3.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 63.82 52.34 2.17 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.666 0.746 . . . . 0.0 109.931 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.8 m 59.99 29.89 19.43 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.493 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.511 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.52 81.26 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.655 -0.525 . . . . 0.0 113.254 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -84.31 -33.73 23.87 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 117.839 0.82 . . . . 0.0 112.07 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -125.68 136.6 53.39 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.783 0.325 . . . . 0.0 111.471 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -81.86 139.59 34.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -94.05 -31.63 14.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.173 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.62 -17.92 56.88 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.907 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.46 132.17 33.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.447 0 CA-C-N 117.736 0.768 . . . . 0.0 109.298 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.9 mt -71.19 144.15 50.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.993 0.425 . . . . 0.0 110.21 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.788 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.7 tp -61.56 -37.99 85.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.955 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 137' ' ' VAL . 66.7 mtp85 -61.32 -50.69 71.94 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.918 0.39 . . . . 0.0 110.937 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.84 -38.13 85.79 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.759 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.5 t-105 -67.2 -42.09 84.72 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.923 -178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.788 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.5 t -60.8 -41.25 87.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.56 -44.37 98.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.359 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -62.58 -42.28 99.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.253 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.58 -38.43 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.8 -50.7 63.71 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.291 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.01 -32.68 71.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.69 0.281 . . . . 0.0 111.588 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -67.88 -20.2 65.1 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.21 26.07 9.78 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.084 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.415 ' O ' HD22 ' A' ' 175' ' ' LEU . . . -63.56 131.82 49.28 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.538 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.75 -45.89 93.25 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -150.06 165.76 31.79 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.958 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.621 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.74 134.65 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.0 tp -104.07 107.03 17.73 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 30.1 tp -86.09 108.92 18.51 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 123.426 0.453 . . . . 0.0 109.931 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -111.66 128.31 56.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.721 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.8 t -101.38 109.82 21.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.205 177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.511 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.89 -35.11 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -64.33 -30.52 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.238 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -98.28 -20.43 17.23 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.2 125.03 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.22 -1.08 88.8 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.4 p -80.65 -37.8 30.29 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.344 1.072 . . . . 0.0 110.516 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 60.62 37.02 19.55 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.206 0.527 . . . . 0.0 110.967 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.4 p -123.0 23.19 9.39 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.816 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.53 150.97 11.79 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 65.4 m-85 -67.91 158.36 32.87 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.56 72.15 2.52 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.611 0.72 . . . . 0.0 110.118 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.616 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.5 p -56.31 -27.42 55.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.252 -175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -65.06 -50.98 64.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.608 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.8 ttm -62.13 -35.72 79.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.131 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 163' ' ' THR . 83.4 mt -63.49 -51.99 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.319 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -62.61 -34.64 77.43 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 110.858 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.5 -42.26 92.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.641 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 165' ' ' MET . 38.4 t -76.45 -35.5 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.03 -177.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.43 -52.21 17.88 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.55 -9.97 26.18 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 121.469 1.446 . . . . 0.0 114.438 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.39 -0.42 28.09 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.7 t -146.2 138.89 25.48 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 118.57 0.623 . . . . 0.0 112.056 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -99.5 18.69 17.25 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.428 173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.621 HD12 HD11 ' A' ' 147' ' ' ILE . 17.5 mt -96.62 167.1 12.79 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -69.98 133.41 25.08 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.337 1.358 . . . . 0.0 111.247 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.4 mt -103.71 121.57 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.931 0.396 . . . . 0.0 110.147 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.708 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.2 mt -101.14 113.07 36.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.294 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -89.06 132.27 34.85 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.607 0.241 . . . . 0.0 110.769 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 t -136.35 128.37 29.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.374 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.87 128.25 3.94 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.89 -17.75 55.85 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.961 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.87 114.66 3.48 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 117.955 0.877 . . . . 0.0 111.44 -176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -126.99 -32.29 0.7 Allowed Glycine 0 CA--C 1.538 1.493 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.745 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.453 ' HA ' HD11 ' A' ' 211' ' ' ILE . 4.2 mmmm -144.62 167.78 21.73 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.511 0.656 . . . . 0.0 110.5 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 61.0 mtt -55.07 -35.54 64.65 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.43 -33.59 72.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.823 0.344 . . . . 0.0 111.34 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 53.5 m170 -70.36 -33.3 71.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.278 -178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -63.22 -48.56 77.74 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.056 0.455 . . . . 0.0 110.471 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.93 -38.84 87.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.1 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -62.76 -45.82 90.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.029 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.59 -38.05 83.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.906 0.384 . . . . 0.0 111.345 -178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.408 ' CG ' ' HB2' ' A' ' 1' ' ' MET . 22.0 m-85 -65.36 -44.03 88.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.778 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.2 mt -60.37 -32.79 71.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.823 0.344 . . . . 0.0 111.323 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.67 -7.81 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.14 7.03 36.06 Favored Glycine 0 CA--C 1.536 1.345 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.181 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.59 146.31 48.48 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 118.391 1.096 . . . . 0.0 109.99 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -94.76 -30.28 14.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.904 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.02 43.13 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.106 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.91 129.88 52.89 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.867 0.365 . . . . 0.0 111.0 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.74 139.57 40.97 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.906 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.487 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.81 135.06 14.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.211 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.0 -45.89 1.85 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.053 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.4 m -61.24 -48.02 83.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.395 -177.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.487 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.0 m -57.31 -22.17 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -91.19 -51.02 5.52 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.871 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -59.68 -34.56 73.02 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -93.62 10.44 32.73 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 57.19 49.12 14.01 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.373 0.533 . . . . 0.0 112.023 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -96.5 -46.15 6.47 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.901 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.3 mt -116.52 138.91 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.713 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -80.36 133.76 35.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.055 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.37 -53.02 49.67 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -59.63 -50.91 72.04 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.3 tp10 -58.41 -35.15 71.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.847 0.356 . . . . 0.0 111.592 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.2 tp -61.86 -46.45 89.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.164 0.507 . . . . 0.0 110.785 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -61.96 -40.54 95.93 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.907 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -61.33 -37.94 85.12 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.346 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -61.2 -48.73 80.16 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.154 0.502 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 4' ' ' ILE . 72.4 mt -62.72 -38.37 90.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.189 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -62.46 -43.88 97.76 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.339 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -59.67 -37.75 79.6 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -79.64 1.76 25.06 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 80.66 28.04 48.67 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.052 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.34 121.59 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -138.82 168.31 20.1 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.73 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.683 HD23 ' O ' ' A' ' 229' ' ' HIS . 15.8 tp -100.13 138.74 36.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.432 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.72 -41.6 95.86 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.683 ' O ' HD23 ' A' ' 227' ' ' LEU . 98.6 m-70 -105.1 111.5 24.29 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.531 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -160.06 90.5 0.91 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.568 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -145.43 163.0 35.99 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.561 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -158.1 -59.35 0.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -133.72 149.84 51.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.49 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.606 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptp . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.15 12.15 19.73 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.539 -0.589 . . . . 0.0 112.643 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mttp -109.99 135.81 50.24 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 118.108 0.954 . . . . 0.0 111.687 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -107.1 129.57 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.862 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -115.6 134.12 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.665 0.269 . . . . 0.0 110.417 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.7 tp -106.8 131.79 53.51 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.076 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.7 mt -107.88 112.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.85 0.357 . . . . 0.0 110.218 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.623 HG11 ' HB2' ' A' ' 17' ' ' ALA . 26.3 t -115.0 105.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.077 0.465 . . . . 0.0 109.783 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -86.67 177.05 7.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.699 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.41 -16.59 37.36 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.7 -15.14 60.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.437 HG23 ' OE1' ' A' ' 16' ' ' GLU . 21.3 m -109.54 143.15 39.61 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.976 0.353 . . . . 0.0 110.168 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -76.0 153.79 36.25 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.742 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.08 -36.56 92.52 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.9 -41.84 98.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.902 0.382 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' OE1' HG23 ' A' ' 12' ' ' THR . 79.6 mt-10 -63.41 -43.76 96.6 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.623 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -60.79 -40.58 93.17 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.355 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.8 t -63.11 -45.33 98.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.359 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -60.26 -39.51 87.05 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.213 0.53 . . . . 0.0 110.995 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -62.35 -41.24 98.44 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.117 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.663 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.0 t80 -63.08 -33.62 75.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.606 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -64.06 -49.78 70.97 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.685 0.279 . . . . 0.0 111.025 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -76.19 -56.14 4.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.035 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.3 tp -67.35 -47.12 71.39 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.7 mttt 57.89 66.38 2.82 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.776 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.87 174.15 13.29 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.66 1.574 . . . . 0.0 111.802 175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -92.9 -37.04 12.47 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.099 0.476 . . . . 0.0 109.954 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.544 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.0 mt -124.77 140.64 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.682 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -132.39 124.99 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.039 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 72.6 p -106.73 118.87 37.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.445 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 32.2 tpp -120.23 131.89 55.13 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.841 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -85.73 125.04 32.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.342 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 ' HE3' ' A' ' 67' ' ' MET . 6.2 pt -113.01 2.95 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.603 HG22 ' N ' ' A' ' 61' ' ' ALA . 61.9 p -56.98 -15.98 6.05 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.436 0.562 . . . . 0.0 112.49 -175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.8 mtt -114.86 87.13 14.34 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -55.65 -22.2 34.97 Favored 'Trans proline' 0 N--CA 1.501 1.97 0 C-N-CA 121.459 1.439 . . . . 0.0 113.281 -170.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -56.98 -20.77 25.66 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.8 mtt -88.5 3.57 49.74 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 60.09 47.8 9.17 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.551 0.691 . . . . 0.0 111.008 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.27 -50.85 63.11 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.912 -177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.69 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.2 mt -64.23 -28.63 45.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.417 -177.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -63.1 -43.46 98.42 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.283 0.563 . . . . 0.0 110.354 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.28 -38.39 86.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.932 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.841 HG23 HG21 ' A' ' 56' ' ' ILE . 84.7 mt -59.07 -41.39 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 CA-C-O 120.935 0.398 . . . . 0.0 110.169 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -61.1 -39.63 90.71 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.609 ' OE1' HG21 ' A' ' 18' ' ' VAL . 54.7 mt-10 -62.43 -41.14 98.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.283 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 mm -62.13 -41.38 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.88 -42.19 97.47 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.68 0.276 . . . . 0.0 111.521 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -62.98 -44.75 95.19 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.086 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 ' CG1' ' A' ' 18' ' ' VAL . 21.5 mt -64.85 -48.47 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.046 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -146.25 87.0 6.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.899 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.56 -18.42 32.39 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.546 1.497 . . . . 0.0 113.351 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -88.77 9.05 25.9 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.663 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.21 152.96 36.45 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.13 0.423 . . . . 0.0 110.671 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -93.76 101.66 13.78 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.841 HG21 HG23 ' A' ' 44' ' ' ILE . 21.0 mt -95.7 129.12 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.197 0.522 . . . . 0.0 109.85 -177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.92 141.06 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.705 HG21 ' HB1' ' A' ' 71' ' ' ALA . 22.6 t -121.83 132.02 71.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.168 0.509 . . . . 0.0 110.132 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.5 t -101.11 112.32 24.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.039 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.2 p -101.97 153.13 20.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 34' ' ' THR . . . -76.48 148.05 37.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.247 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.418 ' CE ' ' HB2' ' A' ' 84' ' ' ALA . 92.4 mtp -58.98 120.12 8.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.354 -0.385 . . . . 0.0 112.024 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.09 56.11 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-O 119.209 -0.773 . . . . 0.0 113.477 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 83.9 mt-30 -99.51 77.98 2.14 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.428 1.114 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -63.84 -49.23 73.62 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.695 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.04 -30.41 70.3 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.207 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.574 ' HE3' HD12 ' A' ' 33' ' ' ILE . 74.9 mmm -64.33 -41.67 96.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.315 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.5 t -59.51 -38.65 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.061 0.458 . . . . 0.0 110.572 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.49 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.6 mm -62.43 -47.82 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.764 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.12 -40.52 94.12 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.705 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.83 86.36 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.282 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.32 -44.12 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.193 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.59 -31.08 69.13 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.799 0.333 . . . . 0.0 111.557 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.66 -2.95 28.47 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.27 0.52 31.3 Favored Glycine 0 CA--C 1.538 1.493 0 CA-C-O 119.267 -0.74 . . . . 0.0 112.902 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.16 149.41 50.34 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 118.35 1.075 . . . . 0.0 110.274 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -115.49 -29.6 6.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.704 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 154.87 20.42 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.071 -0.585 . . . . 0.0 111.669 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.747 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.4 p90 -137.64 149.1 46.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.479 . . . . 0.0 111.003 178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.2 mt -105.97 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.423 0.63 . . . . 0.0 112.057 -168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -136.1 154.6 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.141 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.495 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.3 t-20 -138.74 -93.16 0.19 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.947 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.2 m -62.95 -33.23 74.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 118.238 0.472 . . . . 0.0 111.054 -174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.418 ' HB2' ' CE ' ' A' ' 62' ' ' MET . . . -65.31 -49.73 68.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.764 -178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.13 81.09 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.566 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.5 t -67.0 -46.84 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.35 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -62.44 -38.03 88.18 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.452 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -135.2 79.55 49.52 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.435 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.41 -25.3 7.21 Favored 'Trans proline' 0 N--CA 1.508 2.377 0 C-N-CA 122.016 1.81 . . . . 0.0 113.794 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.7 t -56.96 -29.72 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.01 -0.431 . . . . 0.0 111.868 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.24 -35.39 80.67 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.648 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.2 mt -68.12 -45.45 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.4 m -61.76 -43.36 99.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.43 -44.57 94.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.054 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.747 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 16.4 mt -63.2 -38.67 92.07 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.076 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.69 -47.41 81.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.421 0.153 . . . . 0.0 110.679 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -61.72 -39.44 91.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.719 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 m -74.45 -54.12 8.19 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.44 2.44 20.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.62 130.12 6.89 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 p -56.68 -33.4 66.37 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -67.71 -9.47 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.42 -10.4 35.26 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 t -103.07 120.77 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 118.565 0.62 . . . . 0.0 110.285 -177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.8 t -107.32 127.6 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -101.9 118.14 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.81 42.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.859 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.576 HG23 HG13 ' A' ' 119' ' ' VAL . 43.4 mt -127.86 115.92 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.008 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -93.78 114.01 26.19 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.33 156.32 32.83 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -141.08 164.22 30.85 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.288 173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -88.62 120.66 30.21 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.89 0.376 . . . . 0.0 110.413 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 51.4 t -144.67 138.22 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 57.6 29.16 16.76 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.29 10.03 84.34 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.546 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -141.71 160.28 40.5 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.825 0.813 . . . . 0.0 109.298 178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -77.57 124.73 28.3 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.137 0.273 . . . . 0.0 110.294 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.3 mtp -124.32 143.08 50.78 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.8 0.333 . . . . 0.0 110.914 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 108' ' ' ILE . 30.3 t -84.76 140.62 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.892 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -121.04 137.7 54.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.943 174.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.516 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.5 p -113.66 -179.95 3.78 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.9 52.27 2.15 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.0 109.874 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m 60.16 29.71 19.25 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.437 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.41 14.64 81.2 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.248 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -85.04 -33.11 22.56 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 117.822 0.811 . . . . 0.0 112.147 -177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -126.01 136.92 53.54 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.825 0.345 . . . . 0.0 111.374 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -81.34 139.31 35.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.61 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.37 14.74 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.298 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.99 -17.97 57.9 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 121.163 -0.541 . . . . 0.0 111.915 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.7 mt -69.25 131.86 33.58 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.732 0.766 . . . . 0.0 109.188 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.7 mt -70.11 143.12 52.47 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 123.395 0.434 . . . . 0.0 110.134 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.782 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.4 tp -61.77 -36.93 82.49 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.896 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 39.2 mtp180 -62.01 -50.62 71.33 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.55 -38.17 83.77 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.085 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.762 ' O ' HG23 ' A' ' 139' ' ' VAL . 11.1 t-105 -66.8 -42.42 85.99 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.897 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.1 t -60.82 -41.64 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.4 t -63.43 -43.94 98.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.357 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -62.7 -42.43 99.64 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.225 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.5 t -61.26 -38.47 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.896 -177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -65.96 -51.17 60.88 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.315 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -59.9 -33.19 71.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.778 0.323 . . . . 0.0 111.554 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.04 -19.24 64.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.12 26.1 9.82 Favored Glycine 0 C--N 1.344 0.983 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.247 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.67 131.74 48.9 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.34 0.57 . . . . 0.0 110.556 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.31 -46.1 91.63 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -149.46 164.13 35.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.441 -0.38 . . . . 0.0 110.923 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.678 HD11 HD12 ' A' ' 175' ' ' LEU . 56.1 mt -127.18 135.11 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.9 tp -104.79 106.94 17.65 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 169' ' ' VAL . 31.9 tp -85.49 108.85 18.1 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.468 0.48 . . . . 0.0 109.739 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 58.8 m -112.38 128.28 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.445 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -104.38 109.83 21.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.483 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 43.9 mt -71.49 -34.88 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -63.17 -31.17 72.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.326 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 35.9 mmt-85 -93.25 -24.61 18.12 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -55.53 124.98 19.05 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 -0.95 89.0 Favored Glycine 0 CA--C 1.54 1.624 0 CA-C-O 119.305 -0.719 . . . . 0.0 113.457 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.7 p -81.35 -38.98 25.81 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 118.405 1.102 . . . . 0.0 110.579 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 60.13 36.38 21.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.174 0.512 . . . . 0.0 111.127 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.0 p -123.74 23.13 8.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.879 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 113.75 152.07 10.77 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 46.4 m-85 -68.0 159.07 31.45 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -75.95 72.98 2.84 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.567 0.699 . . . . 0.0 110.215 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.709 ' HA ' HD12 ' A' ' 166' ' ' ILE . 69.7 p -57.5 -29.1 64.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -66.06 -52.57 47.78 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.853 0.358 . . . . 0.0 110.307 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.9 ttm -60.71 -36.49 78.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.137 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' A' ' 163' ' ' THR . 57.6 mt -63.33 -51.31 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.328 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.95 -36.49 81.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -66.19 -40.5 90.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.805 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 39.3 t -75.94 -35.86 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.417 0.151 . . . . 0.0 110.931 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.32 -52.36 16.96 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.38 -9.96 25.86 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 121.446 1.431 . . . . 0.0 114.504 -173.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.4 mt -102.04 -2.4 29.66 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.19 139.64 26.03 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 118.603 0.638 . . . . 0.0 112.106 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.5 p -98.71 18.6 16.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.508 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.678 HD12 HD11 ' A' ' 147' ' ' ILE . 18.9 mt -95.93 167.18 12.98 Favored Pre-proline 0 C--N 1.348 0.511 0 CA-C-O 119.257 -0.401 . . . . 0.0 110.331 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -71.63 133.59 22.49 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.309 1.339 . . . . 0.0 111.094 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.5 mt -103.71 122.53 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.941 0.4 . . . . 0.0 110.248 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.5 mt -100.59 112.05 32.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.33 174.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.5 132.69 34.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.607 0.242 . . . . 0.0 110.767 -176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 17.7 t -137.7 127.87 26.06 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.367 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.0 130.33 3.97 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 99.0 -18.11 57.25 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.914 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.32 125.89 25.4 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.9 0.85 . . . . 0.0 111.527 -176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -140.75 -32.4 0.15 Allowed Glycine 0 CA--C 1.542 1.721 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.471 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -141.62 168.23 20.25 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 117.997 0.898 . . . . 0.0 110.308 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.414 ' HE1' ' CB ' ' A' ' 215' ' ' GLU . 48.2 mtt -54.93 -34.87 63.61 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -60.74 -33.98 73.73 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.795 0.331 . . . . 0.0 111.319 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -69.13 -34.97 75.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.206 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -63.34 -48.48 77.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.071 0.462 . . . . 0.0 110.604 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.91 -38.84 87.15 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.153 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -62.87 -45.89 90.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.59 -37.69 82.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.923 0.392 . . . . 0.0 111.437 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -65.41 -44.3 87.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.721 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.55 -32.27 71.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.849 0.356 . . . . 0.0 111.292 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.25 -8.25 44.23 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.05 36.19 Favored Glycine 0 CA--C 1.536 1.398 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.256 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.02 146.21 47.8 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 118.314 1.057 . . . . 0.0 109.818 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -94.67 -30.64 14.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.99 155.04 43.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.1 129.79 54.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.971 0.415 . . . . 0.0 110.934 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.75 138.63 40.75 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.841 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.89 133.93 12.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.223 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.543 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.03 -46.34 1.83 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.918 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.4 t -61.44 -47.75 84.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.438 -177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.07 -21.49 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -91.42 -51.06 5.47 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.911 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -59.9 -33.78 72.32 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -93.58 10.0 34.46 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 26.7 mmt85 57.27 48.91 14.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.354 0.525 . . . . 0.0 112.047 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -96.59 -46.05 6.48 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.075 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.43 135.91 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.76 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -80.68 131.75 35.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.912 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.86 50.57 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 112.047 -0.421 . . . . 0.0 112.047 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -57.3 -53.59 56.41 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.414 ' CB ' ' HE1' ' A' ' 186' ' ' MET . 84.8 mt-10 -58.89 -33.46 70.54 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.836 0.35 . . . . 0.0 111.499 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.7 tp -61.91 -45.86 91.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.009 0.433 . . . . 0.0 110.742 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.24 -41.23 98.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.808 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -61.3 -37.11 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.307 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -61.28 -48.66 80.39 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.12 0.486 . . . . 0.0 110.818 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.82 -39.14 93.38 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.168 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -62.58 -43.15 99.52 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.309 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.81 -38.74 82.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.592 0.234 . . . . 0.0 111.514 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -79.32 2.0 23.01 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.19 28.14 68.78 Favored Glycine 0 C--N 1.344 1.021 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.2 t -93.82 116.92 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -154.99 167.67 29.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.44 125.3 54.08 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.364 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -96.56 107.81 20.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.612 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -160.0 -62.29 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.51 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.9 p-80 -136.38 170.09 16.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -102.99 129.45 49.74 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.494 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -138.69 118.97 13.61 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -137.45 154.85 49.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.552 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.495 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.09 12.13 19.91 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.898 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -109.91 135.81 50.19 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.204 1.002 . . . . 0.0 111.414 -176.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 220' ' ' LEU . 45.1 mm -106.49 134.16 48.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.228 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -120.2 131.04 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.98 135.6 49.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.143 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.9 mt -113.07 118.55 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.927 0.394 . . . . 0.0 110.199 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.64 HG21 ' HB1' ' A' ' 17' ' ' ALA . 23.3 t -115.0 107.14 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.738 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -90.35 176.99 6.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.609 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -59.87 -18.36 43.87 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.89 -14.97 60.72 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -112.67 142.87 44.77 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 117.972 0.351 . . . . 0.0 110.212 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.39 150.27 41.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.691 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.682 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.07 -37.41 93.86 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -61.78 -41.01 97.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.804 0.335 . . . . 0.0 110.959 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -63.5 -45.19 91.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 8' ' ' VAL . . . -60.8 -39.51 89.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.356 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.0 t -63.04 -45.16 99.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.324 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.88 -38.56 82.55 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.186 0.517 . . . . 0.0 111.039 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -62.48 -42.21 99.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.001 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.568 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -63.26 -32.0 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.674 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -64.46 -50.68 66.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.701 0.286 . . . . 0.0 111.031 177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -75.29 -56.06 5.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.01 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.6 tp -65.59 -47.05 77.06 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 59.09 65.76 2.61 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.566 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.58 174.12 12.75 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.668 1.578 . . . . 0.0 111.723 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.26 -39.99 9.78 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.103 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.561 ' HB ' HG22 ' A' ' 5' ' ' VAL . 53.9 mt -119.94 140.39 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.958 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.0 t -131.03 122.52 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.9 p -107.38 119.99 40.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.263 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 5.2 ttm -120.64 136.52 54.8 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.026 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -89.05 126.06 35.27 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.59 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.624 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.0 p -56.95 -16.15 6.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.411 0.551 . . . . 0.0 112.419 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 13.6 mtt -114.8 87.06 14.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.15 -25.83 7.24 Favored 'Trans proline' 0 N--CA 1.507 2.315 0 C-N-CA 121.818 1.679 . . . . 0.0 114.125 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -55.21 -23.08 20.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 6.5 mmt -87.24 -1.36 57.85 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.9 m120 60.13 50.72 6.21 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.696 0.76 . . . . 0.0 110.839 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -58.97 -55.07 32.96 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.216 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 44' ' ' ILE . 61.5 mt -64.83 -28.23 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.853 0.327 . . . . 0.0 110.49 -176.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.59 -44.84 95.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.386 0.612 . . . . 0.0 110.367 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.39 -40.29 96.01 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.825 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.917 HG23 HG21 ' A' ' 56' ' ' ILE . 87.5 mt -57.87 -39.08 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 120.942 0.401 . . . . 0.0 110.452 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.48 -41.66 97.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.085 0.469 . . . . 0.0 110.825 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 52.8 mt-10 -61.84 -40.6 95.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.373 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.2 mm -62.23 -42.26 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 120.491 0.186 . . . . 0.0 110.503 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.565 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.53 -42.7 97.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.667 0.27 . . . . 0.0 111.471 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -62.66 -45.04 94.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.492 HD11 ' CG1' ' A' ' 18' ' ' VAL . 57.2 mt -65.5 -47.56 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -146.14 86.9 6.84 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.127 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.9 -19.35 31.45 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 121.581 1.52 . . . . 0.0 113.309 -177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -88.64 9.06 25.5 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.86 153.04 37.05 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 118.149 0.431 . . . . 0.0 110.633 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -93.69 101.03 13.16 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.917 HG21 HG23 ' A' ' 44' ' ' ILE . 20.9 mt -95.97 130.21 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.177 0.513 . . . . 0.0 109.986 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.1 mt -117.62 140.0 42.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.793 HG21 ' HB1' ' A' ' 71' ' ' ALA . 18.9 t -121.86 131.99 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.103 0.478 . . . . 0.0 110.216 -177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.1 t -98.02 116.94 31.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.086 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.1 p -105.8 151.22 24.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.624 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.83 148.08 38.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.182 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 2.2 ptp -57.27 119.16 5.93 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 -0.07 56.13 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.175 -0.792 . . . . 0.0 113.574 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -98.09 77.95 2.48 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 118.37 1.085 . . . . 0.0 110.964 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -63.02 -49.3 75.15 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.834 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.281 -178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.439 ' CE ' HD12 ' A' ' 33' ' ' ILE . 64.9 mtp -63.85 -42.29 97.61 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.014 0.435 . . . . 0.0 110.447 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 t -59.79 -38.65 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.623 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.3 mm -62.58 -46.53 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.859 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -61.0 -41.95 97.51 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.229 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.96 -39.24 88.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.244 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 24.2 mt -65.58 -43.26 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -59.34 -32.82 70.45 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.752 0.31 . . . . 0.0 111.54 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -74.33 -2.68 26.23 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.22 0.21 31.35 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.244 -0.753 . . . . 0.0 112.877 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.85 149.05 50.81 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 118.408 1.104 . . . . 0.0 110.252 176.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -111.93 -31.33 6.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.617 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.92 156.85 21.34 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.72 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.806 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.8 p90 -139.6 150.68 45.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.558 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -107.93 145.84 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.347 0.594 . . . . 0.0 111.957 -168.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.62 156.26 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.298 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.6 t-20 -137.86 -93.89 0.2 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.03 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.514 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.3 m -62.83 -33.94 76.29 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.343 0.52 . . . . 0.0 111.031 -174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.28 -48.8 71.89 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.805 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.09 -37.74 83.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.601 -178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.8 t -67.26 -45.87 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.425 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -62.59 -38.05 88.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 111.432 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -135.56 80.07 45.76 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.385 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.7 -24.61 7.02 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.02 1.814 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.92 -28.48 62.11 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.973 -0.454 . . . . 0.0 111.862 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.5 tp -64.12 -36.35 83.75 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.985 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.534 HD11 ' HB1' ' A' ' 85' ' ' ALA . 48.8 mt -67.28 -44.87 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -177.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.7 m -62.18 -44.16 97.21 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.17 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.07 -43.12 99.45 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.071 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.806 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.9 mt -62.24 -40.36 95.91 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.293 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.579 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.29 -47.19 83.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.72 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -62.02 -39.45 92.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.759 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.37 -54.13 8.25 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -110.47 2.8 19.1 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.08 132.94 7.88 Favored Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.579 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 5.7 m -56.09 -34.64 66.2 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.837 0.351 . . . . 0.0 111.929 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -67.88 -9.41 44.61 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.53 -9.26 32.9 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.0 t -103.04 120.28 52.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 CA-C-N 118.573 0.624 . . . . 0.0 110.24 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.2 t -108.53 127.56 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.731 HG21 HG13 ' A' ' 139' ' ' VAL . 25.6 t -101.24 118.86 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.94 133.98 42.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.674 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.454 HG23 HG13 ' A' ' 119' ' ' VAL . 39.3 mt -127.27 115.76 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.896 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.2 114.05 25.8 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.14 158.47 29.26 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.449 ' HG3' HD12 ' A' ' 152' ' ' ILE . 46.1 mtpt -141.15 164.27 30.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.324 173.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 59.4 mtm-85 -90.71 113.92 26.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.929 0.395 . . . . 0.0 110.174 174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -133.76 134.16 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.611 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t0 57.46 28.99 16.29 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.61 10.05 85.98 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.551 177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -139.51 155.86 47.28 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 117.906 0.853 . . . . 0.0 109.251 177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.04 124.12 27.33 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.126 0.266 . . . . 0.0 110.319 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.5 mtp -124.71 143.4 50.78 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.745 0.307 . . . . 0.0 110.918 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG13 HG23 ' A' ' 108' ' ' ILE . 31.6 t -84.52 139.61 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.776 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -121.05 137.88 54.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.861 174.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.514 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.14 179.65 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.79 52.43 2.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.751 0.786 . . . . 0.0 109.922 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.3 m 60.11 29.6 19.15 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.541 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.48 14.81 80.9 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-O 119.682 -0.51 . . . . 0.0 113.197 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.65 -33.6 23.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 117.844 0.822 . . . . 0.0 112.084 -177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -125.8 137.23 53.77 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.474 -174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -82.02 139.76 34.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.592 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.4 p -94.08 -31.2 14.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.222 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.22 -18.21 56.88 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.879 -175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.36 131.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 CA-C-N 117.72 0.76 . . . . 0.0 109.161 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.7 mt -70.64 143.83 51.31 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.969 0.414 . . . . 0.0 110.109 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.1 tp -61.63 -37.18 83.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.788 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -61.81 -51.68 67.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.761 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -65.8 -38.12 88.12 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.069 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.705 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.7 t-105 -66.46 -40.82 89.61 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.022 -177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 132' ' ' LEU . 47.0 t -61.19 -43.03 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 122.451 -0.155 . . . . 0.0 110.61 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.8 t -62.6 -42.21 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.479 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -62.29 -43.4 98.92 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.132 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG13 HG21 ' A' ' 106' ' ' VAL . 58.8 t -61.62 -40.07 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.787 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -65.9 -49.34 68.38 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.411 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -60.15 -34.78 74.03 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.694 0.283 . . . . 0.0 111.588 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.3 mmt-85 -70.33 -16.22 62.97 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.1 9.87 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.302 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.9 131.86 50.15 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.293 0.546 . . . . 0.0 110.78 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.99 -46.05 92.38 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -150.25 164.86 34.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.949 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.718 HD11 HD12 ' A' ' 175' ' ' LEU . 37.1 mt -127.87 135.2 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.715 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.7 tp -104.56 107.0 17.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 169' ' ' VAL . 35.7 tp -85.54 108.76 18.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.848 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.9 m -112.35 129.05 56.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.752 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.9 t -102.92 109.93 21.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.223 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.5 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -72.98 -35.74 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -63.75 -30.9 71.94 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -95.72 -23.32 17.03 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.49 124.16 17.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.14 -1.07 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.308 -0.718 . . . . 0.0 113.424 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 70.5 p -81.32 -35.81 30.52 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.375 1.087 . . . . 0.0 110.438 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 29.2 tttp 60.75 33.89 20.01 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 61.6 p -117.4 23.06 12.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.891 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 109.51 156.62 16.84 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.678 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.4 m-85 -68.01 156.94 36.24 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -75.8 72.34 2.7 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.608 0.718 . . . . 0.0 110.368 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.512 ' HA ' HD12 ' A' ' 166' ' ' ILE . 74.8 p -56.69 -27.28 58.64 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.148 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -65.39 -53.23 46.22 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.963 0.411 . . . . 0.0 110.208 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.673 ' O ' HG23 ' A' ' 169' ' ' VAL . 51.3 ttm -61.92 -36.56 81.72 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 163' ' ' THR . 87.6 mt -63.26 -51.64 68.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.315 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 66.6 ttp85 -62.47 -36.35 82.2 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.973 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -66.1 -40.61 90.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.721 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 165' ' ' MET . 41.3 t -75.35 -37.06 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.861 -177.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.36 18.33 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.95 -9.89 26.54 Favored 'Trans proline' 0 N--CA 1.507 2.275 0 C-N-CA 121.457 1.438 . . . . 0.0 114.474 -173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.01 -6.4 26.55 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.16 144.23 29.82 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 118.63 0.65 . . . . 0.0 112.258 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.1 p -101.7 18.7 19.71 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.463 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.718 HD12 HD11 ' A' ' 147' ' ' ILE . 74.2 mt -92.52 167.2 15.2 Favored Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.43 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.84 132.64 18.81 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.401 1.4 . . . . 0.0 111.003 173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.04 121.52 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.715 ' HB ' HD12 ' A' ' 148' ' ' LEU . 12.3 mt -99.27 111.33 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.33 174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.95 131.69 35.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.64 0.257 . . . . 0.0 110.711 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 16.2 t -137.05 127.78 27.16 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.68 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.27 3.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 104.34 -19.27 43.16 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.02 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.7 125.07 22.33 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 117.912 0.856 . . . . 0.0 111.736 -175.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -132.32 -32.24 0.45 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.118 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.517 ' HA ' HD11 ' A' ' 211' ' ' ILE . 50.0 mtmt -143.62 173.68 11.44 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.897 0.849 . . . . 0.0 110.573 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.9 mtt -56.4 -39.37 72.9 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.09 -29.24 67.21 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.724 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -70.08 -37.77 75.54 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -62.92 -47.26 84.01 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.7 tp -60.75 -39.44 88.73 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.9 -45.91 90.3 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.49 84.67 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.419 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.82 -44.08 86.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.647 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.49 -32.1 71.1 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.868 0.366 . . . . 0.0 111.234 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.78 41.71 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.06 7.1 36.17 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.181 -0.788 . . . . 0.0 113.258 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.15 145.86 47.81 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 118.376 1.088 . . . . 0.0 109.908 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.47 -27.37 16.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.162 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.11 150.05 34.25 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.32 126.79 54.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.08 138.79 40.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.097 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.46 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.51 137.97 16.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.202 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.506 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.2 1.72 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.048 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 25.0 m -60.96 -45.52 94.41 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.591 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.61 -24.49 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.57 -48.42 6.62 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.095 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.89 -34.7 73.52 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 11.95 31.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 56.46 49.01 15.7 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.179 0.514 . . . . 0.0 112.219 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -94.91 -46.05 7.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.927 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 185' ' ' LYS . 57.5 mt -115.79 141.21 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.556 175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.29 131.46 35.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.234 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.59 52.48 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.41 -51.31 70.47 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -58.69 -36.44 74.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.9 0.381 . . . . 0.0 111.557 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.7 tp -61.75 -45.05 95.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 110.773 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -61.89 -41.33 97.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.771 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.51 -37.5 83.93 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.245 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.95 -48.2 82.92 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.061 0.457 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 4' ' ' ILE . 73.3 mt -62.39 -38.39 89.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.233 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.08 -44.99 95.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.438 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -59.86 -37.29 78.88 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -79.18 0.61 27.67 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 73.59 28.0 66.31 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.726 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.36 121.86 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -136.76 -63.91 0.6 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.572 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.453 ' C ' HD23 ' A' ' 227' ' ' LEU . 6.9 tt -154.12 110.19 3.25 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.574 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -131.09 145.21 51.92 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.366 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -158.33 -54.02 0.07 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -126.91 122.0 33.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.026 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -160.08 112.11 2.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.538 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -124.18 144.29 50.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.502 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -135.17 137.01 42.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.465 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.58 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 225' ' ' VAL . 21.5 ptp . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 119.888 -0.101 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.14 12.13 19.76 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 119.545 -0.586 . . . . 0.0 112.753 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -109.92 135.9 50.06 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 118.005 0.903 . . . . 0.0 111.619 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.462 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -104.87 130.01 56.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.104 176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.83 131.35 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 120.748 0.309 . . . . 0.0 110.196 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.49 133.55 51.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.982 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 52.0 mt -110.95 116.94 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.889 0.376 . . . . 0.0 110.122 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -114.99 104.92 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.83 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 7' ' ' ILE . 1.7 m-20 -92.71 177.06 6.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.541 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -59.77 -18.43 43.24 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.8 -14.99 60.76 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -113.84 138.57 50.12 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 118.042 0.383 . . . . 0.0 110.22 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.63 148.07 49.82 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.783 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -32.98 82.24 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -62.15 -43.38 98.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.944 0.402 . . . . 0.0 110.898 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -63.36 -41.74 98.86 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.84 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.05 -40.98 95.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.389 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' GLY . 46.9 t -62.64 -46.3 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.849 0.357 . . . . 0.0 110.225 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.95 -38.87 83.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.546 . . . . 0.0 111.088 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -62.71 -43.63 98.31 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.079 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 48.2 t80 -62.83 -32.03 73.15 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.515 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -64.62 -50.15 68.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.646 0.26 . . . . 0.0 110.888 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -76.67 -56.0 5.0 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.967 -177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.7 tp -65.89 -47.14 75.8 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 mttt 57.68 65.62 3.33 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.756 -175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.65 174.19 11.42 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 121.563 1.508 . . . . 0.0 111.736 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.7 -36.92 12.09 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.962 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.0 mt -126.82 139.52 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.9 t -129.86 122.82 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.039 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 57' ' ' ILE . 80.5 p -107.77 119.32 39.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.212 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.528 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.3 ttm -122.35 138.85 54.38 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 111.096 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -88.14 128.08 35.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.283 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.94 -5.74 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.63 HG22 ' N ' ' A' ' 61' ' ' ALA . 69.5 p -57.05 -15.7 5.76 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -177.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 ttt -114.83 87.24 14.48 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -54.62 -21.12 23.56 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 121.494 1.463 . . . . 0.0 113.447 -169.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -56.24 -24.07 40.03 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 25.5 ttp -83.11 -5.07 58.97 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -176.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 60.91 53.09 3.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.75 0.786 . . . . 0.0 110.645 -177.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.07 -55.01 33.22 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.23 -175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.721 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -64.0 -27.58 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.839 0.319 . . . . 0.0 110.573 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.64 -45.67 91.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.46 0.648 . . . . 0.0 110.229 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -62.22 -38.22 88.35 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.952 176.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.735 HG23 HG21 ' A' ' 56' ' ' ILE . 86.3 mt -58.51 -38.9 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 120.925 0.393 . . . . 0.0 110.24 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.34 -40.88 95.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.79 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.95 -42.37 99.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.14 -42.67 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.539 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.578 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.28 -42.2 98.24 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.712 0.291 . . . . 0.0 111.474 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -62.81 -45.02 94.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.088 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.2 mt -65.76 -47.42 85.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -146.19 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.062 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.3 -18.7 31.59 Favored 'Trans proline' 0 N--CA 1.506 2.216 0 C-N-CA 121.568 1.512 . . . . 0.0 113.358 -177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.7 9.02 25.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.49 153.02 35.9 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.163 0.438 . . . . 0.0 110.902 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -93.37 104.09 16.27 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -98.29 133.43 40.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.221 0.534 . . . . 0.0 110.117 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 30' ' ' THR . 63.3 mt -119.14 140.29 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.742 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.6 t -121.8 132.55 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.126 0.488 . . . . 0.0 110.274 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.405 ' HB2' HD12 ' A' ' 80' ' ' ILE . 7.9 t -97.97 111.99 24.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.91 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 p -95.74 158.67 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.215 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.63 ' N ' HG22 ' A' ' 34' ' ' THR . . . -77.96 148.05 34.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.054 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 7.0 tpp -58.98 110.89 1.12 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.924 0.392 . . . . 0.0 111.903 -175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.91 12.28 40.64 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 119.438 -0.646 . . . . 0.0 113.301 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -105.59 78.0 1.32 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.152 0.976 . . . . 0.0 111.009 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.94 -46.44 89.31 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.968 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.73 -30.8 71.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.138 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.0 mmt -63.99 -41.07 97.61 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.982 0.42 . . . . 0.0 110.312 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.2 t -59.81 -38.9 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.574 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.46 -47.56 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.775 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.07 -41.23 96.25 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.188 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.742 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.34 -39.33 90.18 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 69' ' ' ILE . 22.3 mt -65.37 -43.5 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.216 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -59.39 -32.61 70.31 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.818 0.342 . . . . 0.0 111.557 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.45 -1.63 24.94 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 1.74 31.58 Favored Glycine 0 CA--C 1.537 1.459 0 CA-C-O 119.265 -0.742 . . . . 0.0 113.01 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.55 146.4 51.83 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 118.297 1.049 . . . . 0.0 110.036 176.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -109.12 -33.34 6.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.484 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.51 162.32 23.71 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.707 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.9 p90 -135.69 161.07 36.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.888 0.375 . . . . 0.0 110.392 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 59' ' ' CYS . 37.1 mt -105.84 136.44 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.327 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.3 m -131.4 153.19 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.386 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.1 t-20 -139.24 -92.57 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.004 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.492 HG23 ' HB ' ' A' ' 121' ' ' THR . 15.7 m -62.95 -34.39 77.38 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.066 0.394 . . . . 0.0 111.248 -173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.36 -50.43 65.62 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.612 0.244 . . . . 0.0 110.642 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.62 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.63 -36.35 78.43 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.629 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 82' ' ' ASN . 27.7 t -67.16 -47.4 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.424 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -62.34 -38.18 88.5 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.481 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -133.51 78.75 61.73 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.439 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -48.64 -25.48 8.0 Favored 'Trans proline' 0 N--CA 1.507 2.288 0 C-N-CA 122.042 1.828 . . . . 0.0 113.814 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.0 t -56.97 -29.29 63.1 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.064 -0.397 . . . . 0.0 111.884 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.2 tp -64.17 -35.87 82.18 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.62 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.5 mt -68.59 -44.81 82.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.5 m -61.87 -44.25 97.2 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.157 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -64.1 -44.5 92.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.001 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.624 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 15.0 mt -63.97 -36.54 84.3 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.159 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.37 -49.52 71.28 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.301 -0.16 . . . . 0.0 110.698 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -64.9 -33.67 76.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.788 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -77.59 -54.11 6.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.37 -1.38 21.63 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.17 129.63 6.52 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.15 -32.79 64.6 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.8 -9.21 42.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.17 -14.12 36.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 t -103.01 118.08 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.44 0.564 . . . . 0.0 110.215 -176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 146' ' ' GLU . 93.2 t -106.44 125.34 62.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.821 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.56 115.2 36.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.1 130.05 44.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.614 HG23 HG13 ' A' ' 119' ' ' VAL . 41.0 mt -124.92 115.82 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.929 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -92.18 113.94 26.34 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.62 155.54 33.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.118 0.485 . . . . 0.0 112.22 -171.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.45 ' HG3' HD12 ' A' ' 152' ' ' ILE . 35.3 mtpt -139.98 162.91 34.07 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.278 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 21.3 mtt85 -88.06 121.07 30.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.26 173.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.9 t -144.42 137.06 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.583 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 57.44 29.03 16.33 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.07 10.02 85.32 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.561 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -141.2 159.48 42.14 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 117.902 0.851 . . . . 0.0 109.324 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -77.93 124.24 27.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.271 0.357 . . . . 0.0 110.346 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.6 mtp -123.96 142.34 51.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.866 0.365 . . . . 0.0 111.138 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 108' ' ' ILE . 32.1 t -83.99 140.23 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.788 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -120.96 138.68 54.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.055 174.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.492 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.8 p -113.52 179.98 3.81 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 63.62 52.25 2.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.641 0.734 . . . . 0.0 109.951 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.1 t 60.13 29.75 19.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.44 14.83 80.92 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.204 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.4 mttm -84.82 -33.48 22.9 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 117.834 0.817 . . . . 0.0 112.039 -177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -126.07 137.68 53.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.888 0.375 . . . . 0.0 111.348 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -81.94 139.67 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.614 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -94.03 -30.82 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.302 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.09 -17.96 57.87 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.877 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.9 mt -69.32 132.88 32.7 Favored 'Isoleucine or valine' 0 C--N 1.346 0.439 0 CA-C-N 117.737 0.769 . . . . 0.0 109.278 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.9 mt -71.18 143.44 50.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.026 0.441 . . . . 0.0 110.241 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.759 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.46 -38.44 87.26 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.958 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' O ' HG23 ' A' ' 137' ' ' VAL . 1.2 mtp-105 -61.84 -49.86 74.57 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -67.32 -38.22 84.58 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.204 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.811 ' O ' HG23 ' A' ' 139' ' ' VAL . 9.2 t-105 -66.71 -42.4 86.44 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.728 -177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 132' ' ' LEU . 45.9 t -60.99 -42.57 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.57 -44.69 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.348 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -62.34 -42.36 99.32 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.743 0.306 . . . . 0.0 111.287 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 106' ' ' VAL . 47.3 t -61.54 -37.6 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.898 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -65.4 -49.94 67.38 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.357 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.01 -32.87 71.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.783 0.325 . . . . 0.0 111.562 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.87 -19.29 65.01 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.08 26.2 9.77 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.133 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.547 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.83 131.82 50.1 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.399 0.599 . . . . 0.0 110.757 177.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.32 -46.54 90.4 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' HB2' HG22 ' A' ' 105' ' ' VAL . 38.8 mt-10 -150.75 167.06 28.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.919 -177.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.77 133.95 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HB ' ' A' ' 178' ' ' ILE . 13.5 tp -104.81 107.1 17.89 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.542 HD21 ' HG2' ' A' ' 165' ' ' MET . 30.9 tp -85.09 108.84 17.85 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.491 0.494 . . . . 0.0 109.743 177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.28 129.11 56.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.68 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.6 t -101.37 109.87 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.237 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' A' ' 111' ' ' LYS . 43.1 mt -72.48 -35.63 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -63.81 -30.62 71.69 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.323 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -98.91 -19.37 17.38 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.22 125.72 23.0 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.23 -1.07 88.8 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 119.275 -0.736 . . . . 0.0 113.444 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.4 p -79.56 -38.35 34.33 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 118.314 1.057 . . . . 0.0 110.593 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 94.1 mttt 60.35 36.4 20.49 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.225 0.536 . . . . 0.0 111.032 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.2 p -122.08 23.17 10.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.683 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 110.37 151.95 13.17 Favored Glycine 0 C--N 1.34 0.792 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 72.6 m-85 -67.84 159.16 30.93 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -75.14 72.75 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.646 0.736 . . . . 0.0 110.092 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.601 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.8 p -56.34 -27.75 56.86 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.237 -175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -65.21 -50.99 63.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.999 0.428 . . . . 0.0 110.274 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.7 ttm -61.56 -36.62 81.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 163' ' ' THR . 82.7 mt -63.49 -51.68 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.34 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -62.31 -35.2 78.33 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.042 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -65.9 -42.56 90.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.671 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 36.1 t -76.24 -35.53 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.006 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.41 -52.23 23.15 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.4 -9.88 26.78 Favored 'Trans proline' 0 N--CA 1.506 2.248 0 C-N-CA 121.437 1.425 . . . . 0.0 114.439 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.1 mt -91.22 -17.77 25.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.22 153.05 40.17 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 120.186 -0.606 . . . . 0.0 112.384 -172.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -104.6 18.78 21.59 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.582 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.84 167.13 23.36 Favored Pre-proline 0 C--N 1.348 0.515 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.506 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.11 129.97 14.78 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.481 1.454 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 76.6 mt -103.78 121.23 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 110.13 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.721 ' HB ' HD12 ' A' ' 148' ' ' LEU . 9.9 mt -101.42 113.25 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.305 175.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.22 132.81 34.22 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.708 0.29 . . . . 0.0 110.844 -175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.2 t -136.71 129.33 30.41 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.305 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 117.66 126.34 3.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.22 -17.21 56.16 Favored Glycine 0 CA--C 1.535 1.295 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.04 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.703 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -62.42 120.4 10.98 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.881 0.84 . . . . 0.0 111.292 -176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.13 -32.33 0.27 Allowed Glycine 0 CA--C 1.54 1.627 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.29 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 45.1 mttm -142.12 167.45 22.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 117.906 0.853 . . . . 0.0 110.4 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.5 mtt -54.45 -34.57 61.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -60.98 -34.17 74.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.775 0.321 . . . . 0.0 111.281 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.4 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 48.9 m170 -69.0 -34.4 75.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.162 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -63.25 -48.41 78.33 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.137 0.494 . . . . 0.0 110.564 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.3 tp -60.88 -39.08 87.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.132 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.005 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.58 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -38.52 86.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.385 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 1' ' ' MET . 23.0 m-85 -65.58 -44.3 87.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.2 mt -60.52 -32.33 71.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.84 0.352 . . . . 0.0 111.271 177.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.81 -7.63 41.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 7.06 36.18 Favored Glycine 0 CA--C 1.537 1.422 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.217 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.54 146.14 48.66 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 118.361 1.081 . . . . 0.0 109.983 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -94.16 -30.19 14.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.942 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -146.75 155.08 42.11 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.041 176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.67 130.8 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.7 140.18 38.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.906 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.532 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -153.78 137.81 16.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.266 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.488 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -49.95 1.7 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.013 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.1 m -61.76 -45.0 95.8 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.467 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.532 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.22 -24.48 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -91.73 -50.7 5.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.036 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -59.88 -33.72 72.2 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -95.6 11.42 33.26 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 -176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 57.0 49.09 14.49 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.197 0.522 . . . . 0.0 112.076 177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -95.81 -46.05 6.73 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.994 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -117.99 140.67 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.656 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -80.37 132.79 35.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.154 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.4 -53.0 49.82 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -59.63 -50.73 72.74 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.35 -36.06 72.87 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.398 . . . . 0.0 111.647 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 23.8 tp -61.97 -45.8 92.08 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.104 0.478 . . . . 0.0 110.758 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -61.67 -40.91 96.63 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.973 178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -61.34 -37.78 84.54 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.266 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -61.09 -48.48 81.49 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.101 0.477 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.462 HD11 HD11 ' A' ' 4' ' ' ILE . 32.7 mt -62.56 -39.03 92.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.216 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -62.73 -44.02 97.29 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -59.83 -37.08 78.2 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.645 0.239 . . . . 0.0 111.645 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -80.12 2.05 25.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.11 28.21 58.79 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.85 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.52 HG13 ' HG3' ' A' ' 1' ' ' MET . 23.7 t -79.98 146.65 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -63.99 125.44 24.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.1 tp -119.07 142.09 48.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.379 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -64.9 146.91 54.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.607 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -65.47 118.33 9.27 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.591 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 55.7 m170 -124.24 145.02 49.62 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.459 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -104.16 130.31 51.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.554 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -160.06 88.73 0.83 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -106.22 -34.56 7.46 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.571 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.629 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HB2' ' CG ' ' A' ' 193' ' ' PHE . 22.6 ptm . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.16 12.07 19.73 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.677 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -109.89 135.85 50.11 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.116 0.958 . . . . 0.0 111.749 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.0 mm -108.89 129.47 63.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.7 t -114.93 133.24 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.35 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.87 133.25 51.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.124 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.2 mt -108.22 115.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.925 0.393 . . . . 0.0 110.161 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.513 HG11 ' HB2' ' A' ' 17' ' ' ALA . 22.9 t -114.94 104.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.829 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -89.8 177.01 6.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.669 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -59.69 -18.09 39.51 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.364 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.78 -14.99 60.77 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.6 m -110.57 141.18 44.12 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.982 0.356 . . . . 0.0 110.147 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -74.89 153.27 38.71 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.722 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.0 -36.77 92.79 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -62.04 -42.22 98.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 110.954 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.32 -44.04 96.08 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.15 -39.76 91.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.292 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.3 t -62.76 -45.49 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 120.819 0.342 . . . . 0.0 110.294 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.06 -39.14 85.0 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.23 0.538 . . . . 0.0 111.012 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -62.31 -42.27 99.22 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.045 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.653 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.3 t80 -62.96 -32.88 74.31 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.665 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.36 -50.0 69.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.707 0.289 . . . . 0.0 111.024 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -76.18 -56.12 4.94 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.017 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.0 tp -67.29 -47.18 71.37 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 mttt 57.93 66.29 2.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.679 -175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.36 174.18 12.55 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.601 1.534 . . . . 0.0 111.769 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.19 -37.19 11.68 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.852 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -124.67 139.48 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.653 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.487 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.9 t -130.99 122.58 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.066 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.416 HG22 ' HB ' ' A' ' 57' ' ' ILE . 72.8 p -106.56 119.95 40.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.256 178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.473 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 ttm -123.65 134.87 53.69 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 -177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -87.32 125.66 34.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.348 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -113.09 3.74 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 61' ' ' ALA . 58.8 p -57.91 -15.1 7.56 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 118.427 0.558 . . . . 0.0 112.482 -176.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.5 mmt -114.87 87.1 14.3 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.34 -24.99 12.83 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 121.741 1.627 . . . . 0.0 113.69 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -55.27 -22.43 18.39 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.1 mtt -92.63 4.5 53.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.14 49.54 9.14 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.578 0.704 . . . . 0.0 111.336 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.29 -50.45 67.49 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.72 -177.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.695 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.4 mt -64.39 -27.81 43.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.41 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -62.66 -44.31 96.58 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.409 0.624 . . . . 0.0 110.235 175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.61 -39.19 90.37 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.005 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 56' ' ' ILE . 83.9 mt -58.6 -40.89 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-O 120.89 0.376 . . . . 0.0 110.255 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -61.27 -39.87 92.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.714 ' OE1' HG21 ' A' ' 18' ' ' VAL . 56.0 mt-10 -62.64 -41.29 98.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.277 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -62.0 -42.13 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.607 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.5 mmt -60.77 -42.1 96.83 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.668 0.27 . . . . 0.0 111.457 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.95 -44.84 94.97 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.02 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.432 HD11 HG13 ' A' ' 18' ' ' VAL . 20.1 mt -64.86 -48.45 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.1 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -146.22 87.11 6.71 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.93 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.57 -18.32 32.02 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.505 1.47 . . . . 0.0 113.424 -177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -88.88 9.07 26.14 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -76.14 153.02 36.55 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.157 0.435 . . . . 0.0 110.645 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -93.58 102.61 14.8 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 44' ' ' ILE . 21.7 mt -96.35 130.65 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.33 0.586 . . . . 0.0 110.039 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 80' ' ' ILE . 64.2 mt -115.96 138.26 46.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.5 t -121.9 133.45 68.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.298 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.561 ' HB2' HD12 ' A' ' 80' ' ' ILE . 17.7 t -99.15 122.67 42.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.024 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 p -106.92 159.34 16.33 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.049 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.527 ' N ' HG22 ' A' ' 34' ' ' THR . . . -89.43 148.08 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 84' ' ' ALA . 11.1 tpt -58.59 120.86 9.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.07 56.19 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.537 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -102.9 77.86 1.61 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 118.446 1.123 . . . . 0.0 110.921 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -63.87 -49.13 73.94 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.679 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.99 -29.21 69.55 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.276 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.4 mmt -64.03 -42.58 97.06 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -60.42 -38.09 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.407 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.78 -48.84 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.977 0.417 . . . . 0.0 110.732 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -61.01 -39.47 89.86 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.72 -39.65 89.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.8 mt -65.74 -43.38 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -59.61 -31.49 69.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.834 0.349 . . . . 0.0 111.528 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -73.52 -4.0 31.2 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.73 31.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 119.272 -0.738 . . . . 0.0 113.006 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.26 145.37 51.38 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 118.311 1.056 . . . . 0.0 110.067 175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -108.4 -33.19 7.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.452 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.88 162.49 23.85 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.69 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 48.1 p90 -132.5 162.1 32.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.385 176.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 59' ' ' CYS . 38.6 mt -105.28 132.95 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.136 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.12 150.05 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.382 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 24.5 t-20 -139.15 -92.55 0.18 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.863 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.493 HG23 ' HB ' ' A' ' 121' ' ' THR . 16.8 m -62.94 -32.98 74.41 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.126 0.421 . . . . 0.0 111.15 -174.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB2' ' SD ' ' A' ' 62' ' ' MET . . . -65.82 -51.46 58.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.665 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.712 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.47 -35.92 77.04 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.548 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -67.37 -47.33 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.614 -0.267 . . . . 0.0 110.368 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.15 -38.55 89.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.56 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -134.78 79.23 53.0 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.507 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.09 -24.89 8.33 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.898 1.732 . . . . 0.0 113.786 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.4 m -56.86 -29.24 62.72 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.08 -0.387 . . . . 0.0 111.855 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 95' ' ' LEU . 8.9 tp -64.4 -35.63 81.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.729 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.712 HD11 ' HB1' ' A' ' 85' ' ' ALA . 40.2 mt -68.41 -45.09 82.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 m -62.44 -44.0 97.47 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.193 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -63.86 -44.65 92.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.006 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.69 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 6.0 mt -64.07 -38.19 90.16 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.207 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.43 -46.4 86.5 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 121.276 -0.169 . . . . 0.0 110.766 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.22 -41.12 98.1 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.627 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 m -74.85 -54.04 8.01 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -107.11 -0.67 22.67 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.35 130.54 6.88 Favored Glycine 0 C--N 1.34 0.775 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.9 p -56.36 -33.02 65.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -67.85 -9.19 42.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.66 -15.45 34.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.603 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 17.6 t -101.78 118.01 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 118.297 0.499 . . . . 0.0 110.211 -176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG22 ' HB2' ' A' ' 146' ' ' GLU . 98.0 t -106.78 124.72 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.782 HG21 HG13 ' A' ' 139' ' ' VAL . 24.6 t -97.51 116.81 40.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.52 130.33 45.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.639 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.581 HG23 HG13 ' A' ' 119' ' ' VAL . 40.2 mt -124.65 115.85 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.911 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -94.0 113.97 26.07 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.8 156.86 30.99 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -171.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.443 ' HG3' HD12 ' A' ' 152' ' ' ILE . 51.0 mtpt -140.55 164.27 30.6 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.386 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -88.85 114.05 25.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.435 173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.18 133.85 57.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.593 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.34 29.08 16.27 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.68 10.05 86.06 Favored Glycine 0 CA--C 1.539 1.576 0 CA-C-O 119.714 -0.492 . . . . 0.0 113.619 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -138.55 156.6 47.35 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.852 0.826 . . . . 0.0 109.366 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.66 123.68 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.193 0.308 . . . . 0.0 110.182 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 mtp -125.32 143.65 50.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.581 HG13 HG23 ' A' ' 108' ' ' ILE . 26.5 t -84.39 140.5 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.86 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.01 137.94 54.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.89 174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.493 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.3 179.55 3.93 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 126' ' ' LYS . 16.8 m-85 63.97 52.28 2.11 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.694 0.759 . . . . 0.0 109.89 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.3 m 60.0 29.83 19.37 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.517 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.42 14.65 81.17 Favored Glycine 0 CA--C 1.539 1.552 0 CA-C-O 119.674 -0.515 . . . . 0.0 113.159 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -82.72 -34.72 27.15 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.801 0.801 . . . . 0.0 112.028 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.406 ' HE2' ' CE2' ' A' ' 122' ' ' TYR . 27.0 ttpt -127.74 138.27 52.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.919 0.39 . . . . 0.0 111.458 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -80.96 140.63 35.12 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.637 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 67.4 p -94.07 -31.28 14.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.172 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.48 -18.0 56.92 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 121.154 -0.546 . . . . 0.0 111.804 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.6 mt -69.9 132.43 33.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 117.743 0.771 . . . . 0.0 109.201 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 131' ' ' LEU . 13.2 mt -71.24 144.35 50.1 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.006 0.431 . . . . 0.0 110.258 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.8 tp -61.58 -38.61 88.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.911 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 137' ' ' VAL . 40.6 mtp180 -61.55 -49.98 74.49 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -67.25 -38.17 84.71 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.228 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.778 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.5 t-105 -67.07 -41.81 85.78 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.93 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.73 -42.34 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.554 0.216 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.56 -44.13 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.357 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.38 -43.06 99.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.782 HG13 HG21 ' A' ' 106' ' ' VAL . 50.7 t -61.15 -38.37 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.882 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 -49.82 66.94 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.463 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -59.95 -33.86 72.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.59 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -68.53 -18.61 64.4 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.15 9.82 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.227 178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.465 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.3 131.81 50.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.321 0.561 . . . . 0.0 110.831 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.63 -45.56 94.28 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.424 ' HB2' HG22 ' A' ' 105' ' ' VAL . 68.4 mt-10 -152.35 167.77 27.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.873 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 175' ' ' LEU . 56.9 mt -129.14 134.41 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.717 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -104.35 107.04 17.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 169' ' ' VAL . 38.0 tp -85.23 108.74 17.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.812 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.8 m -112.78 129.21 56.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.695 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -102.99 109.99 21.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.232 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.443 HD12 ' HG3' ' A' ' 111' ' ' LYS . 44.1 mt -71.91 -35.5 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -64.01 -30.46 71.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.34 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -98.6 -19.65 17.46 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -56.61 125.19 21.11 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.913 0.387 . . . . 0.0 111.94 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.2 1.11 88.52 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 119.332 -0.705 . . . . 0.0 113.351 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.9 p -79.73 -39.09 31.91 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-N 118.353 1.076 . . . . 0.0 110.47 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 50.4 mttp 59.48 34.63 22.62 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.135 0.493 . . . . 0.0 111.289 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.7 p -123.57 23.12 8.97 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.756 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 116.5 148.19 8.95 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.039 -0.825 . . . . 0.0 111.039 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.711 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 43.5 m-85 -68.04 158.77 32.18 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -75.53 73.31 2.55 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.529 0.68 . . . . 0.0 110.407 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.681 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.3 p -56.93 -28.51 62.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.187 -176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -66.27 -53.82 32.23 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.974 0.416 . . . . 0.0 110.203 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.611 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.1 ttm -60.62 -35.94 77.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.185 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.681 HD12 ' HA ' ' A' ' 163' ' ' THR . 59.0 mt -63.58 -51.7 66.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -61.9 -35.32 77.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.965 0.412 . . . . 0.0 111.084 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -66.18 -41.6 90.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.671 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 165' ' ' MET . 38.3 t -75.68 -36.13 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 116.746 -0.207 . . . . 0.0 110.913 -177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -44.71 -52.21 19.02 Favored Pre-proline 0 CA--C 1.557 1.235 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 -10.0 26.59 Favored 'Trans proline' 0 N--CA 1.508 2.347 0 C-N-CA 121.478 1.452 . . . . 0.0 114.458 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.0 mt -98.68 -7.72 27.38 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.21 145.55 30.47 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 118.535 0.607 . . . . 0.0 112.191 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.3 p -102.34 18.91 19.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.538 174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.611 HD12 HD11 ' A' ' 147' ' ' ILE . 82.3 mt -91.8 167.17 15.92 Favored Pre-proline 0 C--N 1.348 0.518 0 CA-C-O 119.407 -0.33 . . . . 0.0 110.461 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.74 129.96 16.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.429 1.419 . . . . 0.0 111.152 172.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.2 mt -102.92 121.39 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.214 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.717 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.6 mt -100.39 112.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.11 132.84 33.72 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.827 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t -137.14 127.48 26.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.329 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.01 128.16 3.63 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.59 -17.27 56.85 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 119.535 -0.592 . . . . 0.0 112.87 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.57 125.68 24.67 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.971 0.885 . . . . 0.0 111.469 -176.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -144.71 -32.37 0.08 OUTLIER Glycine 0 CA--C 1.543 1.789 0 CA-C-O 119.475 -0.625 . . . . 0.0 113.425 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.444 ' HA ' HD11 ' A' ' 211' ' ' ILE . 3.1 mptt -140.05 167.72 21.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.066 0.933 . . . . 0.0 110.206 176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 47.3 mtt -55.21 -34.46 63.94 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.67 -33.38 72.73 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.786 0.326 . . . . 0.0 111.364 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -68.66 -37.28 79.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -62.35 -47.0 86.14 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.052 0.453 . . . . 0.0 110.755 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -61.26 -41.07 96.29 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.138 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -62.46 -43.93 97.62 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.055 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.96 86.41 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.93 0.395 . . . . 0.0 111.375 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.406 ' CG ' ' HB2' ' A' ' 1' ' ' MET . 21.3 m-85 -65.4 -44.07 88.63 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.784 178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.1 mt -60.43 -32.69 71.59 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.45 -8.09 43.73 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 7.01 36.06 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.186 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.74 146.15 48.32 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 118.36 1.08 . . . . 0.0 109.97 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -94.36 -31.02 14.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.16 155.05 43.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.067 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -120.32 130.37 54.41 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.966 0.412 . . . . 0.0 111.064 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -105.32 141.28 37.11 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.947 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -158.47 136.44 10.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -124.98 -45.8 1.86 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.874 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.4 p -61.18 -48.11 83.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.48 HG22 ' HB1' ' A' ' 202' ' ' ALA . 28.1 m -57.94 -22.87 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -91.55 -50.69 5.64 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.998 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.97 -34.53 73.41 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -92.9 9.43 35.46 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 57.33 49.05 13.79 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.265 0.555 . . . . 0.0 111.931 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -95.97 -46.1 6.66 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.037 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.444 HD11 ' HA ' ' A' ' 185' ' ' LYS . 59.9 mt -118.44 137.73 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.796 176.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.53 132.73 35.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.03 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.01 -53.02 49.95 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 -57.37 -53.94 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.63 -34.31 71.03 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.87 0.366 . . . . 0.0 111.569 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.1 tp -61.57 -45.7 93.03 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.083 0.468 . . . . 0.0 110.815 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -61.99 -42.11 98.79 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.951 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.39 -39.09 89.44 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.27 -46.81 88.51 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.203 0.525 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 225' ' ' VAL . 72.7 mt -62.86 -40.15 96.58 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.036 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -61.53 -43.83 98.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.504 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -59.55 -36.13 75.57 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -85.56 7.57 22.57 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.21 28.02 29.15 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.371 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 220' ' ' LEU . 39.9 t -79.89 162.29 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.436 ' N ' HG12 ' A' ' 225' ' ' VAL . 36.2 m120 -52.22 128.15 24.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.9 -178.57 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -151.73 -176.12 5.49 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.382 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -66.08 138.83 58.02 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.454 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -87.5 102.18 14.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.627 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -67.09 -39.73 86.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.545 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -106.54 -178.74 3.73 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.594 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.52 166.34 18.99 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.514 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 74.6 m80 . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.543 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.49 12.29 47.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.389 -0.673 . . . . 0.0 112.745 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -109.85 135.82 50.13 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 118.163 0.982 . . . . 0.0 111.596 -176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.4 mm -108.64 134.53 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -117.37 132.18 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.767 0.317 . . . . 0.0 110.198 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 tp -106.98 133.76 51.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.192 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.7 mt -111.12 113.33 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.79 0.328 . . . . 0.0 110.122 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.0 t -115.08 104.91 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.88 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.33 177.01 8.33 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.698 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -60.12 -18.29 46.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.286 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.88 -14.96 60.72 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.85 140.24 39.99 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 118.004 0.366 . . . . 0.0 110.321 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -74.41 149.11 40.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.694 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.725 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -61.02 -35.77 91.26 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -62.08 -43.11 99.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.892 0.377 . . . . 0.0 110.923 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -63.31 -43.27 98.29 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.4 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.2 -39.55 90.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.374 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 14' ' ' GLY . 44.5 t -62.94 -45.89 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.306 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -60.04 -39.29 85.42 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.236 0.541 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -62.64 -41.89 99.29 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.017 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.641 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.6 t80 -62.85 -32.27 73.46 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.588 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -64.59 -50.96 65.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -75.69 -56.08 5.03 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.937 -176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 tp -65.26 -47.17 77.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.8 mttt 58.08 65.77 3.07 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 174.14 12.8 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.616 1.544 . . . . 0.0 111.651 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.11 -41.01 8.93 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.7 mt -120.01 137.11 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.685 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 ' CD2' ' A' ' 21' ' ' TYR . 23.4 t -130.25 121.71 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -107.0 120.4 41.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.332 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 17.4 ttm -121.38 136.46 54.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -87.56 127.92 35.25 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.224 178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -113.06 -3.43 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 61' ' ' ALA . 65.1 p -56.99 -15.67 5.44 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.413 0.551 . . . . 0.0 112.483 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tpp -114.8 87.03 14.01 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.18 -25.64 7.08 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 121.803 1.668 . . . . 0.0 114.113 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -55.06 -23.37 19.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.7 mmt -87.49 -2.14 58.42 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.8 m120 60.27 52.13 5.09 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.62 0.724 . . . . 0.0 110.919 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.515 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.38 -54.98 33.27 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.05 -176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.712 ' HA ' HD12 ' A' ' 44' ' ' ILE . 65.4 mt -63.85 -28.29 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.809 0.305 . . . . 0.0 110.503 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.57 -44.98 94.98 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.397 0.618 . . . . 0.0 110.278 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.76 -39.48 91.78 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 56' ' ' ILE . 88.3 mt -57.74 -40.64 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -61.73 -41.27 97.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.797 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' OE1' HG21 ' A' ' 18' ' ' VAL . 22.0 mt-10 -62.54 -41.15 98.7 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.279 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.13 -42.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.7 mmt -60.91 -40.92 94.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.736 0.303 . . . . 0.0 111.505 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -62.66 -44.21 96.83 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.172 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.559 HD11 ' CG1' ' A' ' 18' ' ' VAL . 32.9 mt -65.61 -49.8 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.972 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -146.15 87.86 6.5 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.995 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.23 -18.62 30.79 Favored 'Trans proline' 0 N--CA 1.507 2.281 0 C-N-CA 121.598 1.532 . . . . 0.0 113.378 -177.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -87.83 9.08 23.07 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.641 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.01 153.07 38.66 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 118.185 0.448 . . . . 0.0 110.638 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -94.0 100.9 12.95 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.819 HG21 HG23 ' A' ' 44' ' ' ILE . 19.0 mt -95.27 130.53 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 0.0 109.886 -177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -118.07 140.76 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.78 HG21 ' HB1' ' A' ' 71' ' ' ALA . 20.8 t -121.86 132.63 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.246 0.546 . . . . 0.0 110.3 -177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.6 t -98.64 118.59 35.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.922 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -105.83 154.73 20.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.982 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.579 ' N ' HG22 ' A' ' 34' ' ' THR . . . -81.19 148.03 29.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.17 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.3 ttt -59.63 120.39 9.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.858 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.02 -0.03 56.18 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.578 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -103.4 77.92 1.56 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.349 1.074 . . . . 0.0 110.963 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -63.62 -46.94 83.46 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.772 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.66 -31.57 70.8 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.413 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 18.3 mtp -64.07 -41.21 97.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.034 0.445 . . . . 0.0 110.315 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.2 t -59.53 -38.65 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.075 0.464 . . . . 0.0 110.595 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.5 -47.21 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.738 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' HD13 ' A' ' 41' ' ' ILE . 31.5 tp10 -60.98 -41.34 96.23 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.237 -178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.78 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.76 -38.42 85.17 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.28 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 69' ' ' ILE . 21.5 mt -65.19 -43.49 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.227 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -59.6 -32.64 70.58 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.718 0.294 . . . . 0.0 111.522 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -69.79 -8.8 51.31 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 5.6 30.19 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.336 -0.702 . . . . 0.0 112.723 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 146.17 54.61 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 118.313 1.056 . . . . 0.0 110.212 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -111.23 -27.8 8.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.95 152.56 19.44 Favored Glycine 0 C--N 1.343 0.962 0 C-N-CA 121.083 -0.58 . . . . 0.0 111.867 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' CE1' HD22 ' A' ' 95' ' ' LEU . 19.1 p90 -135.83 144.87 45.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.109 0.48 . . . . 0.0 110.767 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.2 mt -107.56 148.76 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.436 0.636 . . . . 0.0 112.097 -168.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 m -136.35 157.01 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.254 171.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.9 t-20 -139.01 -94.09 0.18 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.145 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.57 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.6 m -63.14 -35.05 78.99 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 118.333 0.515 . . . . 0.0 111.061 -174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.62 77.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.855 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -61.12 -38.31 85.88 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.603 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 82' ' ' ASN . 28.7 t -66.4 -47.09 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.315 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -62.54 -37.47 86.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.458 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -135.15 79.99 48.64 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.327 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.42 -24.92 6.75 Favored 'Trans proline' 0 N--CA 1.509 2.408 0 C-N-CA 121.885 1.724 . . . . 0.0 113.941 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -56.95 -29.13 62.9 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.034 -0.416 . . . . 0.0 111.885 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.4 tp -64.82 -34.65 78.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.982 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.461 HD11 ' HB1' ' A' ' 85' ' ' ALA . 57.8 mt -67.89 -46.36 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.8 m -61.91 -43.32 99.09 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.174 -178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -63.22 -44.05 96.39 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.06 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' CE1' ' A' ' 79' ' ' PHE . 19.5 mt -62.81 -38.7 91.74 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.166 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.513 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.56 -48.49 77.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.488 0.185 . . . . 0.0 110.694 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -61.61 -38.64 88.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.712 -177.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.62 -54.01 8.27 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -112.45 7.39 19.05 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -173.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.91 129.97 6.86 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.513 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 67.8 m -56.13 -35.81 67.54 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.862 0.363 . . . . 0.0 111.794 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -67.81 -9.48 44.76 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.61 35.42 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 79' ' ' PHE . 12.2 t -103.08 119.98 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 118.625 0.648 . . . . 0.0 110.204 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 90.4 t -108.44 128.0 64.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.721 HG21 HG13 ' A' ' 139' ' ' VAL . 25.8 t -102.39 117.85 48.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.69 133.94 42.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 119' ' ' VAL . 42.4 mt -127.63 115.93 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.988 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 152' ' ' ILE . 68.7 m-20 -92.83 114.05 26.5 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.02 155.76 33.64 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.58 ' HG3' HD12 ' A' ' 152' ' ' ILE . 26.5 mtpt -140.21 163.81 31.76 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.339 174.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -89.2 121.1 31.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.198 173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.6 t -144.45 137.75 23.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.585 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.7 t0 57.59 29.06 16.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.26 10.16 84.32 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.753 -0.47 . . . . 0.0 113.518 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -141.14 159.05 43.04 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.789 0.794 . . . . 0.0 109.21 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -77.67 124.22 27.67 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.253 0.346 . . . . 0.0 110.361 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.7 mtp -123.55 142.57 50.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.839 0.352 . . . . 0.0 111.01 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 108' ' ' ILE . 35.2 t -84.05 139.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -178.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.95 140.14 52.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.979 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.57 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -115.81 179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 64.15 52.32 2.0 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.559 0.695 . . . . 0.0 109.784 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.1 p 61.25 30.86 19.41 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.363 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.12 9.59 86.7 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.663 -0.52 . . . . 0.0 113.296 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -76.52 -36.58 57.64 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 117.931 0.866 . . . . 0.0 112.14 -176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -125.54 140.53 52.67 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 111.598 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -83.47 139.69 32.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.9 p -94.04 -31.14 14.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.197 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.84 -17.72 57.86 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.005 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.5 mt -69.93 132.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 CA-C-N 117.688 0.744 . . . . 0.0 109.284 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 131' ' ' LEU . 12.6 mt -70.31 143.79 51.92 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 123.384 0.428 . . . . 0.0 110.254 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.776 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.73 -38.49 88.12 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 137' ' ' VAL . 65.7 mtp85 -61.55 -50.3 73.19 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.997 0.427 . . . . 0.0 110.976 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -66.42 -38.1 86.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.183 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.763 ' O ' HG23 ' A' ' 139' ' ' VAL . 10.4 t-105 -67.11 -42.38 84.62 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.721 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.63 -40.84 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.495 0.188 . . . . 0.0 110.519 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.1 t -63.64 -44.63 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.32 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -62.41 -41.94 99.06 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.188 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 135' ' ' TRP . 49.0 t -61.51 -38.76 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.882 -178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -65.65 -50.7 64.03 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.361 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -59.98 -33.17 71.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.781 0.324 . . . . 0.0 111.555 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -67.87 -19.59 65.04 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.14 9.78 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.143 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.93 131.8 48.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 117.289 0.545 . . . . 0.0 110.531 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.14 92.72 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.58 166.89 28.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.997 -177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.577 HD11 HD12 ' A' ' 175' ' ' LEU . 57.6 mt -128.73 134.68 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.837 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.706 HD12 ' HB ' ' A' ' 178' ' ' ILE . 16.6 tp -104.45 106.96 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 169' ' ' VAL . 30.0 tp -85.51 108.79 18.09 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 123.477 0.486 . . . . 0.0 109.88 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 54.2 m -111.72 128.19 56.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.648 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.9 t -100.42 109.89 22.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.338 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 111' ' ' LYS . 33.6 mt -73.25 -35.87 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -177.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -64.4 -30.73 71.77 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.174 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -95.87 -21.6 17.98 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -56.01 122.57 11.91 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.09 1.42 88.61 Favored Glycine 0 CA--C 1.54 1.645 0 CA-C-O 119.395 -0.669 . . . . 0.0 113.478 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.7 p -81.63 -34.86 30.6 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-N 118.319 1.059 . . . . 0.0 110.696 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 60.89 34.55 19.54 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.104 0.478 . . . . 0.0 110.898 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.1 p -118.36 23.07 11.78 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.853 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.404 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 104.17 157.95 24.1 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.707 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 63.3 m-85 -67.92 154.2 42.1 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -74.01 73.45 1.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.536 0.684 . . . . 0.0 110.082 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.668 ' HA ' HD12 ' A' ' 166' ' ' ILE . 72.3 p -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.19 -176.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -65.18 -51.55 60.39 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.97 0.414 . . . . 0.0 110.342 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 169' ' ' VAL . 55.1 ttm -61.83 -35.94 79.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.985 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 163' ' ' THR . 78.8 mt -63.53 -51.81 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.323 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -62.57 -34.19 76.46 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.987 0.422 . . . . 0.0 110.856 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -65.19 -43.15 92.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.574 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 165' ' ' MET . 34.9 t -76.24 -35.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.039 -176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -44.66 -52.25 18.71 Favored Pre-proline 0 CA--C 1.559 1.322 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.75 -9.98 26.52 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 121.426 1.417 . . . . 0.0 114.408 -173.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 70.5 mt -101.02 -4.63 27.09 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.8 t -146.25 143.81 29.45 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 118.601 0.637 . . . . 0.0 112.178 -174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.7 p -101.89 18.42 20.61 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.582 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 147' ' ' ILE . 50.0 mt -92.88 167.14 15.0 Favored Pre-proline 0 C--N 1.348 0.517 0 CA-C-O 119.404 -0.332 . . . . 0.0 110.446 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.1 132.1 20.55 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.355 1.37 . . . . 0.0 111.106 172.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 77.5 mt -104.21 121.77 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.135 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -100.47 111.55 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.321 175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.88 132.2 34.78 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.638 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.8 t -137.6 128.08 26.57 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.531 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.98 127.07 3.49 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.98 -19.36 49.64 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.571 -0.571 . . . . 0.0 113.011 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.707 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -60.91 118.54 6.83 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.814 0.807 . . . . 0.0 111.654 -175.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -128.05 -32.23 0.65 Allowed Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.837 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.465 ' HA ' HD11 ' A' ' 211' ' ' ILE . 97.2 mttt -144.96 167.97 21.36 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 117.635 0.717 . . . . 0.0 110.625 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 46.1 mtt -54.66 -36.04 64.18 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -60.08 -33.64 72.36 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.843 0.354 . . . . 0.0 111.342 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.404 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 46.7 m170 -71.13 -33.33 69.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.339 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.53 -47.66 80.74 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.036 0.446 . . . . 0.0 110.451 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.99 -39.99 91.75 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.069 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -62.53 -45.4 93.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.113 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.93 -38.25 85.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.388 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -65.51 -44.14 87.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.806 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.56 -31.79 70.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.885 0.374 . . . . 0.0 111.254 176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -69.78 -7.55 40.59 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.98 36.28 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-O 119.078 -0.846 . . . . 0.0 113.277 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.25 145.83 47.67 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 118.357 1.079 . . . . 0.0 109.944 174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -95.09 -28.87 14.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.086 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -145.35 153.7 41.52 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.127 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.35 127.12 53.39 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.908 0.385 . . . . 0.0 111.03 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.98 142.44 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.96 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.545 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.4 140.92 18.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.037 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.05 -50.02 1.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.942 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 23.3 m -61.7 -47.34 85.73 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.482 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.5 m -58.09 -23.19 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.7 0.629 . . . . 0.0 112.7 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.22 -49.87 5.96 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.07 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.84 -34.48 73.16 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.1 9.78 36.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 57.07 49.04 14.42 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.372 0.533 . . . . 0.0 112.022 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.24 -46.05 6.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.146 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 185' ' ' LYS . 60.0 mt -116.88 138.03 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.865 176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -80.89 132.36 35.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.117 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.05 -51.68 57.83 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -58.05 -52.91 63.59 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -58.63 -34.61 71.36 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 0.0 111.518 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 25.8 tp -61.86 -45.98 91.42 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.153 0.502 . . . . 0.0 110.732 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -61.73 -40.32 94.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -61.24 -37.93 84.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.71 -46.89 88.65 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.199 0.523 . . . . 0.0 110.857 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.34 -38.9 91.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.193 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -61.85 -44.75 96.21 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.448 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -59.73 -37.1 78.01 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -81.52 3.61 24.26 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.51 28.08 62.18 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 118.343 0.519 . . . . 0.0 112.049 175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.59 125.97 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -84.4 132.18 34.61 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.665 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 227' ' ' LEU . 6.7 mp -82.66 164.94 20.41 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.522 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -64.24 -33.58 76.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -90.7 172.09 8.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.564 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -97.86 161.1 13.91 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.604 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -123.99 170.28 10.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.457 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -130.55 157.12 43.55 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -128.94 133.82 47.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.511 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.498 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptp . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 119.844 -0.122 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.07 12.16 19.94 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.347 -0.696 . . . . 0.0 112.961 -176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -109.9 135.77 50.25 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 118.207 1.003 . . . . 0.0 111.428 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -108.93 132.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.151 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.9 t -117.46 130.5 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 tp -104.03 134.89 46.53 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.163 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 203' ' ' ALA . 53.4 mt -111.6 114.88 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.914 0.388 . . . . 0.0 110.156 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 HG11 ' HB2' ' A' ' 17' ' ' ALA . 23.1 t -115.01 105.31 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.774 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.78 177.05 7.12 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.649 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.4 -17.77 46.23 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.335 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.85 -15.04 60.74 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -110.7 136.39 49.86 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 118.076 0.398 . . . . 0.0 110.286 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -68.37 148.7 50.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.86 -34.64 88.04 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.7 tpp85 -61.98 -42.98 99.74 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.919 0.39 . . . . 0.0 110.842 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.24 -42.97 99.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.825 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.545 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -39.88 91.6 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.418 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' GLY . 47.8 t -62.7 -45.48 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.927 0.394 . . . . 0.0 110.298 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -60.22 -38.7 84.18 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.157 0.503 . . . . 0.0 110.971 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -62.56 -42.49 99.58 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.069 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.644 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 47.9 t80 -62.59 -32.98 74.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.476 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -64.11 -50.3 68.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.7 0.286 . . . . 0.0 111.028 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -76.37 -56.11 4.93 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.988 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp -65.1 -47.15 78.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 mttt 57.78 65.69 3.25 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.692 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.13 174.14 13.3 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.63 1.553 . . . . 0.0 111.748 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.09 -41.41 9.97 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.189 0.519 . . . . 0.0 109.8 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 5' ' ' VAL . 54.8 mt -120.26 141.43 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.749 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 21' ' ' TYR . 21.8 t -131.14 123.14 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.958 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.2 p -107.61 119.08 38.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.204 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' A' ' 43' ' ' ALA . 13.5 ttm -120.17 135.27 55.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.996 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -90.36 122.99 33.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.034 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.689 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.8 pt -113.03 5.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.666 HG22 ' N ' ' A' ' 61' ' ' ALA . 71.9 p -57.05 -16.36 7.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtt -114.77 87.21 14.29 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.52 -20.69 27.72 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.512 1.475 . . . . 0.0 113.374 -170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -57.75 -20.89 38.04 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.498 0.135 . . . . 0.0 110.947 -177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 33.0 ttp -87.27 1.67 52.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.29 49.0 13.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.669 0.747 . . . . 0.0 110.244 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.689 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.26 -51.16 60.49 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.883 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.681 ' HA ' HD12 ' A' ' 44' ' ' ILE . 62.7 mt -63.82 -27.21 42.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.566 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -62.75 -44.78 95.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.455 0.645 . . . . 0.0 110.275 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB3' ' SD ' ' A' ' 31' ' ' MET . . . -61.72 -37.76 85.39 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.037 176.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.799 HG23 HG21 ' A' ' 56' ' ' ILE . 87.2 mt -58.7 -40.0 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 120.934 0.397 . . . . 0.0 110.323 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.1 tttt -61.32 -40.49 94.4 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.837 176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -62.16 -42.5 99.32 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.335 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.97 -41.93 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.57 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -61.03 -42.61 98.8 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.724 0.297 . . . . 0.0 111.426 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -62.71 -44.06 97.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.529 HD11 HG13 ' A' ' 18' ' ' VAL . 20.9 mt -65.03 -49.21 80.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.975 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -146.2 87.56 6.58 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.896 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.01 -18.85 30.0 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 121.579 1.519 . . . . 0.0 113.375 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -88.36 9.0 24.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.644 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.66 153.06 37.43 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 118.174 0.443 . . . . 0.0 110.635 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -93.82 101.3 13.39 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.799 HG21 HG23 ' A' ' 44' ' ' ILE . 23.0 mt -95.82 130.36 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 121.193 0.52 . . . . 0.0 109.993 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.5 mt -116.86 140.84 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.746 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.7 t -121.73 131.97 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.177 0.513 . . . . 0.0 110.244 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.0 t -101.55 113.7 27.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.98 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.7 p -104.05 150.04 24.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' N ' HG22 ' A' ' 34' ' ' THR . . . -70.81 148.09 48.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.158 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 51.3 ttp -59.25 120.42 9.21 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.899 0.381 . . . . 0.0 111.931 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.08 -0.15 56.12 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.471 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -97.89 77.91 2.53 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 118.418 1.109 . . . . 0.0 110.952 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -62.85 -48.22 79.99 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.82 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.45 -29.57 70.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.21 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 8.3 mmt -63.97 -42.15 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.957 0.408 . . . . 0.0 110.385 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.65 -38.87 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 121.125 0.488 . . . . 0.0 110.507 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 72' ' ' ILE . 21.1 mm -62.68 -47.74 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.77 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.06 -40.58 94.19 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.221 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.746 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -60.71 -38.91 86.64 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.183 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 69' ' ' ILE . 18.8 mt -65.26 -43.68 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' HG22 ' A' ' 69' ' ' ILE . 92.6 mttt -59.46 -32.79 70.56 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 111.612 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . . . -71.73 -7.02 45.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.13 3.19 31.51 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-O 119.215 -0.77 . . . . 0.0 112.768 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.77 51.46 Favored 'General case' 0 C--N 1.35 0.599 0 CA-C-N 118.306 1.053 . . . . 0.0 110.216 176.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -110.27 -32.72 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.39 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.16 156.78 21.4 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.788 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.729 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.4 p90 -139.1 152.11 47.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.573 176.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.6 mt -105.32 143.72 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.077 -168.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.5 m -133.23 154.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.082 170.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.514 ' O ' HG23 ' A' ' 86' ' ' VAL . 28.0 t-20 -137.74 -93.62 0.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.002 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.507 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -63.15 -33.6 75.83 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 118.351 0.523 . . . . 0.0 110.889 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.62 -49.38 68.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.656 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.536 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.9 -37.36 81.99 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.57 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.1 t -67.06 -46.72 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.503 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -62.71 -37.76 87.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -134.71 79.61 52.38 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.401 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -48.77 -24.66 7.23 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 121.961 1.774 . . . . 0.0 113.863 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 m -56.91 -28.97 62.6 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.074 -0.391 . . . . 0.0 111.879 -178.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.2 tp -64.28 -35.72 81.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.907 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.536 HD11 ' HB1' ' A' ' 85' ' ' ALA . 50.0 mt -67.87 -45.53 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 m -62.2 -43.76 98.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.134 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -63.03 -43.38 98.86 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.998 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 57.4 mt -62.35 -40.5 96.59 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.215 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.561 ' HB1' ' OG ' ' A' ' 101' ' ' SER . . . -63.18 -47.23 83.51 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.767 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -62.04 -39.17 91.42 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.7 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -74.48 -54.07 8.27 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -112.14 4.98 18.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 101.73 133.2 8.0 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.561 ' OG ' ' HB1' ' A' ' 96' ' ' ALA . 8.0 m -56.21 -34.37 66.23 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -67.8 -9.42 44.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.34 -9.82 34.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.1 119.61 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 118.581 0.628 . . . . 0.0 110.175 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG22 ' HB2' ' A' ' 146' ' ' GLU . 96.3 t -108.31 126.92 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.746 HG21 HG13 ' A' ' 139' ' ' VAL . 25.3 t -100.58 118.19 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.63 132.46 44.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.749 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 119' ' ' VAL . 40.9 mt -127.05 115.91 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.903 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.05 113.97 25.73 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.26 157.75 29.63 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.429 ' HG3' HD12 ' A' ' 152' ' ' ILE . 48.5 mtpt -140.84 164.91 28.96 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.378 173.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -89.59 115.05 26.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.475 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -133.04 132.44 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.536 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 57.3 28.99 16.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.08 85.69 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-O 119.766 -0.463 . . . . 0.0 113.648 177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -136.34 154.86 50.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.872 0.836 . . . . 0.0 109.103 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -76.5 124.26 27.31 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.5 mtp -126.08 143.69 51.01 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.694 0.283 . . . . 0.0 110.97 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 108' ' ' ILE . 28.8 t -84.04 140.06 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.822 -177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -121.04 138.06 54.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.887 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.507 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -113.48 179.75 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 63.87 52.29 2.16 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.655 0.741 . . . . 0.0 109.943 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.5 t 60.04 29.68 19.23 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.534 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.45 14.91 80.81 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.158 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -83.4 -34.57 25.5 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 117.856 0.828 . . . . 0.0 112.027 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -126.82 138.53 53.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 111.504 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -82.0 140.34 34.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.637 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.8 p -94.01 -31.58 14.18 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.221 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.2 -17.93 56.29 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.854 -176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.1 131.89 33.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 117.708 0.754 . . . . 0.0 109.137 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 131' ' ' LEU . 16.0 mt -71.38 144.04 49.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.955 0.407 . . . . 0.0 110.339 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.77 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.6 tp -61.58 -37.42 83.8 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' O ' HG23 ' A' ' 137' ' ' VAL . 35.3 mtp180 -61.83 -50.49 72.07 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.64 -38.13 83.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.123 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.785 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.9 t-105 -66.42 -43.01 86.88 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.783 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.4 t -60.8 -41.86 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.45 0.167 . . . . 0.0 110.564 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.7 t -63.5 -44.31 98.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.338 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -62.34 -41.72 98.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.239 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 135' ' ' TRP . 48.7 t -61.48 -39.2 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.923 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -65.77 -49.76 67.18 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.348 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -59.93 -33.44 71.9 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.775 0.322 . . . . 0.0 111.673 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -68.01 -19.14 64.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.15 26.19 9.72 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.09 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.438 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.3 131.82 49.59 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 117.348 0.574 . . . . 0.0 110.652 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.02 -46.55 91.03 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' HG22 ' A' ' 105' ' ' VAL . 59.1 mt-10 -150.06 166.79 28.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.037 -176.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.513 HD11 HD12 ' A' ' 175' ' ' LEU . 57.0 mt -129.45 134.19 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.712 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.32 107.03 17.69 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 169' ' ' VAL . 36.2 tp -85.45 108.84 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.514 0.509 . . . . 0.0 109.783 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 59.4 m -113.04 129.76 56.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.673 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.0 t -103.68 109.9 21.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.206 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.484 HD13 ' HA3' ' A' ' 124' ' ' GLY . 43.7 mt -72.15 -35.14 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -64.48 -30.77 71.8 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -93.05 -23.93 18.49 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -56.46 125.33 21.55 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.918 0.389 . . . . 0.0 112.02 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.16 -0.77 88.89 Favored Glycine 0 CA--C 1.541 1.666 0 CA-C-O 119.367 -0.685 . . . . 0.0 113.394 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.2 p -80.11 -39.09 30.28 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.317 1.058 . . . . 0.0 110.517 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt 60.14 37.03 21.06 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.192 0.52 . . . . 0.0 111.021 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 63.7 p -125.31 23.14 7.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 112.98 153.32 11.4 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.7 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 52.1 m-85 -67.94 162.24 24.74 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -75.53 72.12 2.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.585 0.707 . . . . 0.0 110.223 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.669 ' HA ' HD12 ' A' ' 166' ' ' ILE . 73.1 p -57.06 -30.29 64.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.107 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -66.33 -52.52 46.33 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.858 0.361 . . . . 0.0 110.169 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.631 ' O ' HG23 ' A' ' 169' ' ' VAL . 56.2 ttm -60.38 -36.43 78.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.209 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 163' ' ' THR . 60.3 mt -63.47 -51.59 68.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.237 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -61.66 -36.22 80.2 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.863 0.363 . . . . 0.0 111.174 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.14 -41.16 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.746 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 165' ' ' MET . 39.4 t -75.16 -36.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.92 -177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -45.06 -52.24 20.58 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -67.21 -9.89 26.71 Favored 'Trans proline' 0 N--CA 1.507 2.283 0 C-N-CA 121.446 1.431 . . . . 0.0 114.5 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.5 mt -93.82 -14.41 26.2 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.0 t -146.18 149.65 34.36 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.442 -172.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 79.5 p -103.13 18.62 21.28 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.651 174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 147' ' ' ILE . 78.1 mt -88.86 167.15 19.15 Favored Pre-proline 0 C--N 1.347 0.49 0 CA-C-O 119.354 -0.355 . . . . 0.0 110.497 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.03 131.73 17.2 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.514 1.476 . . . . 0.0 111.176 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 74.5 mt -104.25 120.46 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.132 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.712 ' HB ' HD12 ' A' ' 148' ' ' LEU . 11.0 mt -99.96 112.2 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.322 174.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -87.86 132.88 34.03 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.87 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.4 t -136.95 127.7 27.2 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.42 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 116.79 130.25 4.44 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.09 -19.22 52.69 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.657 -0.524 . . . . 0.0 112.943 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.7 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.42 125.75 24.89 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 117.751 0.776 . . . . 0.0 111.605 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -139.22 -32.29 0.18 Allowed Glycine 0 CA--C 1.541 1.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.458 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.643 ' HA ' HD11 ' A' ' 211' ' ' ILE . 34.1 mtmt -145.05 170.0 17.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.996 0.898 . . . . 0.0 110.411 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.1 mtt -54.29 -35.55 62.71 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.831 0.348 . . . . 0.0 111.317 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -69.56 -34.18 73.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.219 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -63.39 -48.72 76.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.2 tp -60.92 -39.14 88.26 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.2 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -62.81 -45.47 92.48 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.006 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.472 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -61.02 -39.39 89.57 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.825 0.345 . . . . 0.0 111.445 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -66.03 -43.91 86.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.748 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.69 -31.69 70.94 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 111.247 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.15 -7.13 39.22 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.98 36.09 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.221 177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.9 146.04 48.11 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.392 1.096 . . . . 0.0 110.001 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.85 -27.98 15.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.091 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -148.32 152.67 37.48 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.54 129.78 55.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.984 0.421 . . . . 0.0 111.045 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -103.74 139.94 38.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.003 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -156.06 136.49 13.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.171 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . . . -125.1 -46.08 1.83 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.912 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 21.7 m -61.45 -47.27 86.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.443 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.512 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.8 m -58.28 -22.37 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -91.69 -50.81 5.56 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.904 -0.319 . . . . 0.0 111.052 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -60.08 -33.77 72.53 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -93.53 9.79 35.23 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 57.34 48.99 13.87 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.325 0.511 . . . . 0.0 111.924 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -96.41 -46.06 6.53 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.122 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.643 HD11 ' HA ' ' A' ' 185' ' ' LYS . 61.5 mt -119.9 137.17 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.913 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -81.03 134.06 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.63 -53.12 48.71 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -58.81 -50.89 72.26 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -58.55 -35.82 72.94 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.789 0.328 . . . . 0.0 111.486 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 211' ' ' ILE . 22.3 tp -61.87 -45.39 93.97 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.04 0.448 . . . . 0.0 110.807 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -61.64 -41.93 98.19 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.37 -38.01 85.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.231 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -61.04 -48.26 82.6 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.54 -38.86 91.65 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.144 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -62.33 -44.2 97.05 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.273 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -59.58 -36.52 76.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -83.13 5.65 21.89 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.96 27.99 35.94 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.316 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 25.2 t -79.95 150.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -63.97 153.53 36.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.904 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.29 177.14 5.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.582 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -65.24 174.55 2.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.539 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -65.4 142.6 58.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.667 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -65.46 94.83 0.19 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.62 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -69.02 158.15 35.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.535 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -125.22 165.75 17.72 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -102.49 142.61 33.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.56 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.635 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.05 12.2 19.99 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-O 119.37 -0.683 . . . . 0.0 112.876 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -110.02 135.85 50.2 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.211 1.006 . . . . 0.0 111.299 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.7 mm -108.35 134.21 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.208 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 28' ' ' ILE . 22.0 t -118.85 132.55 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.63 132.3 54.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.289 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -111.67 112.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.073 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.527 HG11 ' HB2' ' A' ' 17' ' ' ALA . 27.8 t -115.0 104.93 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.762 178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -82.8 177.08 8.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -59.65 -18.46 42.06 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.87 -14.98 60.73 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -107.04 144.99 32.9 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.094 0.406 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -76.95 148.55 36.28 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.816 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.89 -34.72 88.5 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 tpp85 -62.07 -42.99 99.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.847 0.356 . . . . 0.0 110.902 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.24 -42.91 99.28 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.09 -40.76 94.96 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.332 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 14' ' ' GLY . 41.5 t -63.14 -45.25 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.841 0.353 . . . . 0.0 110.273 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -59.73 -38.99 83.22 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.226 0.536 . . . . 0.0 110.977 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -62.48 -41.75 99.01 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.061 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.647 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 45.5 t80 -63.12 -33.2 74.94 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.714 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -64.39 -49.95 69.59 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.922 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -76.61 -56.08 4.94 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.946 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.3 tp -67.17 -47.13 71.9 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt 57.99 65.53 3.23 Favored Pre-proline 0 CA--C 1.557 1.25 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.684 -175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.48 174.19 12.59 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.605 1.536 . . . . 0.0 111.832 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.4 -39.96 9.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.877 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.537 ' HB ' HG22 ' A' ' 5' ' ' VAL . 55.1 mt -119.93 137.34 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.631 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.497 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.2 t -131.68 123.34 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.132 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.5 p -107.36 119.63 39.93 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 36.0 tpp -119.73 132.88 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.784 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -85.69 122.07 29.26 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.2 pt -105.79 -1.3 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.2 p -57.58 -14.86 5.9 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.441 0.564 . . . . 0.0 112.46 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.0 mmt -114.81 86.02 12.52 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.57 -23.54 15.06 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 121.624 1.549 . . . . 0.0 113.631 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -53.6 -23.02 9.69 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.2 ptp -99.15 7.4 45.85 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.6 m120 58.41 59.25 3.06 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.637 0.732 . . . . 0.0 111.466 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -60.83 -53.11 47.96 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.7 ' HA ' HD12 ' A' ' 44' ' ' ILE . 66.1 mt -63.86 -26.78 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.573 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.95 -45.15 93.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.412 0.625 . . . . 0.0 110.255 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.74 88.45 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.981 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.827 HG23 HG21 ' A' ' 56' ' ' ILE . 83.5 mt -59.01 -41.35 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.894 0.378 . . . . 0.0 110.225 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -61.04 -39.99 91.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.639 ' OE1' HG21 ' A' ' 18' ' ' VAL . 51.4 mt-10 -61.89 -42.33 98.94 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.312 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.9 mm -62.25 -41.32 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.5 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.609 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.6 mmt -60.85 -42.79 98.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.715 0.293 . . . . 0.0 111.46 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.73 -44.47 96.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.157 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.403 HD11 ' CG1' ' A' ' 18' ' ' VAL . 23.7 mt -65.1 -48.33 84.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.086 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -146.2 87.19 6.7 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.034 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.02 -19.03 30.88 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.553 1.502 . . . . 0.0 113.354 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -88.41 9.07 24.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.9 153.06 36.98 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 118.197 0.453 . . . . 0.0 110.813 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -93.8 102.46 14.59 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.827 HG21 HG23 ' A' ' 44' ' ' ILE . 22.8 mt -96.54 131.13 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 121.351 0.596 . . . . 0.0 110.112 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -116.41 141.73 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.775 HG21 ' HB1' ' A' ' 71' ' ' ALA . 21.8 t -121.85 132.01 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.109 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.501 ' HB2' HD12 ' A' ' 80' ' ' ILE . 8.8 t -100.96 111.99 24.33 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.966 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -102.5 150.36 23.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.05 -175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.627 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . . . -75.57 148.04 39.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.111 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 90.7 mtp -58.05 121.06 9.72 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.06 0.02 56.13 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.628 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.627 ' OE1' ' HB3' ' A' ' 61' ' ' ALA . 63.6 mt-30 -100.08 77.82 2.03 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 118.398 1.099 . . . . 0.0 110.937 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -64.46 -46.93 80.95 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.572 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.11 -30.02 70.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.185 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.2 mtt -64.69 -41.89 95.7 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.889 0.376 . . . . 0.0 110.222 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 t -59.12 -38.29 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.061 0.458 . . . . 0.0 110.672 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.1 mm -63.08 -49.28 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.575 ' HG2' HD13 ' A' ' 41' ' ' ILE . 36.1 tt0 -60.91 -39.17 88.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.2 -178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.775 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.19 -39.96 92.13 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 mt -65.46 -43.54 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.211 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -59.49 -32.06 69.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.742 0.306 . . . . 0.0 111.64 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.41 -2.24 27.68 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.09 31.56 Favored Glycine 0 CA--C 1.538 1.479 0 CA-C-O 119.271 -0.738 . . . . 0.0 112.93 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.23 149.23 48.78 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 110.062 175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -112.13 -32.55 6.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.575 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -133.62 162.25 24.37 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.936 -0.65 . . . . 0.0 111.804 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 50.8 p90 -135.41 162.45 32.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.851 0.358 . . . . 0.0 110.44 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 59' ' ' CYS . 34.1 mt -106.13 137.51 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.515 -172.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 m -132.7 152.43 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.378 171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.533 ' O ' HG23 ' A' ' 86' ' ' VAL . 25.6 t-20 -139.07 -93.31 0.18 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.102 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.519 HG23 ' HB ' ' A' ' 121' ' ' THR . 18.0 m -62.8 -33.54 75.41 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.288 0.495 . . . . 0.0 111.164 -174.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.64 -50.15 66.04 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.717 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.62 -36.26 78.17 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.689 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 82' ' ' ASN . 25.7 t -67.28 -47.17 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.419 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -61.97 -38.0 86.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.682 -0.236 . . . . 0.0 111.517 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -134.15 79.0 57.37 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.57 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -49.22 -25.13 9.15 Favored 'Trans proline' 0 N--CA 1.508 2.327 0 C-N-CA 121.958 1.772 . . . . 0.0 113.749 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.8 m -56.93 -28.52 62.15 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.029 -0.419 . . . . 0.0 111.972 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 tp -63.53 -36.89 85.27 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.651 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.9 mt -68.47 -45.49 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 m -61.84 -42.94 99.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.3 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -64.25 -45.9 86.13 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.994 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.614 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 mt -64.03 -37.21 86.6 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.257 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.5 85.62 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 121.247 -0.181 . . . . 0.0 110.671 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -62.03 -41.09 97.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.607 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 m -75.0 -54.04 7.87 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -106.69 -2.04 22.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.18 130.57 6.79 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -56.25 -32.66 64.71 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -67.72 -9.24 42.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.93 -15.25 34.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 t -101.86 118.05 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 118.317 0.508 . . . . 0.0 110.267 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 146' ' ' GLU . 89.7 t -106.32 124.48 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.795 HG21 HG13 ' A' ' 139' ' ' VAL . 24.7 t -97.46 116.5 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.26 129.93 44.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.537 HG23 HG13 ' A' ' 119' ' ' VAL . 43.1 mt -123.82 115.98 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.851 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -91.87 113.98 26.4 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.86 157.89 31.51 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -171.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -141.79 163.34 33.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.383 174.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -90.79 113.93 26.19 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.17 131.94 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.573 -174.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 57.51 29.66 17.44 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.86 10.08 86.27 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.678 -0.512 . . . . 0.0 113.497 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -139.01 152.88 47.98 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.89 0.845 . . . . 0.0 109.212 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -76.98 123.13 25.89 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.13 0.268 . . . . 0.0 110.377 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.5 mtp -124.13 142.52 51.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.932 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.537 HG13 HG23 ' A' ' 108' ' ' ILE . 33.8 t -84.29 140.43 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -121.08 138.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.795 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.519 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.7 p -113.81 179.41 3.97 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 64.16 52.3 2.0 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.704 0.764 . . . . 0.0 109.839 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.4 t 60.09 29.82 19.35 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.535 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.0 14.9 81.47 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 119.706 -0.497 . . . . 0.0 113.173 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -84.28 -33.84 23.91 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 117.837 0.819 . . . . 0.0 111.961 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -126.12 136.98 53.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.79 0.329 . . . . 0.0 111.379 -174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -80.64 139.31 36.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 p -94.08 -30.02 14.89 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.375 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.08 -17.97 58.3 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.923 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.48 130.58 34.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 117.634 0.717 . . . . 0.0 109.205 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -69.68 142.81 53.31 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.014 0.435 . . . . 0.0 110.345 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 136' ' ' VAL . 8.5 tp -61.64 -37.49 84.22 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.912 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.506 ' O ' HG23 ' A' ' 137' ' ' VAL . 46.2 mtp180 -61.57 -49.7 75.57 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.058 0.456 . . . . 0.0 110.805 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.99 -38.19 79.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.942 -174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.794 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.3 t-105 -66.46 -42.94 86.8 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.736 -178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.2 t -60.81 -42.12 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 120.532 0.206 . . . . 0.0 110.525 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.5 -44.3 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.373 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -62.55 -42.31 99.45 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.196 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.795 HG13 HG21 ' A' ' 106' ' ' VAL . 48.0 t -61.44 -38.16 79.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.888 -177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -65.4 -50.21 66.34 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.33 178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -60.12 -32.55 71.11 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.589 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -68.0 -19.9 64.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.18 26.21 9.69 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.035 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.481 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -62.98 131.83 49.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 117.419 0.61 . . . . 0.0 110.732 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.96 -45.93 92.77 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HB2' HG22 ' A' ' 105' ' ' VAL . 44.3 mt-10 -151.58 167.71 27.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.841 -177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.635 HD11 HD12 ' A' ' 175' ' ' LEU . 57.8 mt -129.05 134.41 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.716 HD12 ' HB ' ' A' ' 178' ' ' ILE . 15.7 tp -104.93 107.0 17.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 169' ' ' VAL . 29.7 tp -84.24 108.82 17.33 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 123.562 0.539 . . . . 0.0 109.657 177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.2 m -111.43 126.43 54.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.418 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t -101.71 109.92 21.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.436 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.443 HD13 ' HA3' ' A' ' 124' ' ' GLY . 44.0 mt -71.81 -34.39 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -62.68 -33.69 75.6 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.943 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -91.15 -25.16 19.71 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -53.87 119.25 4.76 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.926 0.393 . . . . 0.0 111.062 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.15 -1.04 88.91 Favored Glycine 0 CA--C 1.541 1.703 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.459 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.2 p -83.16 -33.44 26.23 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.298 1.049 . . . . 0.0 110.738 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 62.0 mttp 60.83 34.82 19.58 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.113 0.482 . . . . 0.0 110.989 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.0 p -115.02 23.1 12.82 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.743 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.413 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 97.6 163.78 31.62 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.681 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 80.4 m-85 -67.94 156.43 37.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.205 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.98 72.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.5 0.667 . . . . 0.0 110.072 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.641 ' HA ' HD12 ' A' ' 166' ' ' ILE . 47.1 p -55.02 -28.02 48.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -64.99 -51.33 62.29 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.082 0.468 . . . . 0.0 110.277 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 169' ' ' VAL . 52.6 ttm -61.62 -35.75 78.76 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.2 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 163' ' ' THR . 84.3 mt -63.14 -51.89 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.296 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -62.8 -35.72 80.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.962 0.41 . . . . 0.0 111.037 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -65.88 -40.96 92.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.833 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 165' ' ' MET . 41.2 t -75.99 -36.63 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.967 -177.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -45.02 -52.22 20.36 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.02 -9.91 26.71 Favored 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 121.39 1.393 . . . . 0.0 114.37 -173.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -99.64 -6.4 27.31 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.9 t -146.15 143.73 29.5 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 118.569 0.622 . . . . 0.0 112.155 -174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.1 p -101.46 18.7 19.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.516 174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.635 HD12 HD11 ' A' ' 147' ' ' ILE . 35.5 mt -93.69 167.11 14.46 Favored Pre-proline 0 C--N 1.347 0.493 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.529 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.43 131.64 20.7 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.423 1.415 . . . . 0.0 111.134 172.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.7 mt -104.24 120.88 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 110.078 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.716 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.3 mt -100.44 111.63 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.462 175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.14 131.84 34.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.692 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.9 t -138.07 128.87 26.88 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.524 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 119.83 127.3 3.54 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.97 49.73 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-O 119.544 -0.586 . . . . 0.0 112.929 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.681 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.62 116.26 4.61 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.7 0.75 . . . . 0.0 111.515 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -123.95 -32.17 0.88 Allowed Glycine 0 CA--C 1.535 1.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.566 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.493 ' HA ' HD11 ' A' ' 211' ' ' ILE . 25.9 mtmm -144.35 167.31 22.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.439 0.619 . . . . 0.0 110.724 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 55.0 mtt -54.23 -35.87 62.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -60.07 -33.82 72.6 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.835 0.35 . . . . 0.0 111.475 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.413 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 34.0 m170 -71.3 -32.31 68.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.374 -178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.1 -48.43 78.58 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.112 0.482 . . . . 0.0 110.453 177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.2 -39.37 89.97 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.077 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.42 -45.21 94.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 111.126 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.565 ' HB2' ' CD2' ' A' ' 161' ' ' TYR . . . -60.92 -39.26 88.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.872 0.367 . . . . 0.0 111.392 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -65.56 -44.04 87.98 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.79 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.63 -31.99 71.16 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.811 0.338 . . . . 0.0 111.229 177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.01 -7.31 39.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.09 7.13 36.02 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-O 119.039 -0.867 . . . . 0.0 113.165 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.58 145.88 48.76 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.434 1.117 . . . . 0.0 109.913 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -94.22 -28.56 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.085 -178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -147.17 152.76 38.94 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.196 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.94 127.47 54.26 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 110.907 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -104.74 139.77 39.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.863 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 205' ' ' VAL . . . -153.14 135.72 15.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.213 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.01 -49.67 1.71 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.851 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 85.2 p -62.37 -43.68 98.25 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.256 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.654 ' CG2' ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.07 -23.71 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -92.17 -49.98 5.91 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.995 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -59.75 -32.62 70.74 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -100.63 21.11 13.89 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 47.75 49.1 16.94 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 174.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -95.29 -45.93 6.95 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.964 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 185' ' ' LYS . 58.3 mt -118.95 137.08 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.762 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -80.98 132.95 35.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.285 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -59.38 -53.04 49.56 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 111.919 -0.472 . . . . 0.0 111.919 178.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -59.36 -50.54 73.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.719 0.295 . . . . 0.0 111.732 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -58.72 -35.36 72.54 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.827 0.346 . . . . 0.0 111.479 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.9 tp -61.78 -45.4 94.05 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.057 0.455 . . . . 0.0 110.846 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.876 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.18 -36.8 80.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.33 178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -61.08 -48.47 81.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.093 0.473 . . . . 0.0 110.828 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 69.9 mt -62.59 -38.17 89.1 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.203 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -62.27 -45.95 90.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.439 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -59.72 -36.5 76.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -79.22 -1.2 35.29 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.55 28.17 33.47 Favored Glycine 0 C--N 1.344 1.004 0 C-N-CA 120.978 -0.629 . . . . 0.0 111.985 175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 226' ' ' ASN . 25.5 t -79.91 159.8 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.432 ' N ' HG12 ' A' ' 225' ' ' VAL . 76.4 m-20 -59.99 127.76 33.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.797 0.332 . . . . 0.0 111.576 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.655 HD13 ' NE2' ' A' ' 229' ' ' HIS . 58.3 mt -73.07 159.84 32.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.583 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -104.15 32.06 4.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.655 ' NE2' HD13 ' A' ' 227' ' ' LEU . 5.3 p-80 -142.25 32.83 1.52 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.745 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -147.78 162.44 39.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.588 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -91.04 136.81 32.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.549 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -65.15 -35.99 82.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.659 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -95.86 124.63 39.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.648 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.532 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mtm . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.19 12.16 19.61 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 119.54 -0.589 . . . . 0.0 112.788 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -109.84 135.83 50.11 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.02 0.91 . . . . 0.0 111.678 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 220' ' ' LEU . 43.4 mm -106.68 130.17 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.968 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 HG22 ' HB ' ' A' ' 28' ' ' ILE . 21.5 t -116.8 133.0 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.661 0.267 . . . . 0.0 110.315 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.68 132.01 53.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.072 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.57 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 0.0 110.106 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.439 HG13 ' HB ' ' A' ' 12' ' ' THR . 26.2 t -115.0 105.01 17.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.868 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.12 177.14 8.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.627 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -59.56 -18.31 39.76 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.86 -15.07 60.73 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 8' ' ' VAL . 21.2 m -109.17 139.55 43.94 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 117.983 0.356 . . . . 0.0 110.178 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -70.43 145.4 51.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.736 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -60.77 -35.61 90.25 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -61.0 -41.05 95.77 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.985 0.422 . . . . 0.0 110.897 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -63.61 -39.76 95.19 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.622 178.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 8' ' ' VAL . . . -61.07 -40.1 92.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.377 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 14' ' ' GLY . 25.3 t -62.55 -47.44 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 120.975 0.417 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -60.08 -39.49 86.27 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -62.63 -43.07 99.74 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.126 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' OH ' ' HB2' ' A' ' 54' ' ' ALA . 46.7 t80 -63.18 -32.37 73.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.653 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -64.43 -50.48 67.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.732 0.301 . . . . 0.0 110.977 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -76.47 -56.03 4.99 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.872 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.6 tp -65.18 -47.04 78.34 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt 57.71 65.45 3.42 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.766 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.43 174.24 12.89 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.646 1.564 . . . . 0.0 111.825 175.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -94.54 -36.99 11.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.917 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 ' HB ' HG22 ' A' ' 5' ' ' VAL . 39.8 mt -124.75 140.94 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.762 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 21' ' ' TYR . 22.1 t -132.71 124.54 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.109 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.4 p -106.91 118.97 38.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.353 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 42.0 tpp -118.92 132.2 56.08 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.763 -178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -85.04 126.3 33.45 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.192 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG22 ' HA3' ' A' ' 40' ' ' GLY . 6.1 pt -112.95 -2.61 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 61' ' ' ALA . 72.7 p -56.96 -15.97 5.99 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.1 tpt -114.79 87.01 13.96 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -48.6 -25.81 8.34 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.888 1.725 . . . . 0.0 113.963 -174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -55.58 -23.55 27.71 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 tpt -88.22 0.68 55.81 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.7 m120 59.92 53.08 4.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.704 0.764 . . . . 0.0 111.058 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA3' HG22 ' A' ' 33' ' ' ILE . . . -59.83 -54.82 34.35 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.015 -176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.699 ' HA ' HD12 ' A' ' 44' ' ' ILE . 63.9 mt -63.44 -26.65 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.724 -177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -62.89 -46.43 87.89 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.397 0.617 . . . . 0.0 110.213 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -38.39 85.82 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.156 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.763 HG23 HG21 ' A' ' 56' ' ' ILE . 84.1 mt -58.71 -40.42 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 120.825 0.345 . . . . 0.0 110.203 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -60.91 -40.31 92.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.045 0.45 . . . . 0.0 110.89 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.43 -42.08 99.18 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.043 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.84 -42.23 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.601 ' HE3' HD12 ' A' ' 56' ' ' ILE . 4.8 mmt -61.17 -41.75 97.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.705 0.288 . . . . 0.0 111.449 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -62.55 -44.3 96.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.171 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.4 mt -65.42 -49.32 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.005 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -146.16 87.84 6.5 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.979 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.39 -18.34 30.78 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.484 1.456 . . . . 0.0 113.412 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -88.66 9.08 25.44 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB2' ' OH ' ' A' ' 21' ' ' TYR . . . -75.29 153.04 38.14 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 118.162 0.437 . . . . 0.0 110.808 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -93.03 101.03 13.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.763 HG21 HG23 ' A' ' 44' ' ' ILE . 24.1 mt -96.05 132.28 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.15 0.5 . . . . 0.0 110.091 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.0 mt -118.81 141.24 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.764 HG21 ' HB1' ' A' ' 71' ' ' ALA . 19.6 t -121.83 133.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.111 0.481 . . . . 0.0 110.19 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.2 t -98.94 118.38 35.58 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.011 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.4 p -107.97 148.64 29.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.986 -177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' N ' HG22 ' A' ' 34' ' ' THR . . . -75.61 148.02 39.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.121 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -58.48 122.03 12.35 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 112.103 -176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.0 0.04 56.2 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-O 119.224 -0.764 . . . . 0.0 113.477 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -100.16 77.91 2.02 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 118.376 1.088 . . . . 0.0 110.905 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -64.25 -49.98 69.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.679 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.6 70.6 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 13.4 mmt -63.94 -42.73 97.26 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.8 t -56.69 -39.67 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.423 ' HA ' HD12 ' A' ' 72' ' ' ILE . 22.0 mm -62.29 -47.18 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.766 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -60.92 -41.49 96.26 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.199 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.764 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -61.02 -38.74 87.18 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.247 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 69' ' ' ILE . 27.2 mt -65.33 -43.45 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.208 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -59.39 -32.72 70.42 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.874 0.369 . . . . 0.0 111.567 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 41' ' ' ILE . . . -70.72 -7.38 44.38 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.24 4.06 31.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.708 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.14 50.86 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 118.301 1.05 . . . . 0.0 109.97 175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt -110.01 -31.65 7.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.566 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -129.01 157.83 21.76 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.173 -0.537 . . . . 0.0 111.887 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.821 ' CZ ' HD22 ' A' ' 95' ' ' LEU . 19.9 p90 -139.62 151.06 45.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.072 0.463 . . . . 0.0 110.624 176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.0 mt -107.83 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.416 0.626 . . . . 0.0 112.014 -168.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.43 156.13 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.15 171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 27.5 t-20 -138.59 -93.88 0.19 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.975 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 121' ' ' THR . 20.1 m -62.96 -33.63 75.8 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 118.286 0.493 . . . . 0.0 110.93 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.22 -49.24 70.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.737 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 92' ' ' ILE . . . -60.87 -37.57 82.59 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.683 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 82' ' ' ASN . 26.7 t -68.3 -44.84 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.424 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -62.5 -38.33 89.49 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.492 0.187 . . . . 0.0 111.393 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -134.67 79.36 53.29 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.371 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.47 -25.02 6.98 Favored 'Trans proline' 0 N--CA 1.509 2.418 0 C-N-CA 121.962 1.775 . . . . 0.0 113.876 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -56.97 -29.13 62.95 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 122.007 -0.433 . . . . 0.0 111.873 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.3 tp -64.14 -36.28 83.54 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.903 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.582 HD11 ' HB1' ' A' ' 85' ' ' ALA . 58.1 mt -67.75 -44.6 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 m -62.2 -44.18 97.16 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.17 -179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -62.86 -42.67 99.84 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.821 HD22 ' CZ ' ' A' ' 79' ' ' PHE . 29.4 mt -62.25 -41.39 98.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.233 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.69 85.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.839 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -62.13 -38.91 90.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.714 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 m -74.49 -54.06 8.28 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -111.15 3.3 18.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -173.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 102.32 131.71 7.44 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.5 p -56.92 -33.08 66.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.95 -9.29 44.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -93.08 -10.61 35.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 15.9 t -103.05 121.43 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 118.496 0.589 . . . . 0.0 110.282 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 89.6 t -108.93 126.35 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.796 HG21 HG13 ' A' ' 139' ' ' VAL . 23.9 t -100.6 117.89 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -98.76 133.3 43.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.827 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 119' ' ' VAL . 43.6 mt -128.51 115.89 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.004 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -93.65 114.41 26.72 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.07 157.09 30.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HG3' HD12 ' A' ' 152' ' ' ILE . 41.7 mtpt -140.93 163.54 32.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.398 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 -88.97 114.26 25.41 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.006 0.431 . . . . 0.0 110.36 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.1 134.51 55.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.602 -176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.39 29.03 16.25 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.44 10.11 85.74 Favored Glycine 0 CA--C 1.54 1.623 0 CA-C-O 119.668 -0.518 . . . . 0.0 113.575 177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -138.88 156.34 47.37 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.914 0.857 . . . . 0.0 109.355 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -76.45 122.89 25.18 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 mtp -124.12 142.94 50.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.781 0.324 . . . . 0.0 110.851 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 108' ' ' ILE . 27.3 t -84.0 140.21 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.785 -177.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.1 139.35 53.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.888 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.52 ' HB ' HG23 ' A' ' 83' ' ' THR . 11.6 p -114.42 179.83 3.84 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 63.95 52.28 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.627 0.727 . . . . 0.0 109.893 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 75.5 m 59.89 29.64 19.2 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.543 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 152' ' ' ILE . . . 79.59 14.67 80.92 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.277 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -84.6 -33.7 23.31 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 117.884 0.842 . . . . 0.0 112.068 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -125.64 137.66 53.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.881 0.372 . . . . 0.0 111.41 -175.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -81.73 140.54 34.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.695 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 68.2 p -94.02 -30.87 14.49 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.199 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.59 -17.74 57.96 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 121.168 -0.539 . . . . 0.0 111.895 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 77.1 mt -69.91 133.15 32.35 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 CA-C-N 117.684 0.742 . . . . 0.0 109.286 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 131' ' ' LEU . 12.5 mt -71.23 142.82 50.58 Favored 'General case' 0 C--O 1.227 -0.128 0 CA-C-O 121.046 0.45 . . . . 0.0 110.371 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 136' ' ' VAL . 7.9 tp -61.24 -39.62 90.98 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.089 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 137' ' ' VAL . 33.3 mtp180 -61.06 -48.76 80.23 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.055 0.455 . . . . 0.0 110.93 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -68.58 -38.23 80.51 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.13 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.818 ' O ' HG23 ' A' ' 139' ' ' VAL . 12.4 t-105 -66.69 -42.35 86.61 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.714 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 132' ' ' LEU . 46.3 t -60.71 -42.57 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.567 0.223 . . . . 0.0 110.533 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 133' ' ' ARG . 40.2 t -63.23 -44.68 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.375 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -62.34 -42.48 99.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.169 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 135' ' ' TRP . 46.4 t -61.75 -37.26 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.94 -177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -65.53 -50.0 66.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.269 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -60.0 -32.65 71.06 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.814 0.34 . . . . 0.0 111.46 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -67.91 -19.13 64.96 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 26.15 9.77 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.222 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.485 ' CB ' HG12 ' A' ' 139' ' ' VAL . . . -63.98 131.77 48.63 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 117.326 0.563 . . . . 0.0 110.516 176.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -64.42 -47.11 87.72 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -149.82 167.35 26.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.867 -177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.588 HD11 HD12 ' A' ' 175' ' ' LEU . 58.8 mt -129.78 134.93 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 178' ' ' ILE . 14.2 tp -103.61 107.24 18.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.525 HD21 ' HG2' ' A' ' 165' ' ' MET . 33.8 tp -84.91 108.79 17.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.699 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.1 m -112.29 129.08 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.63 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.0 t -102.18 109.82 21.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.245 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.491 HD13 ' HA3' ' A' ' 124' ' ' GLY . 42.2 mt -73.34 -35.02 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -177.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -63.91 -30.66 71.73 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.4 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -102.17 -17.56 15.93 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -56.76 123.74 16.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.051 0.387 . . . . 0.0 111.97 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 85.18 2.44 87.95 Favored Glycine 0 CA--C 1.542 1.723 0 CA-C-O 119.316 -0.714 . . . . 0.0 113.357 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.5 p -80.47 -35.71 34.49 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.331 1.065 . . . . 0.0 110.591 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 60.37 34.94 20.63 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.15 0.5 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 p -121.67 23.09 10.35 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 188' ' ' HIS . . . 111.55 152.05 12.1 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.724 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 44.5 m-85 -67.9 159.36 30.68 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -75.51 72.86 2.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.514 0.673 . . . . 0.0 110.299 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.7 ' HA ' HD12 ' A' ' 166' ' ' ILE . 68.6 p -57.09 -29.17 63.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.183 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -66.24 -52.97 42.54 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.931 0.396 . . . . 0.0 110.18 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.586 ' O ' HG23 ' A' ' 169' ' ' VAL . 57.2 ttm -60.34 -36.34 77.74 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.179 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.7 HD12 ' HA ' ' A' ' 163' ' ' THR . 58.7 mt -63.63 -51.67 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.229 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -62.05 -35.91 80.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.078 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.85 -42.43 90.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.656 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 165' ' ' MET . 37.2 t -76.48 -35.2 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.12 -177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -45.26 -52.3 21.85 Favored Pre-proline 0 CA--C 1.559 1.293 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -67.25 -9.9 26.79 Favored 'Trans proline' 0 N--CA 1.508 2.337 0 C-N-CA 121.387 1.391 . . . . 0.0 114.301 -174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 69.3 mt -91.49 -16.12 27.74 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 4.6 t -146.19 152.99 40.12 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-O 121.366 0.603 . . . . 0.0 112.413 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 80.6 p -97.27 -10.19 26.18 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.077 174.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.588 HD12 HD11 ' A' ' 147' ' ' ILE . 52.3 mt -62.75 167.08 6.28 Favored Pre-proline 0 C--N 1.349 0.58 0 CA-C-N 118.274 0.488 . . . . 0.0 110.845 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.11 135.62 23.24 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.562 1.508 . . . . 0.0 111.376 172.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.36 120.97 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 120.94 0.4 . . . . 0.0 110.003 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.705 ' HB ' HD12 ' A' ' 148' ' ' LEU . 10.8 mt -100.52 111.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.238 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.32 132.61 34.34 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.824 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 21.1 t -137.15 127.82 27.01 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.462 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 120.02 128.99 3.74 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 100.38 -17.71 56.43 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.484 -0.62 . . . . 0.0 112.916 176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.724 ' HB2' ' CZ ' ' A' ' 161' ' ' TYR . . . -61.56 117.08 5.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.914 0.857 . . . . 0.0 111.414 -176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -127.19 -32.21 0.69 Allowed Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.736 179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -146.68 168.03 22.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.534 0.667 . . . . 0.0 110.552 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 11.2 mtp -54.67 -35.67 63.8 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -60.61 -34.17 73.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.403 ' CG ' ' HA2' ' A' ' 160' ' ' GLY . 49.2 m170 -69.91 -32.88 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.297 -177.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.22 -48.74 76.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.069 0.461 . . . . 0.0 110.43 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 16.6 tp -60.84 -38.78 86.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.72 -45.62 91.91 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.056 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.65 -38.42 84.78 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.358 . . . . 0.0 111.357 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -65.22 -44.26 88.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.693 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 83.3 mt -60.44 -32.08 71.04 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.822 0.344 . . . . 0.0 111.285 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -70.24 -6.82 37.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.99 36.35 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 119.152 -0.804 . . . . 0.0 113.197 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -72.39 146.03 47.29 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.314 1.057 . . . . 0.0 109.669 173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.33 -31.53 14.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.816 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -144.51 155.06 43.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.64 129.26 54.5 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.944 0.402 . . . . 0.0 110.915 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.42 43.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.912 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' A' ' 205' ' ' VAL . . . -154.77 133.94 12.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.114 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -125.07 -46.19 1.83 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 65.5 p -62.11 -44.92 95.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' A' ' 202' ' ' ALA . 27.3 m -58.4 -22.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -92.45 -49.43 6.13 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.903 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -59.73 -33.32 71.49 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -99.24 20.12 14.13 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 47.7 49.07 16.85 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -94.27 -46.11 7.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.89 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 57.3 mt -114.5 140.59 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.763 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -81.03 128.46 33.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.305 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -58.65 -50.58 65.73 Favored Glycine 0 CA--C 1.534 1.261 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -57.98 -53.66 55.67 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -58.36 -34.86 71.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.871 0.367 . . . . 0.0 111.602 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.11 -45.77 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.045 0.45 . . . . 0.0 110.783 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.56 -40.94 96.53 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.948 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -61.48 -40.04 93.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.26 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -60.93 -45.5 94.43 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 4' ' ' ILE . 68.0 mt -63.82 -44.88 91.92 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.365 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -66.16 -35.01 79.34 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.649 -0.42 . . . . 0.0 110.521 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -60.54 -38.83 85.72 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.426 0.155 . . . . 0.0 111.405 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -83.69 6.18 21.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 69.86 28.15 72.28 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.42 116.93 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -154.9 -68.25 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.457 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.3 tp -123.23 129.5 51.47 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.341 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -124.84 104.39 8.59 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.5 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -146.13 149.72 34.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.404 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -64.82 -36.03 83.01 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.709 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -102.77 136.08 43.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -137.99 -48.11 0.55 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.719 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.8 m170 -130.69 161.9 30.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' HIS . . . . . . . . . . . . . 81.1 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.612 -179.948 . . . . . . . . 0 0 . 1 stop_ save_